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ABSTRACT 
The presence of DNA modifications is pervasive among both prokaryotic and eukaryotic 
species. In bacteria, the study of DNA methylation has largely been in the context of 
restriction-modification systems, where DNA methylation serves to safeguard the 
chromosome against restriction endonucleases that are intended to cleave invading 
foreign DNA. There has been a growing recognition that the methyltransferase 
component of restriction-modification systems can also function in the regulation of 
gene expression. Outside of restriction modification systems, DNA methylation from 
orphan methyltransferases, which lack cognate restriction endonucleases, have been 
shown to regulate critical cellular processes.  The majority of research articles focuses 
on the epigenetic regulatory roles of bacterial DNA methylation in the context of Gram-
negative bacteria, with particular bias towards Escherichia coli, Caulobacter crescentus, 
and related Proteobacteria. Despite the critical functions of DNA methylation in Gram-
negative bacteria, far less is known about how DNA methylation contributes to 
epigenetic regulation of gene expression in Gram-positive bacteria. In this thesis I 
investigated the effects of DNA modifications in Gram-positive bacteria. I showed that 
DNA methylation from an active Type I restriction-modification system in Streptococcus 
pyogenes also functions in the epigenetic regulation of a small subset of virulence 
genes, all of which are significantly down regulated in the absence of DNA methylation. 
Moreover, I showed that the methylation-dependent decrease in gene expression 
results in attenuated virulence of an S. pyogenes clinical isolate, implicating DNA 
methylation as an important contributor to S. pyogenes pathogenesis. I also 
characterized the methylomes for two strains of the Gram-positive Firmicute Bacillus 
subtilis and demonstrated that DNA methylation regulates the expression of a small 
subset of genes involved in chromosome structure and maintenance. I further identified 
a methylation-sensitive transcriptional regulator, providing some of the first insight into 
the mechanisms of methylation-dependent gene regulation in Gram-positive bacteria. 
Finally, I identified a previously uncharacterized gene, rnhP, which is a plasmid encoded 
	 xi 
RNase HI. I found that RnhP contributes to genome maintenance in B. subtilis NCIB 
3610 by removing RNA-DNA hybrids with four or more ribonucleotides embedded in 
DNA. I showed that RnhP does not contribute to plasmid maintenance or hyper-
replication. Importantly, I showed that RnhP contributes to genome maintenance by 
allowing DNA replication forks to progress through the terminus region. Together, my 
work highlights the importance of DNA modifications and noncanonical nucleotides in 
Gram-positive bacteria and provides a framework for future studies of epigenetic 
regulation by RM systems in bacterial pathogenesis and development.  
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CHAPTER I 
 
A Positive Perspective on DNA Methylation: Regulatory Functions of DNA 
Methylation Outside of Host Defense in Gram-positive Bacteria 
 
 
 
Abstract 
The presence of post-replicative DNA methylation is pervasive among both prokaryotic 
and eukaryotic species. In bacteria, the study of DNA methylation has largely been in 
the context of restriction-modification systems, where DNA methylation serves to 
safeguard the chromosome against restriction endonuclease cleavage of invading 
foreign DNA. There has been a growing recognition that the methyltransferase 
component of restriction-modification systems can also regulate gene expression, with 
important contributions to virulence factor gene expression in bacterial pathogens. 
Outside of restriction-modification systems, DNA methylation from orphan 
methyltransferases, which lack cognate restriction endonucleases, has been shown to 
regulate critical processes, including origin sequestration, DNA mismatch repair, and 
the regulation of gene expression.  The majority of research and review articles focuses 
on the epigenetic regulatory roles of bacterial DNA methylation in the context of Gram-
negative bacteria, with emphasis towards Escherichia coli, Caulobacter crescentus, and 
related Proteobacteria. Here we summarize the epigenetic functions of DNA methylation 
outside of host defense in Gram-positive bacteria, with a focus on the regulatory effects 
of both phase variable methyltransferases and traditional restriction-modification system 
DNA methyltransferases.  
 	
 The contents of this chapter are going to be submitted for publication by Taylor M. Nye, Nicolas Fernandez, and Lyle 
A. Simmons. I wrote the original draft and constructed the figures for the manuscript. LAS, NF, and I edited the 
manuscript. 
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Introduction 
The occurrence of genomic DNA methylation is ubiquitous across all three domains of 
life, where modification events function in diverse and critical cellular processes. In 
eukaryotes, the predominant type of DNA methylation is 5-methylcytosine (m5C) and 
the presence of these modifications is necessary for the regulation of gene expression 
and development (16; 39). In humans, aberrant DNA methylation events are implicated 
in numerous disease states, including cancer (39; 81; 99). In addition to m5C, the 
genomes of bacteria are known to include N4-methycytosine (m4C) and N6-
methyladenine (m6A) modifications [(10) and references there in]. A recent survey of 
prokaryotic genomes demonstrates the widespread occurrence of m5C, m4C, and m6A, 
where at least one type of modification was detected in 93% of the ~230 genomes 
analyzed (10). For all of the prokaryotes included in the study, DNA methylation was 
detected using Pacific Biosciences (PacBio) Single-Molecule Real-Time (SMRT) 
sequencing platform (25). PacBio SMRT sequencing uses inferences from DNA 
polymerase kinetics during sequencing reactions to detect the presence of DNA base 
modifications without a priori knowledge of the presence of genomic methylation or the 
sequence contexts in which modifications occur (25). In the survey, 75% of the 
modifications detected were m6A, which is likely an overrepresentation of m6A relative 
to cytosine methylation because PacBio SMRT sequencing is more robust for detection 
of m6A and m4C modifications but is not well suited for the detection of m5C 
modifications (10; 25). In addition to the Blow et al. study, New England Biolabs (NEB) 
maintains a free database, REBASE, that serves as a repository for bacterial genome 
methylomics results as well as information about predicted MTases, REases, and their 
recognition sites (http://rebase.neb.com). This resource is available to scientists 
interested in understanding if DNA methylation is detected or predicted in a genome of 
interest.  
 
The importance of DNA methylation in bacterial genomes can also be highlighted by the 
diverse processes in which they function, including protection from the invasion of 
foreign DNA (49; 50), phase variation (4; 33), the regulation of DNA replication (31; 64), 
strand discrimination during DNA mismatch repair (5), and the regulation of gene 
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expression (13). The majority of the methylation-dependent processes listed above 
have been extensively studied and reviewed for Gram-negative bacteria (1; 55; 59; 76). 
This bias in study towards Gram-negative bacteria is reflected in the organisms included 
in the survey of prokaryotic DNA methylation, where 57% of the prokaryotes included 
were Gram-negative organisms, 33% were Gram-positive, and 10% were undefined or 
belonged to the domain Archaea (10) (Fig 1.1). Gram-positive bacteria include 
members of the high GC content phylum Actinobacteria and the low GC content 
Firmicutes, accounting for 6.6% and 26.3% of surveyed genomes, respectively (10) (Fig 
1.1). Actinobacteria include the genus Streptomyces, which are responsible for the 
production of two thirds of clinically relevant antibiotics, while Firmicutes include several 
important human pathogens from the genera Staphylococcus, Streptococcus, 
Enterococcus, and Clostridia. Despite the importance of Gram-positive bacteria to 
human health and industry, the functions of DNA methylation outside of host defense 
have been understudied (Fig 1.2). Here we summarize the current knowledge of the 
presence and known biological functions of DNA methylation in Gram-positive bacteria 
with the goal of opening new and important areas of study within this important field. 
 
DNA Methyltransferases: Origins in orphan methyltransferases and host defense 
systems. Enzymes called DNA methyltransferases (MTases) catalyze post-replicative 
modifications in DNA by transferring a methyl group from the donor S-
adenosylmethionine (SAM) to adenine or cytosine bases in DNA (40). DNA MTases can 
function as part of a host defense system, such as the well-studied restriction-
modification (RM) systems and the newly discovered bacterial exclusion (BREX) 
systems, or as stand-alone “orphan” MTases (Fig 1.3). RM systems are minimally 
comprised of an MTase component and a restriction endonuclease (REase) partner. 
RM systems are hypothesized to predominately function as bacterial defense systems 
against the invasion of foreign DNA, however they have also been shown to function in 
phase variation and the regulation of gene expression(23). Similar to RM systems, 
BREX systems also function as bacterial defense systems and use DNA methylation to 
distinguish between self and foreign DNA (8; 28). However, as opposed to the cleavage 
of foreign DNA observed in RM systems, BREX systems function by blocking replication 
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of phage DNA (8; 28). Orphan MTases, as the name suggests, only have MTase 
activity and orphan MTases contribute to a variety of DNA processes, including DNA 
mismatch repair, origin sequestration, and the regulation of gene expression with the 
majority of orphan MTase characterization occurring in Gram-negative bacteria (1; 55; 
59; 76). 
 
Regulatory functions of methylation from orphan MTases. Orphan Mtases are 
hypothesized to be the products of RM systems that have lost their REase component 
(79) (Fig 1.3). The most well studied orphan MTases are Dam and CcrM from Gram-
negative Escherichia coli and Caulobacter crescentus, respectively. Dam methylates 
GATC sites throughout the E. coli genome and functions in origin sequestration, strand 
discrimination during DNA mismatch repair, and the regulation of gene expression (1; 
54; 76). CcrM methylates GANTC sites and regulates cell cycle progression in C. 
crescentus (53; 59). While CcrM homologs are only conserved through α-
Proteobacteria, Dam homologs are conserved throughout Proteobacteria and even 
occur in several strains of Gram-positive bacteria (54; 59). Notably, in many Gram-
positive systems the Dam homolog is typically paired with a cognate endonuclease as 
part of an active Type II RM system as in Streptococcus mutans, a dental pathogen (6).  
 
The Blow et al. survey of DNA methylation in prokaryotic genomes identified 165 
candidate orphan MTases, a subset of which were identified in the Gram-positive 
genera Clostridia, Nocardia, and Arthrobacter. In agreement with previous studies, the 
authors found that orphan MTases tend to be far more conserved than MTases that 
belong to an RM system, with 57% and 9% conservation at the genus level, respectively 
(10; 79). A candidate orphan MTase from two Arthrobacter species, which are Gram-
positive bacteria belonging to the Actinobacteria phylum, was also conserved in 93% 
(39/42) of the available Arthrobacter genome sequences for which PacBio SMRT 
sequencing data does not exist. The strong conservation of this orphan MTase in 
Arthrobacter highlights the potential biological significance to this genus (10). For both 
Arthrobacter and Nocardia species, another Gram-positive Actinobacteria, the 
recognition site for the candidate orphan MTase was enriched in the putative origin of 
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replication (10). Recognition sites for Dam MTase are also enriched in the E. coli origin, 
where they function in origin sequestration during DNA replication initiation, suggesting 
that the orphan MTases from Arthrobacter and Nocardia species may also contribute to 
the regulation of origin firing (31; 64).  
 
It is worth noting that both Arthrobacter and Nocardia species also have conserved 
unmethylated recognition sites upstream of putative transcriptional regulators. In 
Nocardia, unmethylated recognition motifs from the orphan MTase are enriched up to 
20-fold in regions upstream of transcriptional regulators (10). In E. coli, although the 
majority (99.9%) of Dam recognition sites are fully methylated, there is a small subset of 
unmethylated sites on both strands of DNA that have important functions in gene 
regulation (10; 33; 94). The presence and conservation of unmethylated motifs suggests 
that the orphan MTases from Arthrobacter and Nocardia may also function in the 
regulation of gene expression.  
 
A Type II RM system MTase lacking a cognate endonuclease has also been identified 
across 36 clinical isolates of the Gram-positive pathogen Clostridioides difficile. Oliveira 
et al. identified the CamA MTase, which methylates CAAAAA motifs at an average of 
7,721 sites across Clostridioides difficile genomes (67). Unlike the enrichment of 
recognition motifs for the putative orphan MTase observed in the origin of Arthrobacter 
species, CamA recognition motifs were not enriched in the origin but were present 
upstream of genes involved in transcriptional regulation, cell wall protein production, 
membrane transport, and sporulation (67). Consistent with a regulatory role for CamA-
dependent methylation, deletion of camA resulted in global transcriptome changes and 
defects in both sporulation and in animal models for colonization and infection (67). It is 
worth noting that, unlike the conservation of the putative orphan MTases across the 
genera Arthrobacter and Nocardia, CamA is not well conserved across Clostridiales and 
is instead fairly unique to C. difficile (67). As a direct role in host defense has not been 
tested we cannot exclude the possibility that CamA functions both as part of a host 
defense system and in the regulation of gene expression. Given the important roles of 
orphan MTases in Gram-negative bacteria, and the conservation of orphan MTases in 
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Gram-positive bacteria, more studies are needed to understand the contributions of 
orphan MTases to the regulation of gene expression and chromosome dynamics in 
Gram-positive bacteria. 
 
DNA methylation from BREX defense systems. Relative to the study of orphan 
MTases and RM systems, the discovery of the BREX family of defense systems is new. 
The term BREX (bacterial exclusion) was coined in a 2015 paper characterizing the 
system from Bacillus cereus, a Gram-positive Firmicute (8; 28). BREX systems were 
identified based on conservation of a putative alkaline phosphatase gene, plgZ, which is 
commonly found on genomic defense islands surrounded by 4-8 conserved BREX 
systems genes (28). The majority of putative systems identified contain six genes, 
which include pglZ, the putative alkaline phosphatase, plgX, which contains a 
methyltransferase domain, a gene encoding a Lon-like protease domain, a putative 
RNA binding protein, a gene of unknown function, and a gene containing an ATP 
binding motif (28). A previous study in the Gram-positive Actinobacteria Streptomyces 
coelicolor showed that the pgl gene, along with three surrounding genes, conferred 
resistance to phage infection following an initial round of infection (17; 87). In the 
Goldfarb et al. study researchers found that the six-gene BREX system from B. cereus 
was sufficient to provide protection from both temperate and virulent phages when 
expressed in B. subtilis (28). The PglX protein, containing the MTase domain, was 
found to catalyze the formation of m6A at TAGGAG sites throughout the host 
chromosome (Fig 1.3). While the MTase activity is necessary to confer protection 
against the invasion of foreign DNA, in the B. cereus system there is no decrease in cell 
viability in the absence of the MTase or observable cleavage of foreign DNA, 
suggesting that BREX systems do not achieve protection through the cleavage 
mechanism of a canonical RM system (28). Further, although the mechanism(s) of 
protection remain unclear, it is evident that BREX systems allow for adsorption of phage 
but not replication of phage DNA. Of the 1,500 bacterial genomes surveyed in Goldfarb 
et al., 10% contained a putative BREX system across both Gram-positive and Gram-
negative bacteria (28). More work will be necessary to understand the mechanism(s) of 
BREX defense systems and to determine if DNA methylation from BREX MTases has 
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additional regulatory roles outside of conferring protection to the host by blocking phage 
replication (Fig 1.2).   
 
DNA methylation from RM systems. While MTases from RM systems methylate the 
bacterial chromosome subsequent to replication, invading double-stranded foreign DNA 
from phages often enters the cell unmethylated at these recognition sites, which allows 
for cleavage of the foreign DNA by the cognate REase activity. There are several 
different types of RM systems that vary in subunit composition, cofactor requirement, 
recognition site, and cleavage pattern that are reviewed extensively elsewhere (23; 74; 
96). Types I-III all have MTase and REase activities and are reviewed briefly here while 
Type IV systems, which lack MTase activity and instead cleave methylated DNA, are 
not discussed further and are reviewed elsewhere (50).  
 
Type I RM systems consist of hsdM, hsdS, and hsdR genes which encode the MTase, 
specificity, and REase subunits, respectively (23; 61). The specificity subunit is 
composed of two target recognition domains that recognize specific bipartite recognition 
sites in the DNA (Fig 1.3) (26; 61; 62). The bipartite recognition sites, which are 
characteristic of Type I RM systems, consist of conserved DNA sequences at the 5' and 
3' ends with 6-8 base pairs of degenerate sequence in the middle (61). Methylation is 
achieved at hemi-methylated bipartite motifs through the complex of two MTase 
subunits and one specificity subunit, resulting in methylation of both DNA strands (88; 
89). Restriction activity requires complex formation of two MTase subunits, two REase 
subunits, and one specificity subunit. The REase complex recognizes fully 
unmethylated bipartite recognition sequences and collision of the complex with a DNA 
binding protein is required for cleavage events, which can occur several kilobases away 
from the original recognition site (22).  
 
Type II RM systems are most commonly used for biotechnology applications and 
typically consist of stand-alone MTase and REase genes. A notable exception is the 
Type IIG family, which consists of a single polypeptide with both MTase and REase 
activities (70; 74). Type II REase enzymes, which bind to and cleave unmethylated DNA 
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independent of the MTase, are incredibly diverse and exhibit very low sequence identity 
(70). The Type II systems generally have 4-8 base pair palindromic recognition motifs, 
methylate both DNA strands, and cleave unmethyated sites within or near the 
recognition site (Fig 1.3)(70). The defined cleavage within the recognition sites from 
REases of Type II RM systems as well as the independent activities of the MTase and 
REase proteins make them well-suited for applications in biotechnology (70).  
 
Type III systems are comprised of mod and res genes that encode components for the 
MTase and REase activities (73).  The complex of two Mod subunits is necessary to 
bind and methylate one strand of DNA at 5-6 base pair non-palindromic motifs (Fig 
1.3)(11; 73). Restriction activity requires the complex of one or two Res subunits with 
two Mod subunits, because the DNA binding activity is intrinsic to the Mod subunits and 
not the Res subunit (36). Cleavage by the REase complex requires two recognition 
motifs oriented in opposite directions that results in cleavage 25-27 base pairs 
downstream of the recognition site (30; 57; 69; 73).  
 
Type I-III RM systems are present across Gram-positive bacteria as a means of 
protection against the invasion of foreign DNA. Oftentimes, RM systems act as a barrier 
for horizontal gene transfer among closely related bacteria, resulting in clade separation 
among important pathogens (35; 93). Some Gram-positive species have overcome the 
restriction barrier to allow for the acquisition of pathogenicity islands in similar strains 
while maintaining the RM system for protection from phage predation (37; 38). In 
addition to DNA restriction, these systems also provide underappreciated roles in the 
regulation of gene expression and virulence potential of Gram-positive pathogens (48; 
51; 65). Below, we review the functions of RM system methylation outside of protection 
from phage predation in Gram-positive bacteria. 
 
Balancing host protection and the benefits of genetic transformation.  In addition 
to host defense, Type I RM systems have been shown to regulate strain separation in 
Gram-positive bacteria. Enterococcus faecium isolates are separated into clades, where 
clade A consists of multi-drug resistant isolates and clade B consists of drug susceptible 
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fecal commensals (44). Clade A is further separated into subclades A1 and A2. 
Subclade A1 isolates are associated with hospital acquired infections and have a larger 
genome size and higher mutation rate relative to subclade A2 (44). Hou et al. identified 
multiple putative Type I RM systems across clades A and B and showed that the MTase 
and REase components of a Type I RM system shared greater than 90% sequence 
identity between these subunits in subclade A1 and clade B strains (35). However, 
subclades A1 and B showed high variability in their S subunits, which are required for 
DNA recognition and binding (35). The S subunits were highly conserved between 
strains from subclade A1 but appeared to be strain-specific across clade B. The authors 
speculate that the divergence in S subunits and subsequent methylation patterns 
between the subclades act as a barrier to horizontal gene transfer between members of 
different clades (35). Type I systems in the human pathogen Staphylococcus aureus 
also mediate horizontal gene transfer by restricting exchange from strains possessing 
variable S subunits (93). 
 
While the E. faecium and S. aureus RM systems function to prevent horizontal gene 
transfer from between clades, other Gram-positive RM systems restrict phage DNA 
while maintaining mechanisms for acquisition of pathogenicity islands from related 
strains.  Strains of the Gram-positive pathogen Streptococcus pneumoniae typically 
encode one of two Type II RM systems, DpnI or DpnII, which cleave at palindromic 
GATC sites throughout the genome (42). DpnI represents an atypical system because it 
cleaves fully methylated sites while DpnII cleaves at fully unmethylated sites. Strains 
with DpnII encode two upstream DNA MTases, a Dam homolog, DpnM, and a single-
stranded DNA MTase, DpnA (14).  
 
The occurrence of both RM systems across strains serves a mixed S. pneumoniae 
population in two ways.  First, the occurrence of both systems protects against a broad 
range of phage predation, allowing for degradation of DNA independent of the 
methylation status at GATC sites. Second, the mixed population promotes preferential 
acquisition of DNA from kin. DpnI cells can acquire methylated genomic DNA from 
DpnII cells because the newly acquired DNA will exist in a hemi-methylated state that 
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DpnI cannot cleave (37; 38). Conversely, uptake of DpnI DNA in DpnII cells would also 
result in hemi-methylated DNA. If the newly acquired hemi-methylated DNA is not 
methylated prior to replication, the DNA will exist in a complete unmethylated state and 
can be cleaved by DpnII.  Cleavage of unmethylated DNA in DpnII cells is prevented via 
methylation of the new DNA from the unique single-stranded DNA MTase DpnA. DpnA 
is only expressed during genetic competence ensuring that the DpnII RM system 
remains active against incoming phage DNA but allows for the acquisition of beneficial 
pathogenicity islands from related DpnI strains (37; 38).  
 
Therefore, in addition to protecting against phage predation, RM systems function as 
barriers to horizontal gene transfer to maintain strain separation in Gram-positive 
bacteria such as E. faecium and S. aureus. Conversely, other Gram-positive species 
have adapted special mechanisms that use DNA methylation to acquire beneficial DNA 
(e.g. pathogenicity islands) while maintaining restriction activity to protect against phage 
predation. In the next sections we will review how RM system methylation functions in 
epigenetic regulation in bacteria. 
 
Phasevarions: Epigenetic regulation by RM system MTases. Bacteria must have 
the ability to adapt to rapidly changing environmental conditions in order to survive. One 
mechanism bacteria use to cope with rapidly changing conditions is through phase 
variation. Phase variation occurs when certain genes, often those that encode cell 
surface proteins, undergo random differential expression in a reversible fashion among 
bacterial subpopulations (32; 68). This variation can be achieved through the presence 
of simple sequence repeats within genes (e.g. tandem repeats or homopolymer runs), 
where DNA polymerase is prone to errors that can result in non-functional or non-
expressed proteins, subsequently resulting in ON/OFF expression of the gene product 
within a subpopulation of cells (60; 68; 92). The variation in expression can also occur 
as a result of genetic exchange of differentially expressed loci through homologous 
recombination, which typically occurs at inverted repeats within the exchanged loci (68). 
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Phasevarions (phase variable regulons) consist of multiple genes that are differentially 
regulated within various subpopulations based on epigenetic control from phase-
variable MTases (86). In Gram-positive organisms, MTases from both Type I and Type 
III RM systems have been shown or predicted to be regulators of phasevarions (for 
review (4; 20). In Type I systems, homologous recombination occurs at inverted repeats 
within the genes for multiple specificity subunits to generate unique methylation patterns 
throughout the genome (Fig 1.4A) (19; 24; 48; 51). The subspecies specific methylation 
patterns act as an epigenetic signal that gives rise to differential gene expression and 
subsequent phenotypic differences between the subpopulations (48; 51). In Type I and 
Type III RM systems, variation in simple sequence repeats can result in DNA 
polymerase errors that give rise to subpopulations with active and inactive MTases, 
resulting in loss of methylation and subsequent differential gene expression (Fig 1.4B) 
(for review (83) and (2; 3). This mechanism allows for gene expression heterogeneity 
within a population of cells.  
 
Regulation from S subunit variation in Type I RM systems. In the Gram-positive 
pathogen Streptococcus pneumoniae Type I phasevarions have been shown to regulate 
virulence via global epigenetic changes (48; 51). In one system, three separate 
specificity subunit genes containing inverted repeats allow for six possible specificity 
subunit variants (Fig 1.5) (51). Manso et al. “locked” the strains into one epigenetic 
state by expressing only one of the six specificity subunits and then used PacBio SMRT 
sequencing to show that each variant methylated different motifs, with the frequency of 
the various motifs differing within the genome (Fig 1.5) (51). The locked strains showed 
differential gene expression relative to one another that resulted in phenotypic 
consequences. Most notably, the different subtypes varied in colony opacity, which is a 
reversible morphological change between opaque and transparent colonies (Weiser, 
Infect Immun, 1994). While some variants were 100% opaque others were as low as 
7% opaque colonies (Fig 1.5). The colony opacity phenotypes correlated with invasive 
disease and carriage phenotypes, where a variant with 100% opaque colonies had poor 
colonization ability but was highly virulent and the variant with the majority of 
transparent colonies was greatly attenuated for virulence but not colonization (51; 95). 
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Moreover, the authors showed variant switching with the “unlocked” wild type strain 
during the course of invasive disease infection, where the cells had predominately 
switched to the highly virulent state with reduced colonization as early as 4 hours post-
challenge (51). 
 
A similar Type I RM system encoding two specificity subunits with inverted repeats has 
been shown to produce four specificity subunit variants in S. suis, a major veterinary 
pathogen, though no differential expression has been associated with the variants to 
date (3). In fact, an analysis of 393 S. suis genomes identified that 262 strains 
contained Type I RM systems with multiple hsdS specificity subunits containing inverted 
repeats, suggesting that the occurrence of phase variable Type I RM systems may be 
pervasive across this species (3).  Additionally, the presence of phase variable Type I 
RM systems have been predicted or identified in strains of Enterococcus faecalis, 
Listeria monocytogenes, Clostridium botulinum, and Lactobacillus salivarus (19; 20; 24). 
More work needs to be completed to understand how phase variable Type I RM 
systems affect virulence gene expression across Gram-positive pathogens.  
 
Regulation from bi-phasic MTases in Type III RM systems. In various Gram-
negative pathogens, including species of Haemophilus, Neisseria, Kingella, 
Helicobacter, and Moraxella, phase variable Type III mod alleles, encoding the Mod 
protein responsible for MTase activity, have been implicated in the regulation of gene 
expression (for review (83) and (9; 82; 84-86). The Mod proteins from these Type III 
systems exhibit ON/OFF expression within a population due to the presence of simple 
sequence repeats (SSRs) within the mod gene, which can cause DNA polymerase 
slippage at the SSRs (60; 68; 92). While no studies, to our knowledge, have 
demonstrated a phase variable Type III RM system regulating gene expression in 
Gram-positive bacteria, the presence of candidate phase variable Type III systems have 
been identified in S. thermophiles, S. galactiae, S. mitis, and L. saerimneri strains (4). 
These candidate phase variable Type III systems were identified based on the presence 
of SSRs within the mod allele (4). Putative epigenetic regulation by these novel systems 
remains an area of continued investigation. 
	 13 
 
In addition to the examples of the Type I and Type III systems discussed above, both 
SSRs and inverted repeats have been observed in the PglX MTase of BREX systems, 
resulting in phase variation for expression of the system (28). Phase variable MTases 
represent an important mechanism of epigenetic regulation in Gram-positive bacteria, 
allowing for differential methylation patterns and subsequently differential gene 
expression within various bacterial subpopulations (68). Few studies have investigated 
the regulatory effects of DNA methylation from active and inactive RM systems outside 
of Type I RM systems with multiple specificity subunits or Type III RM systems 
containing short sequence repeats within the mod allele. Below we will discuss our 
current understanding of the important regulatory functions of DNA methylation from 
non-phase variable RM systems across bacteria from the two Gram-positive phyla, 
Actinobacteria and Firmicutes. 
 
DNA methylation-dependent mechanisms for the regulation of gene expression in 
Actinobacteria. The Actinobacteria comprise one of the largest and most diverse 
bacteria phyla, including Gram-positive filamentous bacteria with high GC content 
genomes (for review (7; 45)). Actinobacteria can be found in aquatic and terrestrial 
environments where they are important contributors to diverse ecosystems (7; 29). The 
impact of DNA methylation outside of RM systems on the cell physiology of 
Actinobacteria remains largely unexplored, with the first studies focusing on 
Streptomyces and Mycobacterium.  The soil dwelling Streptomyces have been well 
studied for their multicellular behaviors and complex lifestyles (7; 98). Streptomyces are 
also of tremendous importance to biotechnology and human health as they are 
responsible for the production of 2/3 of clinically relevant antibiotics (45; 63; 72). 
Mycobacterium species are well known for causing a broad range of human diseases, 
particularly in immunocompromised individuals, and represent significant burdens on 
healthcare systems across the world (21; 41; 90). Given the importance of 
Streptomyces and Mycobacterium on human health, as well as the impact of other 
Actinobacteria genera on terrestrial and aquatic ecosystems, the initial studies 
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suggesting an important regulatory role for DNA methylation in the adaptive lifestyles of 
these bacteria is of particular importance for on-going and future research.  
 
Mycobacterium tuberculosis is a Gram-positive pathogen that represents a significant 
worldwide public health burden, causing more than 1.5 million deaths in 2018 ([WHO] 
(21).  The antibiotics rifampin and isoniazid, among others, have been used to cure 
tuberculosis infections, however multi-drug resistant tuberculosis (MDR-TB) strains, 
which are resistant to both rifampin and isoniazid, are emerging (41; 90). Among the 
mechanisms for emerging antibiotic resistance, a study by Chen et al. suggests that the 
extent of methylation differs between rifampicin and isoniazid treated M. tuberculosis 
H37Rv strains compared to the untreated wild type strain (15).  A separate study of 
para-aminosalicylic acid (PAS) resistant Mycobacterium suggests differential 
methylation in PAS resistant H37Rv, with 1,161 hyper-methylated and 227 hypo-
methylated genes relative to the susceptible parent strain (47). These data suggest that 
DNA methylation contributes to antibiotic resistance of Mycobacterium tuberculosis with 
the strong potential to contribute to formation of persister cells. 
 
Another study suggests that DNA methylation may play an important role in M. 
tuberculosis survival under hypoxic conditions (80). Latent infections with M. 
tuberculosis can last decades, requiring the bacteria to survive, persist, and adapt to a 
range of environmental conditions within the human host (27).  Shell et al. discovered a 
Type II MTase, MamA, present in a subset of M. tuberculosis strains that catalyzes m6A 
at CTGGAG sites throughout the genome (80).  MamA is also conserved in other 
Mycobacterium species including M. smegmatis, M. bovis, M. avium, and M. leprae. 
Upon loss of mamA in M. tuberculosis, a small but significant decrease in the 
expression a subset of genes was observed where the MamA recognition site 
overlapped with putative sigma factor -10 binding boxes. Moreover, the researchers 
found that the mamA deficient cells had decreased viability in hypoxic conditions 
relative to wild type cells. These hypoxic conditions were used to simulate those of 
hypoxic granulomas formed in the human host (91). A separate study of nineteen 
Mycobacterium tuberculosis complex strains found that MamA had 13 binding sites that 
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overlapped with SigA and that strains with inactive MamA variants showed decreased 
expression of the downstream genes relative to strains with active MamA (18). The 
same study showed that while methylation from a separate Type I RM system in M. 
tuberculosis strains did not directly influence the expression of genes through overlap 
with known sigma factor binding sites, loss of methylation indirectly affected expression 
of a small subset of genes in the absence of a recognition site near the affected genes 
(18).  Therefore these results suggest both direct and indirect mechanisms for DNA 
methylation in the regulation of gene expression (Fig 1.6) highlighting the importance of 
DNA methylation beyond restriction-modification systems in clinically important 
Actinobacteria. 
 
In addition to m6A-dependent regulation, m5C modifications have been shown to 
function in the regulation of antibiotic production and development in Actinobacteria. 
Streptomycetes are Gram-positive soil-dwelling bacteria that produce two thirds of all 
clinically relevant secondary metabolites (63; 72). In addition to antibiotic production, 
Streptomyces species are known for their complex life cycles, which include 
differentiation and programmed cell death (PCD) (for review (7; 98). Briefly, subsequent 
to uninucleoid spore germination, hyphae growth gives rise to a first/vegetative 
mycelium (MI) (52). Upon nutrient depletion, PCD occurs as the multinucleated 
second/differentiated mycelium (MII) develops, which consists of multiple cell types 
including the aerial mycelium and sporulating mycelium (52). The sporulating mycelium 
undergoes PCD to form the uninucleoid spore (52). A recent study showed that both 
antimicrobial production in Streptomyces and development are affected by m5C 
methylation (71). DNA extracted from strains of S. coelicolor, S. avermitilis, S. griseus, 
and S. lividans showed less m5C in the MII stages compared to MI in all four species 
(71). Moreover, the researchers used a gene interruption in the putative MTase 
SCO1731 (SCO1731::Tn5062) and found significant reduction in the genomic m5C 
signal in the S. coelicolor genome in MI but only a slight reduction in signal in MII (71). 
Phenotypically, the SCO1731::Tn5062 strain displayed a substantial delay in 
differentiation on solid media, with aerial mycelium formation occurring at 96 hours 
relative to formation at 48 hours in wild type cells. The mutant was also severely 
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impaired for production of the antibiotic actinorhodin (71). S. coelicolor encodes 37 
putative DNA MTases in addition to SCO1731, a subset of which are differentially 
expressed in MI and MII stages of development (71; 98). Further studies are necessary 
to determine the extent to which various methylation events regulate development and 
the expression of clinically relevant secondary metabolites across Streptomyces. 
Nevertheless, it appears that further studies will reveal an important regulatory 
contribution for DNA methylation in the complex life cycles of Streptomyces, raising 
broadly conserved biological parallels with the developmental regulatory functions of 
DNA methylation in eukaryotes. 
 
DNA methylation-dependent mechanisms for the regulation of gene expression in 
Firmicutes. The Firmicutes phylum includes Gram-positive bacteria with low GC 
content genomes. In addition to being one of the dominating phyla in the human gut 
microbiome, members of the Firmicutes also encompass several important human 
pathogens, including Stapylococcus, Streptococcus, Enterococcus, Clostridium, and 
Listeria species (46). Despite the very limited research available outside of regulation by 
phase variable MTases, RM system MTases have been shown to regulate gene 
expression in Firmicutes outside of host defense, prompting important possibilities for 
the functions of DNA methylation across Firmicutes.  
 
Epigenetic regulation of virulence factors from a Type I RM system has been shown for 
the important human pathogen Streptococcus pyogenes.  Loss of m6A from an active 
Type I RM system resulted in substantial down regulation of 20 genes that clustered 
into six distinct loci in a clinical isolate of S. pyogenes (Chapter II (65)). Many of the 
differentially expressed genes were part of the core regulon for the stand-alone 
transcriptional regulator, Mga (Chapter II (65)). The Mga core regulon consists of genes 
that encode cell surface proteins, including the M-protein, C5a peptidase, which cleaves 
host complement, and the Mga regulator itself, which are important for adhesion, 
internalization, and immune evasion phenotypes (34; 56). The m6A-dependent 
decrease in expression of the Mga regulon resulted in decreased adhesion of S. 
pyogenes cells to host epithelial cells, a decreased ability of the bacteria to survive 
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within host neutrophils, and a decreased ability to evade the host immune response.  
Interestingly, the S. pyogenes genome contains another putative Type I specificity unit 
(AWM59_04585), which is not surrounded by hsdM or hsdR genes. However, 
AWM59_04585 is located 691kb from the S subunit (AWM59_07900) of the active Type 
I RM system and REBASE annotates AWM59_04585 as unlikely to be a genuine S 
subunit (http://rebase.neb.com). Thus, more work is necessary to determine if S-subunit 
switching occurs in S. pyogenes as it does it in S. pneumonae or if the epigenetic 
regulation described in Nye et al. represents a phase variation independent mechanism 
of regulation by a Type I RM system. Either biological mechanism would impart 
regulation of S. pyogenes virulence.  
 
Gene regulation in Streptococcus is also governed by the presence of a Type II RM 
system. As previously discussed, in Gram-negative E. coli and related Proteobacteria, 
Dam MTase occurs as a stand-alone orphan MTase that functions in many important 
cellular processes, including origin sequestration (31; 64), DNA mismatch repair (5; 43), 
and the regulation of gene expression (13). Homologs of Dam MTase occur in a subset 
of Gram-positive bacteria, however they often exist as part of an active RM system, 
such as the DpnM-DpnA-DpnII system from S. pneumoniae discussed above (6; 37). 
Homologs of the DpnM-DpnA-DpnII system occur in a subset of strains from other 
Gram-positive bacteria such as Streptococcus mutans, Lactococcus lactis, 
Streptococcus sanguinis, and Streptococcus suis (6; 58; 78; 97). In S. mutans, it was 
shown that deletion of the DpnM homolog, DamA, resulted in the differential expression 
of over 100 genes, of which 70 were up regulated and 30 were down regulated at least 
two fold in the damA mutant relative to wild type (6). The differentially expressed genes 
included virulence factors, bacteriocins, and genes involved in sugar metabolism, which 
would contribute to the formation of dental caries and tooth decay (6). Importantly, this 
study showed that the differences in gene expression had effects at the phenotypic 
level. The up regulation of the cell surface glucan receptor, GpbC, in the damA mutant 
resulted in increased clumping in dextran-dependent aggregation assays and the 
increases in bacteriocin gene expression resulted in larger zones of clearing in the 
damA mutant against Streptococcus godonii and Lactococcus lactis strains (6). Thus, in 
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addition to functioning as part of a restriction-modification system, the S. mutans DNA 
MTase DpnM also functions in the regulation of gene expression. It remains unknown if 
the DpnM homologs in other Streptococcus species have regulatory functions beyond 
host restriction. 
 
Another example of DNA methylation regulating gene expression in Firmicutes was 
demonstrated in a recent study of the Bacillus subtilis MTase, DnmA. In Nye et al. 
researchers characterized the methylomes of the lab and ancestral strains of B. subtilis 
PY79 and NCIB 3610, respectively (Chapter III (66)). They found that the DnmA MTase 
from a Type I-like RM system catalyzed the formation of m6A at non-palindromic 
GACGAG sites throughout the chromosome. The absence of DnmA did not affect 
natural transformation efficiency, suggesting that DnmA either does not have activity as 
a canonical Type I RM-like system or the activity cannot be measured during natural 
transformation (Chapter III (66)). Moreover, deletion of dnmA resulted in small but 
significant decreases in expression for a subset of genes that are important for 
chromosome structure and maintenance. DnmA recognition sites were proximal to the -
35 box for sigma factor SigA binding in the promoters of the differentially expressed 
genes. Further, this study found that the transition state transcriptional repressor ScoC, 
preferentially bound an unmethylated promoter, providing mechanistic insight into the 
MTase-dependent regulation of gene expression in Gram-positive bacteria (Chapter III 
(66)). These data show that ScoC binding to a reporter promoter region is stronger for 
unmethylated relative to methylated DNA demonstrating that ScoC repressor binding 
serves to reduce gene expression when methylation is absent (Chapter III (12; 66)).  
 
Conclusions and Future Perspectives 
Methylation of genomic DNA is pervasive across bacterial genomes, where it has been 
most extensively studied as a self-recognition mechanism in host defense. The majority 
of the pioneering studies exploring the function of DNA methylation outside of host 
defense have been done in Gram-negative bacteria (1; 53; 54; 59; 75). However, 
outside of the CamA MTase conserved only in specific species of Clostridiales, much 
less is known about the functions of orphan MTases in Gram-positive bacteria (67). A 
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critical area of future investigation is understanding the biological contribution for 
enrichment of orphan MTase recognition sites in the putative origin of replication region 
for Arthrobacter species, which are used for commercial production of glutamic acid, 
and Norcardia species, a subset of which can cause opportunistic infections in 
susceptible populations (10). The over-representation of MTase sites in their predicted 
origin region suggests that orphan MTase methylation regulates origin firing in a subset 
of Gram-positive species. Additionally, unmethylated recognition sites from Gram-
positive orphan MTases can be also be found in promoter regions for transcriptional 
regulators, suggesting an additional contribution in regulated gene expression (10).  
Given the conservation of putative orphan MTases in Gram-positive bacteria it is 
tempting to speculate that MTase function is conserved across distantly related species. 
In our opinion experiments are necessary to determine the function of orphan MTase 
methylation in Gram-positive bacteria and how methylation regulates cell proliferation 
and gene expression.  
 
In addition to orphan MTases, the regulatory functions of methylation from RM systems 
has also focused on Gram-negative bacteria. While phase variable Type I RM MTases 
have been found to be important for Streptococcus virulence (48; 51), as discussed 
here, most other studies of Type I and Type III phase variable RM systems have been 
completed in Gram-negative bacteria. Outside of epigenetic regulation from phase 
variable RM systems, few studies have explored the regulatory consequences of DNA 
methylation from non-phase variable RM systems in both Gram-positive and Gram-
negative bacteria. Here we have discussed epigenetic regulation from non-phase 
variable RM systems in Mycobacterium, Streptomyces, Streptococcus, and Bacillus 
species. In some systems, such as MamA and DnmA from M. tuberculosis and B. 
subtilis, respectively, the mechanism of methylation-dependent regulation appears to be 
direct, where m6A modifications overlap with transcription factor binding sites in 
differentially expressed genes (Fig 1.6) (80) (Chapter III (66)). In B. subtilis researchers 
identified an m6A sensitive transcriptional regulator, ScoC, which bound near the sigma 
factor binding site, providing some of the first insight into the mechanism of m6A-
dependent regulation in Gram-positive bacteria (Chapter III (66)). It remains to be 
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determined if m6A regulation of ScoC binding is a common mechanism for ScoC 
regulated genes or specific to particular loci. In other systems, such as the Type I RM 
systems in M. tuberculosis and S. pyogenes, the mechanism of methylation-dependent 
regulation of gene expression appears to be indirect, with modified recognition motifs 
occurring distal to the differentially expressed genes (Fig 1.6) (Chapter II, (18; 65)). 
Both direct and indirect mechanisms of regulation from non-phase variable RM systems 
appear to have important consequences for cell physiology, where they affect virulence 
potential, adaptability to environmental conditions, and bacterial development. Given the 
widespread occurrence of DNA methylation in Gram-positive bacteria and the 
importance of Actinobacteria and Firmicutes to human health, industry, and the 
environment, further study of DNA methylation in Gram-positive bacteria is important for 
understanding regulatory and phenotypic variations among bacteria within populations. 
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Figure 1.1. DNA methylation has been most intensely studied in Gram-negative 
bacteria. (A) Gram stains of bacteria included in the Blow et al. survey of prokaryotic 
genome methylation (10).  Bacteria were grouped based on Gram-stain.  The percent of 
Gram-negative (pink), Gram-positive (purple), and Other (green) species is indicated on 
the y-axis. The number of species in each category out of the total surveyed is indicated 
as a fraction underneath each bar. The ‘Other’ category consisted of Archaea and 
bacterial species from Chloroflexi, Plantomycetes, and Deinococcus-Thermus, which 
exhibit atypical Gram stains based on cell wall structure. (B) The percent of 
representative bacteria from the major Gram-positive phyla in the Blow et al. survey 
(10). The percent of Actinobacteria (gray) and Firmicutes (black) species is indicated on 
the y-axis with the number of species included out of the total surveyed indicated as a 
fraction underneath each bar. 
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Figure 1.2. The functions of DNA methylation in Gram-positive bacteria. Genomic 
DNA methylation in Gram-positive bacteria occurs from the activity of RM system 
MTases (brown), orphan MTases (blue), or BREX MTases (green). Methylation from 
both BREX and RM MTases has been shown to function in host defense. Both phase 
variable and non-phase variable MTases from RM systems have been shown to 
regulate gene expression in Gram-positive bacteria as well. To date, a regulatory 
function for DNA methylation from BREX system MTases has not been experimentally 
demonstrated. 
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Figure 1.3. DNA MTases in Gram-positive bacteria. DNA methylation in Gram-
positive bacteria comes from DNA MTases that exist as part of RM systems (brown), 
BREX (green), and orphan MTases (blue). The composition of the MTase component 
from Types I-III RM systems is indicated as well as the typical recognition motifs and 
methylation patterns. The typical recognition motif and methylation pattern from BREX 
systems and orphan MTases is also included (8; 28).  
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Figure 1.4. Phase variable MTases from Type I and III RM systems. (A) Phase 
variable MTases from Type I RM systems occur through S-subunit switching. Random 
recombination of the TRDs from hsdS and hsdS’ occurs at inverted repeats within the 
genes by the proximally encoded recombinase. The recombination events produce 
multiple S-subunits with different combinations of TRDs that target the MTase, 
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comprised of HsdM and HsdS subunits, to different recognition sites throughout the 
genome resulting in bacterial subpopulations with various methylation patterns. The 
subpopulation specific methylation patterns can result in differential gene expression 
between subpopulations. (B) Phase variable MTases from Type III RM systems occur 
through DNA polymerase slippage at SSRs. Random DNA polymerase slippage at a 
homopolymer track in the coding region of the mod allele results in subpopulations with 
truncated and full length Mod proteins. The subpopulations with the truncated Mod 
protein lack the DNA methylation present in the population with the functional full length 
Mod-protein, resulting in subpopulation specific DNA methylation patterns that can 
result in differential gene expression between the populations (77). 
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Figure 1.5. Phase variable MTase in S. pneumoniae regulates virulence in distinct 
subpopulations. Shown are the six different S-subunits produced from recombination 
of the TRDs from three hsdS genes to produce systems A-F as described in Manso et 
al. The distinct recognition site for each system is listed according to the color-coded 
TRDs in the S-subunit. The percent of colonies displaying the opaque phenotype for 
each subpopulation is also indicated (51). This figure is based on the following 
reference (51). 
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Figure 1.6. Mechanisms of DNA methylation-dependent regulation of gene 
expression in Gram-positive bacteria.  Direct regulatory mechanisms result from the 
occurrence of methylation within a promoter region of a gene that affects binding of 
transcriptional regulators that influence RNA polymerase activity, subsequently affecting 
gene expression. Indirect regulation can occur through differential expression of a gene 
that is directly regulated by DNA methylation, such as transcription factors (TF). The 
methylation-dependent differential expression of the TF can result in downstream 
differential expression of many genes within the TF regulon. Indirect regulation can also 
occur at genes that are differentially expressed upon loss of DNA methylation but are 
not proximal to any methylated sites. Such indirect mechanisms are poorly understood 
but occur in a number of bacteria. 
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CHAPTER II 
 
DNA Methylation from a Type I Restriction Modification System Influences Gene 
Expression and Virulence in Streptococcus pyogenes 
 
 
 
  
Abstract 
DNA methylation is pervasive across all domains of life. In bacteria, the presence of N6-
methyladenosine (m6A) has been detected among diverse species, yet the contribution 
of m6A to the regulation of gene expression is unclear in many organisms. Here we 
investigated the impact of DNA methylation on gene expression and virulence within the 
human pathogen Streptococcus pyogenes, or Group A Streptococcus. Single Molecule 
Real-Time sequencing and subsequent methylation analysis identified 412 putative 
m6A sites throughout the 1.8 Mb genome. Deletion of the Restriction, Specificity, and 
Methylation gene subunits (DRSM strain) of a putative Type I restriction modification 
system lost all detectable m6A at the recognition sites and failed to prevent 
transformation with foreign-methylated DNA. RNA-sequencing identified 20 genes out of 
1,895 predicted coding regions with significantly different gene expression. All of the 
differentially expressed genes were down regulated in the DRSM strain relative to the 
parent strain. Importantly, we found that the presence of m6A DNA modifications 
affected expression of Mga, a master transcriptional regulator for multiple virulence 
genes, surface adhesins, and immune-evasion factors in S. pyogenes. Using a murine 
subcutaneous infection model, mice infected with the DRSM strain exhibited an 
enhanced host immune response with larger skin lesions and increased levels of pro-
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inflammatory cytokines compared to mice infected with the parent or 
complementedmutant strains, suggesting alterations in m6A methylation influence 
virulence. Further, we found that the DRSM strain showed poor survival within human 
neutrophils and reduced adherence to human epithelial cells. These results 
demonstrate that, in addition to restriction of foreign DNA, gram-positive bacteria also 
use restriction modification systems to regulate the expression of gene networks 
important for virulence. 
 
Author Summary 
DNA methylation is common among many bacterial species, yet the contribution of DNA 
methylation to the regulation of gene expression is unclear outside of a limited number 
of gram-negative species. We characterized sites of DNA methylation throughout the 
genome of the gram-positive pathogen Streptococcus pyogenes or Group A 
Streptococcus. We determined that the gene products of a functional restriction 
modification system are responsible for genome-wide m6A. The mutant strain lacking 
DNA methylation showed altered gene expression compared to the parent strain, with 
several genes important for causing human disease down regulated. Furthermore, we 
showed that the mutant strain lacking DNA methylation exhibited altered virulence 
properties compared to the parent strain using various models of pathogenesis. The 
mutant strain was attenuated for both survival within human neutrophils and adherence 
to human epithelial cells, and was unable to suppress the host immune response in a 
murine subcutaneous infection model. Together, these results show that bacterial m6A 
contributes to differential gene expression and influences the ability of Group A 
Streptococcus to cause disease. DNA methylation is a conserved feature among 
bacteria and may represent a potential target for intervention in effort to interfere with 
the ability of bacteria to cause human disease.    
 
Introduction 
DNA methylation has been shown to regulate diverse pathways across all domains of 
life [1]. In eukaryotes, cytosine methylation regulates developmental gene expression 
	 36 
and aberrant DNA methylation patterns have been implicated in many disease states, 
including cancer [2, 3]. Although studied in a limited number of prokaryotic organisms, 
DNA methylation has been implicated in a myriad of cellular processes, including 
protection from the invasion of foreign DNA, cell cycle regulation, DNA mismatch repair, 
and the regulation of gene expression [4]. It was recently shown that within the 
genomes of over 200 prokaryotes surveyed greater than 90% contained N6-
methyladenosine (m6A), N4-methylcytosine (m4C), or 5-methylcytosine modifications 
(m5C) [5]. These results demonstrate that DNA methylation among prokaryotes is more 
pervasive than originally anticipated. What remains uncertain is if DNA methylation 
imparts any regulatory controls influencing virulence properties or other phenotypes 
amongst the array of diverse prokaryotic species.   
DNA methylation in bacteria has been well characterized in the context of 
restriction modification (RM) systems [4, 5]. RM systems are a mechanism of bacterial 
host defense to prevent the invasion of foreign DNA. RM systems are generally 
comprised of a site-specific restriction endonuclease (REase), methyltransferase 
(MTase), and, in some cases, a specificity subunit that together form a protein complex 
that cleaves foreign DNA after it enters the cell. Methylation of the host DNA at the 
same recognition site serves to safeguard the host chromosome from cleavage. In 
addition to RM systems, DNA can also be methylated by orphan MTases. Orphan 
MTases methylate DNA in site-specific sequences and lack an active cognate 
endonuclease [5, 6]. In bacteria, the two most well studied orphan MTases are 
Escherichia coli DNA adenosine methyltransferase (Dam) and Caulobacter crescentus 
cell cycle regulated methyltransferase (CcrM) [5, 6]. Site-specific DNA methylation by 
Dam and CcrM has been shown to regulate DNA mismatch repair, cell cycle 
progression, origin sequestration, and gene expression, demonstrating that DNA 
methylation imparts critical regulatory functions [6].  
Despite the importance of RM systems and orphan MTases, the lack of genome-
wide detection tools has hindered the identification of DNA base modifications and 
characterization of the physiological consequences resulting from MTase inactivation in 
bacteria. The use of methylation-sensitive restriction endonucleases to identify sites of 
DNA base modifications is limited by the sequence specificity of the recognition site, 
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potentially missing many base modifications that could occur outside of a particular 
sequence context ([5] and references therein). While bisulfite sequencing allows for 
genome-wide detection of m5C in sequence specific-contexts, no such genome-wide 
detection tool has been available for the detection of m6A or m4C until the recent 
advent of Pacific Biosciences (PacBio) Single Molecule Real-Time (SMRT) sequencing 
platform [7-11]. SMRT sequencing relies on differences in DNA polymerase kinetics to 
detect base modifications in the template strand in a sequence-context specific manner 
without a priori knowledge of the modification.  
Our group previously used the PacBio SMRT sequencing platform to complete 
whole genome sequencing and reference genome assembly of two strains of the 
bacterial human pathogen Streptococcus pyogenes, or Group A Streptococcus (GAS) 
[12, 13]. S. pyogenes causes a wide variety of human infections, ranging from the 
relatively common streptococcal pharyngitis and cellulitis to the relatively uncommon, 
but severe, streptococcal toxic shock syndrome and necrotizing fasciitis, which have 
high morbidity and mortality rates [14-16]. S. pyogenes is a model bacterial pathogen, 
not only for the infections it produces, but also for the great diversity of toxins and 
virulence factors expressed by the organism and the highly complex nature of 
regulatory mechanisms employed to control virulence factor expression [14, 16-18]. 
Indeed, S. pyogenes utilizes over 30 recognized transcriptional regulatory proteins and 
13 two-component regulatory systems to coordinate virulence factor expression in 
response to varying environmental signals (e.g., carbohydrate availability, temperature, 
pH, oxygen tension, salt concentrations, osmolality, etc.), growth phase, intracellular 
metabolite concentrations, and signaling pheromones involved in quorum sensing [17, 
18]. DNA methylation has not been previously investigated as a significant mechanism 
influencing virulence factor expression within S. pyogenes, and DNA methylation may 
represent an unrecognized target for therapeutic intervention to help prevent or treat 
severe streptococcal disease.      
In this study, we show that in S. pyogenes strain MEW123, a representative derivative 
of a serotype M28 clinical pharyngitis isolate, the active Type I RM system 
SpyMEW123I is responsible for the bipartite m6A motif identified throughout the 
genome. We show that deletion of the RM system and subsequent loss of m6A from S. 
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pyogenes results in the down regulation of a distinct set of operons involved in 
streptococcal virulence. Importantly, our study shows that methylation by a Type I RM 
system correlates with differential expression of Mga, a major transcriptional regulator of 
multiple virulence factors, surface adhesins, and immune evasion factors in S. 
pyogenes. The results presented here demonstrate that RM systems can integrate their 
methylation signal to influence the expression of gene networks important for bacterial 
virulence. 
 
Results 
SMRT sequencing and methylation analysis identifies m6A modifications in a 
bipartite recognition sequence in the S. pyogenes genome. Previously we 
completed whole genome assembly using PacBio SMRT sequencing with S. pyogenes 
strain MEW123, a representative serotype M28 isolate used by our group to investigate 
streptococcal mucosal colonization [12] (for strain list refer to Table 2.1). To begin our 
investigation, we performed methylation analysis of the SMRT sequencing data. We 
identified m6A DNA base modifications in the MEW123 genome at the consensus 
sequence 5' GCANNNNNTTYG and its corresponding partner motif 5' 
CRAANNNNNNTGC, consistent with m6A modification motifs previously reported by 
Blow et al. (Table 2.2) [5]. Within the MEW123 genome, 412 occurrences of each m6A 
site within the bipartite recognition motif were identified; the majority occurred in 
predicted coding (92%) and intergenic (6%) regions of the MEW123 genome. The 
bipartite recognition motif is characteristic of Type I RM systems, which are typically 
comprised of three separate subunits, including a restriction endonuclease, a specificity 
subunit, and a methyltransferase subunit, that act together as a single protein complex 
and typically act at large distances from the methylation site. The RM system annotation 
pipeline used in Blow et al. identified the putative Type I restriction modification system, 
annotated as SpyMEW123I, consisting of a three-gene cluster with separate restriction 
endonuclease (hsdR), specificity (hsdS), and methyltransferase (hsdM) genes, as a 
predicted match for modification of the identified m6A motif in S. pyogenes [5, 19] (Fig 
2.1A and Fig 2.1B). This three-gene cluster exhibits high amino acid sequence 
homology to the Type I RM system identified in S. pyogenes SF370 at Spy_1904 
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(hsdR), Spy_1905 (hsdS), and Spy_1906 (hsdM), with 99%, 87%, and 99% identity, 
respectively [20]. This Type I RM system is present in virtually all sequenced S. 
pyogenes strains to date, with rare exception reported in some emm1 strains from 
Japan with spontaneous deletion of a two-component regulatory system and the 
adjacent Type I RM system [21]. Notably, we did not detect the 5mC modifications at 
CmCNGG reported by Euler et al. in our PacBio SMRT sequencing results, which is not 
surprising given the MTase, M.SpyI, is absent from the S. pyogenes M28 serotype [22]. 
The REase and MTase activities of SpyMEW123I are annotated as R.SpyMEW123I 
and M.SpyMEW123I, respectively. 
 
M.SpyMEW123I is responsible for m6A modifications in the S. pyogenes genome. 
To determine if the SpyMEW123I RM system was responsible for the observed m6A 
modifications in strain MEW123, an in-frame deletion mutation was constructed using a 
plasmid vector designed for allelic replacement (pGCP213) as previously described [26] 
(Table 2.1 and Fig 2.1A). Approximately 95% of the three-gene sequence encoding the 
hsdR, hsdS, and hsdM genes was deleted producing strain MEW513 (referred to as 
∆RSM); the in-frame deletion was confirmed by PCR amplification and Sanger DNA 
sequencing (Table 2.1). Growth of the MEW123 parent strain, referred to as wild-type 
(WT) and the ∆RSM mutant were not significantly different in rate or final growth density 
when measured in either the nutrient rich Todd-Hewitt medium with 0.2% yeast extract 
(THY broth) or the low-carbohydrate C-medium (Fig 2.8). To confirm a reduction in m6A 
base modifications and to determine the sequence context lacking m6A base 
modifications in the ΔRSM strain, genomic DNA was isolated and sequenced via 
PacBio SMRT sequencing. Modification analysis showed loss of detectable m6A base 
modifications at 5' GCANNNNNTTYG and 5' CRAANNNNNNTGC sites, demonstrating 
that streptococci with a SpyMEW123I deletion no longer have m6A DNA base 
modifications at the consensus sequence identified in the WT strain (Fig 2.1B, Table 
2.3). A number of additional methylation events were identified in MEW513; however, 
these occurred at far lower frequencies compared to the modifications at the consensus 
sequences in the parent strain and the quality of the read scores (Mod QV) were low 
compared to the RSM-dependent modifications. Based on these low quality read 
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scores, we feel it is unlikely that these additional modifications reflect compensatory 
methylation events. Furthermore, SMRT sequencing of the MEW513 genome did not 
identify any unforeseen mutations outside of the in-frame deletion within hsdRSM that 
we anticipated.   
To further confirm that the MTase component of the RSM gene cluster, 
M.SpyMEW123I, was indeed responsible for producing m6A DNA modifications, 
genomic DNA was harvested from the WT and the ΔRSM strain and spotted onto a 
nitrocellulose membrane for immunodetection using an α-m6A antibody. We found that 
the α-m6A signal was substantially reduced in genomic DNA blots from the ΔRSM strain 
compared to the WT parent, suggesting a significant and near complete reduction in 
m6A base modifications in the ΔRSM strain (Fig 2.1C). Complementation in trans of the 
∆RSM mutant with a plasmid encoded copy of the three gene cluster (hsdRSM) 
produced strain MEW552 (referred to as ∆RSM/pRSM) and successfully restored 
detection of the α-m6A signal to levels comparable to the WT strain (Fig 2.1C). These 
results demonstrate that the MTase activity of SpyMEW123I is responsible for base 
modifications at 5' GCANNNNNTTYG and 5' CRAANNNNNNTGC sites in vivo.  
 
The SpyMEW123I RM system influences S. pyogenes transformation efficiency 
demonstrating functional restriction of foreign DNA acceptance. Deletion of the 
three-gene cluster, hsdRSM, containing the predicted endonuclease, specificity, and 
methylation gene subunits abolished m6A base modifications in the ΔRSM mutant 
strain. In Type I RM systems, DNA cleavage is dependent on the MTase and specificity 
subunits, in addition to the REase subunits which are often independently regulated by 
a separate promoter [29]. Fully unmethylated recognition motifs induce REase activity 
that results in DNA cleavage typically between two fully unmethylated motifs at sites 
distant from the recognition sequence; this distance may range from 40 base pairs to 
several kilobases away from the RM site. Type I MTases can function to add m6A de 
novo on fully unmethylated DNA or act as maintenance MTases at hemi-methylated 
recognition sites [29-31]. Additional mechanisms also protect DNA from restriction, 
including proteolysis of the REase subunits or protection by DNA binding proteins that 
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can protect unmethylated sites from cleavage in the host chromosome [32].	To establish 
the function of the REase component of SpyMEW123I, a transformation efficiency 
assay was performed using pJoy3 plasmid DNA methylated in an E. coli host (Table 
2.1). This 6.3 kb plasmid contains eight predicted Dam MTase RM sites (5' GATC) and 
is delivered in its native double-stranded circular form via electroporation into 
electrocompetent S. pyogenes where the plasmid is maintained and replicates 
extrachromosomally [27]. In addition to testing the effect of deleting the entire hsdRSM 
gene cluster in the ΔRSM mutant strain, we constructed an additional strain derivative 
of MEW123 with a spectinomycin-resistance cassette disrupting the hsdR REase gene 
subunit alone producing strain MEW489 (referred to as ΩRE, Table 2.1). If the 
SpyMEW123I RM system has true restriction enzyme activity to foreign-modified DNA, 
then we would expect that inactivating the hsdR gene subunit, either individually or 
within the entire RSM gene cluster, would enhance the transformation efficiency of the 
plasmid. Indeed, we found that the rates of transformation with foreign-methylated 
plasmid DNA increased significantly for both the ΔRSM mutant and the ΩRE mutant 
strains compared to the WT parent strain, providing evidence that the restriction 
endonuclease component of SpyMEW123I is active and functional (Fig 2.2A). We were 
unable to compare our complementation strain ΔRSM/pRSM for transformation 
efficiency as this strain already carries the pJoy3 plasmid encoding the hsdRSM gene 
cluster. As a control, we undertook transformation of a MEW123 mutant in the gene 
encoding the C5a peptidase, scpA (strain 489 or ΩscpA), as mutants in this gene would 
not be expected to show enhanced transformation efficiency; as expected, the 
transformation efficiency of ΩscpA was not significantly different than the WT (Fig 
2.2A). Interestingly, inactivation of the endonuclease subunit hsdR alone in the ΩRE 
mutant strain conferred significantly greater transformation efficiency than that observed 
in the ΔRSM mutant (Fig 2.2A). In many Type I RM systems the restriction subunit is 
generally under control of a separate promoter from the specificity and methylation 
subunits in the RSM gene cluster [29]. We found that the α-m6A signal generated by dot 
blot of genomic DNA from the ΩRE strain was intermediate in intensity between the WT 
and ∆RSM strains (Fig 2.1C). This result suggests that the methyltransferase subunit 
was still functional in the ΩRE strain, but that there may have been some degree of 
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polar effect from the spectinomycin-resistance cassette used to inactivate hsdR that 
was reducing transcription of the hsdS and hsdM gene products compared to WT 
levels. We speculate that the residual functional activities of the specificity and 
methyltransferase subunits in the ΩRE mutant strain, even though less than WT levels, 
may have conferred additional stability to the incoming foreign-methylated plasmid 
DNA, possibly offering protection from other minor endonucleases, thereby enhancing 
overall transformation efficiency.      
 
Variation in m6A base modification occurrence at RM recognition sites identified 
by SMRT sequencing in the S. pyogenes genome. As discussed above, the MTase 
activity of Type I RM systems may function to maintain the state of hemi-methylated or 
fully methylated DNA, whereas REase cleavage only occurs on fully unmethylated DNA.  
Thus, RM sites can exist in the genome in a hemi-methylated state while still conferring 
protection from digestion [29]. Having shown that SpyMEW123I functions as an active 
RM system, we sought to establish the fraction of reads that were called as methylated 
at each recognition site. Our analysis of sequencing data from WT S. pyogenes 
MEW123 found substantial variation in the fraction of sequencing reads modified at RM 
sites (Fig 2.2B). The fraction of reads called as modified at a given RM site did not 
appear to be dependent on orientation or genome position. Of the m6A modifications 
called at RM sites, 4.9% of sites were called as m6A modified in less than 50% of 
sequencing reads, 23.7% of sites were called as modified in between 50-75% of 
sequencing reads, and finally 71.4% of sites were called as modified at greater than 
75% of aligned reads. Previous studies have also reported heterogeneity in the 
frequency of SMRT sequencing reads with base modifications; it has been 
hypothesized that these differences are due to timing in DNA replication and 
subsequent methylation [33-35]. Whether there is a temporal component accounting for 
the heterogeneity in m6A DNA modifications, and whether this impacts other functions 
of m6A modifications, such as in influencing gene transcription in S. pyogenes, is 
unknown. Given the heterogeneity observed in the fraction of reads called as m6A 
methylated, we hypothesized that m6A modifications produced by the SpyMEW123I RM 
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system might have additional functions outside of host protection from foreign DNA 
prompting the experiments below.  
 
RNA-sequencing shows that deletion of the SpyMEW123I RM system results in 
the down regulation of several transcripts involved in streptococcal immune 
evasion and adherence. In addition to functioning in RM systems, m6A base 
modifications from orphan MTases have been shown to function in cell cycle regulation, 
DNA mismatch repair, and the regulation of transcription [4]. In the pathogenic 
Escherichia coli serotype O104:H4 strain C227-11 associated with hemolytic uremic 
syndrome, deletion of the ϕStx104 RM system results in the differential expression of 
over 38% of the genes, including genes involved in motility, cell projection, and cation 
transport [33]. Mismatch repair is not coupled to methylation in S. pyogenes or most 
other gram-positive bacteria [36].  Therefore, we asked if m6A originating from the 
SpyMEW123I RM system in S. pyogenes might have additional functions outside of 
host defense from foreign DNA. We isolated RNA from streptococcal cells during mid-
exponential growth phase in C media broth culture from WT and ΔRSM strains followed 
by RNA-sequencing. The results of the differential expression analysis showed that 20 
genes were differentially expressed in the ΔRSM strain compared to WT (adjusted p. 
val < 0.05, log2 fold change >1, data set available at NCBI repository). Interestingly, all 
20 genes were down regulated in ΔRSM relative to WT suggesting a common 
regulatory mechanism (Fig 2.3A and 2.3B, Table 2.4). The three genes (hsdRSM) of 
the SpyMEW123I RM gene cluster showed the greatest log2 fold change in expression 
of -10.8, -10.7, and -11.7, respectively, which was expected because these genes were 
deleted in the ΔRSM strain. 
The majority of the differentially expressed genes are located in approximately 6 
separate operons or gene clusters as indicated in Table 2.4. Interestingly, several of 
these gene groups are transcriptionally regulated, at least in large part, by activity of the 
multiple gene regulator protein, Mga [37-39]. During mid-exponential growth phase, 
Mga acts as a transcriptional activator to regulate a core set of virulence factors at the 
mga locus [37]. The mga locus consists of several components: a) the M protein (emm 
gene) a major surface protein involved in resistance to phagocytosis and intracellular 
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killing by neutrophils and used to distinguish S. pyogenes isolates, b) a fibronectin-
binding protein that binds host complement regulator factors, c) an emm-like protein that 
binds IgG and fibrinogen, d) the C5a peptidase (ScpA) which cleaves C5a chemotaxin, 
e) the enn protein that binds IgA, and f) the mga gene itself. All genes at the mga locus 
displayed log2 fold changes ranging from -1.2 to -8.7 in the ΔRSM strain relative to WT 
(Fig 2.3A). To confirm this differential expression, we again isolated total RNA from 
strains during mid-exponential growth phase in C media broth culture and performed 
quantitative RT-PCR for detection of transcripts mga, emm28, and scpA (Fig 2.3B). 
Consistent with the RNA-seq results, the qRT-PCR results showed that these genes 
were significantly down regulated in the ∆RSM strain, with approximately 5-fold to over 
300-fold decreased expression in the ΔRSM strain relative to WT (Fig 2.3B). 
Complementation in trans in the ∆RSM/pRSM strain restored transcript expression 
patterns similar to WT values. Deletion of the mga gene produced qRT-PCR results in a 
similar trend to the ∆RSM strain for the examined transcripts, with significantly 
decreased detection of emm28 and scpA transcripts; mga transcript was not detected in 
the ∆mga strain (Fig 2.3B). Examination of these transcripts in the hsdR insertional 
inactivation mutant ΩRE showed transcript detection of mga and emm28 comparable to 
WT levels, with detection of scpA transcript approximately four to five-fold of WT levels. 
This transcript pattern was very different than those of the ∆RSM and ∆mga mutant 
strains and more similar to the WT pattern. Even though the spectinomycin resistance 
cassette insertion into hsdR may have produced some polar effect with slightly 
decreased methyltransferase activity as noted on the anti-m6A dot blot (Fig 2.1C), it 
seems sufficient residual m6A base modifications persisted to not significantly disrupt 
gene expression (Fig 2.3B). Taken together, these results from RNA sequencing and 
qRT-PCR provide evidence that m6A base modifications correlate with patterns of 
differential gene expression in S. pyogenes, including those of several recognized 
virulence factors and major regulators of virulence gene expression.    
 
Disruption of m6A DNA modifications enhances the host inflammatory response 
to streptococcal infection in a murine subcutaneous ulcer model. Given that the 
genes in the Mga regulon were significantly down regulated in the ΔRSM strain relative 
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to WT, we were interested in determining the impact of disrupting m6A DNA 
modifications on S. pyogenes virulence using a murine subcutaneous infection model 
[40, 41]. C57BL/6J mice were inoculated at the shaved flank with 1 x 107 CFUs of either 
MEW123 (WT) or the ΔRSM mutant strain and resulting skin ulcers were photographed 
daily for sizing the skin ulcer area. As shown in Fig 2.4A, there was no significant 
difference in skin lesion size at day two post-infection in comparison of the mice infected 
with either the WT or the ΔRSM strains. However, by three to four days post-infection, 
and for the remainder of the experiment, the skin lesions of mice infected with the 
ΔRSM strain were significantly larger than those of mice infected by the WT strain (Fig 
2.4A). No strain caused a lethal infection among any of the mice with the 1 x 107 CFU 
inoculum. Representative images of skin lesions for mice infected with the WT, the 
ΔRSM strain, and the complemented ∆RSM/pRSM strain over time are shown in Fig 
2.4B, with skin lesions of mice infected with the ΔRSM strain notably larger on average 
at 4 and 6 days compared to those of mice infected with the WT or complemented 
strain. Complementation of the ∆RSM mutation in trans by strain MEW552 
(∆RSM/pRSM) produced murine skin lesions smaller than the ∆RSM mutant but not 
significantly different than the WT strain throughout the duration of the experiment (Fig 
2.4C).  
Skin lesion sizes reached a mean peak size at four to six days post infection. To 
determine if the difference in skin lesion size correlated with the concentration of viable 
streptococci at the site of infection, the skin lesions of mice were dissected and 
homogenized at day four post-infection to obtain viable CFU counts. Upon dissection, 
we made the observation that skin lesions from mice infected with the ∆RSM strain 
were grossly more purulent than lesions of mice infected by the WT and complemented 
∆RSM/pRSM strains. The skin lesions contained on average CFU counts of 
approximately 1 x 106 to 1 x 107 CFUs; while there was a slight trend to higher CFU 
counts on day four post-infection for the ∆RSM streptococci compared to the WT and 
complemented strain CFUs, there were no statistically significant differences in CFU 
counts between these groups (Fig 2.9). We noted that skin lesions of mice infected with 
the WT and complemented strain ∆RSM/pRSM strains seemed to heal more quickly 
than those of mice infected with the ΔRSM strain (Fig 2.4C).      
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With the subcutaneous ulcer model, skin lesion size tends to correlate closely 
with the degree of the host immune response, with particular regards to the neutrophil 
influx [40, 41]. To compare the inflammatory response in skin lesions of mice infected 
with the WT and the ΔRSM strain, we performed skin biopsies for cytokine analysis and 
histologic examination at six-days post-infection; this time point was chosen as it was 
the time point with the greatest difference in skin lesion size between the experimental 
groups. Measurements of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-17A 
(IL-17A), and tumor necrosis factor alpha (TNFα), were obtained as evidence of pro-
inflammatory cytokine activity. Cytokine concentrations for all four cytokines measured 
were significantly greater from mice infected with WT streptococci than mice mock-
infected with sterile phosphate-buffered saline (PBS) (Fig 2.5A). Cytokine 
concentrations from mice infected with the ΔRSM strain were significantly greater than 
mock-infected or mice infected with the WT strain (Fig 2.5A). Furthermore, histologic 
analysis of skin lesions shows predominantly increased neutrophil influx, but also a 
modest increase in the number of macrophages in the subcutaneous tissue of mice 
infected with the ΔRSM strain compared with WT (Fig 2.5B). Infiltration of T 
lymphocytes was not appreciably different between skin lesions of mice infected with 
WT or the ΔRSM strain (Fig 2.5B). Cytokines IL-6 and IL-17A, in particular, are 
important for coordinating neutrophil trafficking to areas of infection [42-44]. Our results 
in mice infected with the ΔRSM strain showing enhanced pro-inflammatory cytokine 
detection, increased neutrophil infiltration, and larger skin lesions, suggests an effect of 
altered gene transcription patterns in the ΔRSM strain and a more robust host 
inflammatory response compared to mice infected with the WT parent strain. Given the 
known association of several of the streptococcal gene transcripts down regulated in the 
ΔRSM strain, including mga, emm28, and scpA, with immune evasion properties, we 
hypothesized that m6A DNA modifications and proper regulation of gene expression are 
important contributors to immune evasion strategies and/or disruption of host immune 
responses by S. pyogenes.      
To determine if the loss of specific virulence factors recapitulates the phenotype 
of the ∆RSM strain in the murine subcutaneous ulcer model, we infected mice with 
derivatives of strain MEW123 with in-frame deletions of mga (strain MEW480, ∆Mga), 
	 47 
and spectinomycin-resistance cassette disruption mutations of emm28 (strain 409, 
Ωemm28) and scpA (strain 380, ΩscpA). As shown in Fig 2.4C, infection of mice by the 
∆Mga strain produced skin lesions significantly larger than the WT strain and 
comparable to the ∆RSM strain in size throughout the experiment. Infection by the 
Ωemm28 strain was not statistically different than the WT strain at day 2 and day 4 
post-infection; however, by day 6 and day 8 post-infection, the Ωemm28 strain 
produced lesions that were statistically significantly larger than the WT (Fig 2.4C). 
Infection of mice by the ΩscpA strain produced the widest range of murine skin lesion 
sizes, with some mice having very large lesions following infection (Fig 2.4C); however, 
at no time point was the average size of the lesions produced by the ΩscpA strain 
statistically different than WT. Overall, these results suggest that the presence of m6A 
DNA base modifications produced by M.SpyMEW123 activity correlate with differential 
transcriptional expression of several S. pyogenes virulence factors, especially those 
within the Mga operon, and that these seem to influence host-pathogen interactions at 
the site of infection. 
 
Disruption of m6A DNA modifications inhibits streptococcal survival within 
human neutrophils. A major function of the S. pyogenes M protein is to promote 
streptococcal survival, resisting killing by human leukocytes by interfering with 
bactericidal activity within neutrophils following phagocytosis [45, 46]. Staali et al. found 
that S. pyogenes strains with or without M protein underwent phagocytosis by 
neutrophils to similar levels, but only strains expressing M protein survived intracellularly 
whereas strains lacking M protein expression were rapidly killed [45]. Given our findings 
that elimination of m6A DNA modifications was associated with decreased transcript 
expression for mga and emm28, we wished to compare survival within human 
neutrophils. Purified human neutrophils were incubated with WT or ΔRSM S. pyogenes 
strains using a neutrophil bactericidal assay similar to a previous report [45]. Briefly, 
streptococci and neutrophils were mixed together allowing the neutrophils to internalize 
S. pyogenes strains followed by elimination of extracellular bacteria with penicillin and 
gentamicin. It was previously determined that there was no significant difference in 
susceptibility to penicillin and gentamicin at the high concentrations used in these 
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experiments between the WT or ∆RSM strains (Fig 2.8). Streptococcus surviving within 
neutrophils were liberated by treatment with the detergent saponin and plated for viable 
CFUs. As shown in Figure 2.6, we utilized serotype M14 HSC5 and a derivative strain 
with disruption in the M14 emm gene (Ωemm14) as positive and negative controls, 
respectively. As expected, the Ωemm14 mutant was significantly attenuated for 
intracellular survival within neutrophils compared to the M14 parent strain (Fig 2.6). 
Similarly, we compared survival of the MEW123 parent strain (M28) and its cognate 
strain with disruption of the M28 emm gene (Ωemm28) or the ΔRSM mutant. We found 
that both the Ωemm28 and the ΔRSM mutant were significantly attenuated for 
intracellular survival compared to the M28 parent strain, further confirming the role of M 
protein in promoting intracellular neutrophil survival by the serotype M28 MEW123 
strain, in addition to demonstrating correlation of m6A DNA base modifications with 
differential expression of M protein (Fig 2.6). These results provide further support for 
m6A DNA base modifications in S. pyogenes as important for promoting streptococcal 
virulence, possibly by influencing virulence factor expression.          
 
Disruption of m6A DNA modifications inhibits adherence to human vaginal 
epithelial cells in vitro, but does not appear to impair carriage in vivo in a murine 
vaginal colonization model. From the RNA-seq results we found that the ΔRSM strain 
had significantly decreased transcript expression of several recognized and known 
adhesin proteins, including M28, M-like protein, collagen-binding protein, and 
fibronectin-binding proteins, as well as several hypothetical surface proteins [38, 47-49]. 
As a group, serotype M28 S. pyogenes are overrepresented in cases of human infection 
within the female urogenital tract, including vulvovaginitis and puerperal sepsis (a.k.a. 
“childbed fever”) [50-53]. Serotype M28 S. pyogenes have a particular predilection for 
cervical and vaginal epithelium due to surface proteins, including protein R28 among 
others, which may explain the overrepresentation of this serotype with infections in this 
niche [15, 54]. Therefore, we asked if m6A DNA modifications influenced adherence of 
the serotype M28 MEW123 strain to human vaginal epithelial cells.  
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As shown in Figure 2.7A, disruption of m6A DNA modifications in the ΔRSM 
strain was indeed associated with significantly decreased adherence to human vaginal 
epithelial cells in vitro compared to the WT parent strain. The attenuation in vaginal 
epithelial cell adherence by the ΔRSM strain was comparable to a strain lacking 
expression of the M protein (Ωemm28), suggesting that decreased expression of M 
protein, among other adhesins, by the ΔRSM strain was at least partly responsible for 
decreased adherence (Fig 2.7A). To determine if impaired adherence to human vaginal 
cells in vitro translated to impaired vaginal mucosal colonization in vivo, we utilized a 
murine vaginal model and compared streptococcal carriage burdens over time [40, 55]. 
In contrast to the results of the in vitro adherence assay, using the murine vaginal 
carriage model we found no significant difference in vaginal streptococcal burdens in 
comparison of mice inoculated with either the WT or the ΔRSM strains over the course 
of the 28-day experiment (Fig 2.7B). Given that human cells are the natural hosts of S. 
pyogenes, this may be an example of the human-restricted nature of S. pyogenes in 
which a murine model cannot adequately replicate the natural human environment in 
which this pathogen evolved to survive. Nevertheless, our overall results showed 
several key differences in virulence phenotypes correlating with alterations in gene 
transcription associated with streptococcal m6A DNA methylation. 
 
Discussion 
In this report, we provide evidence that m6A DNA base modifications influence gene 
transcription patterns and overall virulence properties in a major gram-positive bacterial 
pathogen of humans, S. pyogenes. The S. pyogenes RM system, SpyMEW123I, is a 
Type I RM system and is responsible for the majority of m6A base modifications 
distributed throughout the S. pyogenes genome. The target consensus sequences 
identified by our study, 5' GCANNNNNTTYG and its corresponding partner motif 5' 
CRAANNNNNNTGC, were consistent with m6A motifs identified in S. pyogenes 
previously reported by Blow et al [5]. We found approximately 412 occurrences of each 
m6A site with the majority found within coding regions. Interestingly, we found that not 
all m6A sequence motifs were consistently modified to the same extent; only about 70% 
of consensus sites were modified in at least 75% of sequencing reads, suggesting that 
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m6A modifications may be intermittently present with additional functions beyond simple 
protection from restriction, including influencing gene expression patterns based on 
timing of hemi- or full-methylation status. It is not known at this time whether all of the 
m6A sites, or only the sites within the intergenic regions, would participate in influencing 
transcriptional expression, but methylation events modifying access of transcriptional 
regulators to intergenic promoter regions would be a potential mechanism.     
With the introduction of SMRT sequencing, groups have now identified m6A DNA 
modifications within a diversity of prokaryotes, including E. coli, Campylobacter jejuni, 
Salmonella enterica serovar Typhimurium, Vibrio breoganii, Geobacter metallireducens, 
Chromhalobacter salexigens, Bacillus cereus, and Borrelia burgdorferi [33-35, 56, 57]. 
Additional evidence of 5-methylcytosine (m5C) DNA modifications influencing 
transcriptional expression of multiple genes with an impact on several phenotypic traits 
has recently been described in Helicobacter pylori, further expanding the recognized 
influence of prokaryotic methylation modifications [58]. Some of the DNA modifications 
described have been linked to orphan MTases without an associated endonuclease, 
such as DNA Adenine Methyltransferase (Dam) of S. enterica, E. coli, and Haemophilus 
influenzae [56, 59, 60]. Uncoupling DNA methylation from restriction endonuclease 
protection is conceptually easier to envision with an orphan MTase, freeing the orphan 
MTase to have roles in DNA mismatch repair and influencing gene expression of 
potential virulence factors [6]. Indeed, Dam-dependent DNA modifications in S. enterica 
have been linked to alterations of gene expression and virulence [56]. However, two 
examples have recently been reported in C. jejuni and B. burgdorferi of intact RM 
systems also influencing gene expression patterns [34, 35]. Both of the RM systems in 
these organisms are representatives of Type IIG RM systems, which differ significantly 
from the Type I RM system described here for S. pyogenes in that they consist of a 
single polypeptide with both REase and MTase activity [34, 35, 61]. The effects on gene 
expression conferred by these systems in C. jejuni and B. burgforferi were noted by 
Casselli et al. to be more modest in terms of numbers of genes influenced by m6A base 
modifications when compared to the larger number of transcriptional changes found 
from the standalone activity of Dam MTase in Salmonella [34, 35, 56]. It would seem 
that with an intact RM system the conditions involved in determining gene expression is 
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more stringent and regulates a fewer number of genes than orphan MTases. DNA 
methylation from Type I RM systems has also been well-established in phase variation 
in a number of Gram-positive pathogens, including Streptococcus pneumoniae, 
Streptococcus suis, Listeria monocytogenes, and Mycoplasma pulmonis, which can 
have downstream effects on gene expression [62-65]. In phase variation, switching of 
specificity subunits of Type I RM systems results in cells with different sites of 
methylation within the population, which can create heterogeneity in gene expression. 
The role of methylation in phase variation differs from our findings here as we show that 
loss of methylation at a single site (i.e. not switching of specificity subunits to create 
methylation at diverse sites) results in the down regulation of a very defined subset of 
genes. 
The M.SpyMEW123I MTase activity we describe here modifies 412 sites in the 
MEW123 genome, whereas Dam-modified recognition sites approximate 19,000 per 
chromosome [56]. Perhaps the context of the m6A recognition motif in a particular 
intergenic promoter region, combined with specific transcription factors sensitive to the 
presence or absence of m6A modifications, determines the specificity of which genes 
an intact RM system will influence. Our results reported here demonstrate that the S. 
pyogenes Type I RM system is functional as a protective mechanism with restricting 
uptake of foreign DNA (Fig 2.2A). Similar results were found by Okada et al. in a series 
of emm1 S. pyogenes isolates from Japan with spontaneous deletions in their Type I 
RM systems; isolates lacking the Type I RM system had significantly increased rates of 
transformation with foreign plasmid DNA [21]. While their study did not specifically 
address virulence properties of isolates lacking the RM system, the authors speculated 
that enhanced rates of DNA uptake and transformation exhibited by strains lacking 
REase activity may be beneficial by allowing uptake of potentially advantageous genes 
from the environment contributing to overall fitness.  
Inactivation of the SpyMEW123I RM system was associated with significant 
dysregulation of gene transcript expression in broth culture, with 20 genes from at least 
six separate gene clusters/operons significantly down regulated (Table 2.4). Notable 
among the down regulated genes were the trans-acting regulator Mga, the M-like 
protein, M28 protein, C5a peptidase (ScpA), a cell surface protein, a collagen-like 
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surface protein (SclA), the Serum Opacity Factor (SOF), and a fibronectin-binding 
protein (SfbX). Most of these genes are regulated by the Mga transcriptional regulator in 
serotypes that have been investigated. Mga is a ubiquitous stand-alone regulator 
primarily active during exponential growth phase and is responsible for influencing 
expression of over 10% of the S. pyogenes genome, primarily genes involved in 
metabolism, but also many virulence factors including adhesins and surface proteins 
involved in immune evasion [37, 38]. Mga binds to upstream promoter regions to 
activate high-level transcription of genes in the Mga core regulon [66]. The majority of 
Mga-regulated promoters, including most of the genes in the core Mga regulon, contain 
a single Mga binding site centered around position -54 and overlapping the -35 region of 
the gene promoter, likely interacting with the α-subunit of RNA polymerase [67]. In 
theory, m6A base modifications at or around this site could potentially influence Mga 
and RNA polymerase binding to the promoter region, perhaps by stabilizing or localizing 
Mga to the proper site, promoting activation of gene transcription. Consistent with this 
hypothesis, examination of the genome sequences upstream of the Mga open reading 
frame for S. pyogenes strains MEW123, MEW427, and SF370, all reveal the existence 
of the m6A consensus motifs approximately 800 bp upstream of the mga start codon 
[12, 13, 20]. It is unclear if, or how, this m6A motif site located upstream of the predicted 
Mga promoter region activates Mga expression. The mechanism of m6A-dependent 
regulation of the mga locus is the subject of active investigation by our group.         
Regulation of virulence factor expression in response to different environmental 
cues and stresses is critical to the success of S. pyogenes survival and pathogenesis.  
Over 30 recognized transcriptional regulatory proteins and 13 two-component regulatory 
systems must function to coordinate virulence factor expression properly [17, 18]. We 
found that loss of m6A DNA modifications in our ΔRSM mutant correlated with 
significant changes in virulence properties of S. pyogenes. In a murine model of 
subcutaneous ulcer formation, we noted that mice infected with the ΔRSM mutant 
displayed enhanced inflammatory responses compared to mice infected with the WT 
strain, with comparatively larger skin lesions, increased detection of pro-inflammatory 
cytokine levels, and enhanced neutrophil infiltrates on histologic examination (Fig 2.4 
and 2.5). Disruption of m6A DNA modifications and an associated dysregulatio
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transcript expression may result in failed activation of multiple important adhesins and 
streptococcal proteins involved in evading host immunity (Fig 2.3 and Table 2.4). For 
example, neutrophilic infiltration in response to bacterial infections is enhanced by 
activity of host chemotaxins, chiefly complement protein C5a. A major virulence 
determinant of S. pyogenes aiding immune evasion is to degrade complement C5a 
through activity of ScpA, a surface-expressed, serine-protease specifically degrading 
host C5a and interfering with neutrophil recruitment [68]. We found that the ΔRSM 
mutant exhibited significantly decreased transcript expression for ScpA which may 
partly explain a more exaggerated neutrophil response to infection with the ΔRSM 
mutant strain, resulting in more inflammation and larger skin lesions (Fig 2.4C and 2.5). 
Previous investigation into the contribution of ScpA to host immune responses was 
performed using a murine air sac model of subcutaneous infection performed by Ji et al. 
[69]; air sacs infected with S. pyogenes lacking ScpA expression exhibited a 
significantly enhanced host inflammatory response compared to the WT parent, with a 
neutrophil predominance analogous to our results. Another report found similar to 
slightly larger skin lesions in mice infected subcutaneously with S. pyogenes lacking 
ScpA compared to WT [70]. The effect of S. pyogenes virulence factors in murine 
models is not always similar to activity in the human environment; it is known that ScpA 
does cleave murine C5a, but at slower rates compared to human C5a, and these 
differences may impact our ability to detect phenotypes in these non-human systems 
[71]. Similar to our own results with the ΩscpA strain infections, the results reported by 
Li et al. were not statistically significant suggesting that the individual contribution of 
ScpA in this murine model may be modest, but when the expression of multiple 
virulence factors is disrupted the effects may be more apparent. Indeed, our 
experiments in the skin lesion model with the ∆RSM and the ∆mga strains showed 
significant differences in lesion size and inflammatory response compared to the WT 
and complemented mutant strains. Both of these mutant strains would be expected to 
have similar patterns of differential gene expression and as result they phenocopy each 
other in this model. Decreased expression of several adhesins and other factors may 
have contributed to enhanced spread of the infection together with an exaggerated host 
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inflammatory response resulting in larger areas of inflammation and larger skin lesion 
formation.  
Decreased M protein expression, among other adhesins, also explains the 
decreased in vitro adherence of the ΔRSM mutant to human vaginal epithelial cells. 
Interestingly, the decreased adherence to human vaginal epithelial cells in vitro did not 
correlate with disrupted carriage in the murine vaginal mucosa colonization model. This 
suggests that there are additional adhesins not influenced by m6A DNA modifications 
that are important for promoting and maintaining carriage in vivo. One example would 
be the R28 adhesin of serotype M28 S. pyogenes strains, which is a major 
streptococcal adhesin to human cervical epithelial cells [54]. Our RNA-sequencing 
experiments did not find significant differences in the transcription of the MEW123 R28 
gene (AWM59_02815) between WT and the ΔRSM mutant (full data set available in 
NCBI repository). With only 20 genes significantly downregulated in the ∆RSM mutant 
clearly not all major S. pyogenes adhesins and virulence factors are impacted by m6A 
DNA modifications. Our data show that only a few gene operons, or regulons as in the 
case of Mga, are differentially expressed in the absence of m6A base modifications in 
S. pyogenes and that down regulation of these genes impacts virulence.        
In this study, we have demonstrated that the SpyMEW123I RM system and m6A 
DNA modifications in S. pyogenes significantly influence DNA restriction activity, in 
addition to correlating with differential gene transcription and virulence properties of this 
important human pathogen. Disruption of the SpyMEW123I Type I RM in S. pyogenes 
altered the transcriptional profile of the mutant strain resulting in attenuated virulence 
and impaired evasion of the host immune response in both in vitro and in vivo models. 
Similar to our results, disruption of Type IIG RM systems in C. jejuni and B. burgdorferi 
also interfered with genetic regulation of virulence factors of those pathogens [34, 35]. 
Together, these findings demonstrate that intact RM systems in these bacterial 
pathogens, and likely many other prokaryotes, can exert multiple functions, including 
restriction-mediated protection from foreign DNA in addition to influencing gene 
expression. Understanding how m6A DNA modifications influence virulence properties 
in these organisms could potentially identify targets for therapeutic intervention, 
potentially changing patterns of virulence factor expression resulting in strain 
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attenuation helping to prevent human disease. Further investigation is necessary to fully 
comprehend the many functions of DNA methylation and the complex nature of 
bacterial physiology and pathogenesis. 
 
Materials and Methods 
Ethics statement. Experimental protocols involving the use of mice were reviewed and 
approved by the Institutional Animal Care and Use Committee (IACUC) of the University 
of Michigan Medical School (Ann Arbor, MI, USA). The University of Michigan IACUC 
complies with the policies and standards as outlined in the Animal Welfare Act and the 
“Guide for the Care and Use of Laboratory Animals,” [72]. The protocol numbers 
approved by the University of Michigan IACUC are as follows: Skin and Soft Tissue 
Infection Model of Streptococcus pyogenes Virulence (PRO00007495), and Murine 
Vaginal Colonization Model for Streptococcus pyogenes (PRO00007218). For 
consistency, all experiments utilized female C57BL/6J mice at approximately 6 weeks of 
age at the time of use. Mice were purchased from The Jackson Laboratories (catalog 
#000664) (Bar Harbor, ME, USA), and maintained in a University of Michigan animal 
facility with biohazard containment properties. Following arrival, mice were allowed to 
acclimatize in the facility for one week prior to beginning experiments. When 
manipulated, mice were briefly sedated by inhalation of isoflurane via drop jar dosing. 
Animals were inspected at least once daily for evidence of suffering, manifested by 
significantly diminished or no activity, decreased appetite, poor grooming, increased 
respiratory rate, or weight loss greater than 15% of body weight; if evidence of suffering 
was identified, then the mouse was euthanized. Euthanasia was primarily through 
carbon dioxide asphyxiation with a subsequent secondary method of euthanasia, 
including induction of bilateral pneumothorax, decapitation, and/or removal of a vital 
organ.          
 
Bacterial strains, media, and growth conditions. The principal strain used in this 
study was S. pyogenes MEW123, a streptomycin-resistant (rpsLK56T), serotype M28 
pharyngeal isolate [55]. Other strains used are listed in Table 2.1. Growth rates and 
yields of MEW123 and associated mutant strains were measured using a Synergy HTX 
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plate reader (BioTek, Winooski, VT, USA) in 96 well plates (Greiner Bio-One, Monroe, 
NC, USA). Briefly, 4µl of overnight culture grown in THY broth was inoculated into 200µl 
of the described fresh media, with identical strains and conditions measured in at least 
triplicate. Growth was at 37oC, room air, in static conditions for 12 hours and 
OD620nm was measured every 3 seconds. Unless otherwise noted, all S. pyogenes 
strains had equivalent growth rates and yields under all in vitro conditions tested (S1 
Fig).  Routine culture of S. pyogenes was performed in Todd-Hewitt medium (Becton 
Dickinson, Franklin Lakes, NJ, USA) supplemented with 0.2% yeast extract (Difco 
Laboratories, Detroit, MI, USA) (THY media). Where required, Bacto agar (Difco) was 
added to a final concentration of 1.4% (w/v) to produce solid media. Gene expression 
experiments used C-Medium, a lower-glucose, higher-protein media that more closely 
resembles in vivo conditions [73]. Incubation was performed at 37°C under anaerobic 
conditions (GasPack™, Becton Dickinson) for solid media, or in sealed tubes without 
agitation for broth media. Aerobic culture was conducted as described [74]. For 
inoculation of mice, S. pyogenes was harvested from culture in THY broth at early 
logarithmic-phase (OD600 0.2), washed once in PBS, briefly sonicated on ice to break up 
long streptococcal chains, and resuspended in PBS to 108 CFU/mL. Molecular cloning 
used Escherichia coli strain DH5a (Invitrogen, Grand Island, NY, USA) cultured in LB 
broth. When appropriate, antibiotics were added at the following concentrations: 
erythromycin, 500 µg/mL for E. coli and 1 µg/mL for S. pyogenes; chloramphenicol, 20 
µg/mL for E. coli and 3 µg/mL for S. pyogenes; spectinomycin,100 µg/mL for both E. coli 
and S. pyogenes; and streptomycin, 1000 µg/mL for S. pyogenes. In some experiments, 
growth was monitored in THY broth supplemented with either penicillin, gentamicin, or 
erythromycin at concentrations ranging from 0.05 µg/mL to 100 µg/mL. All antibiotics 
were obtained from Sigma Chemical Co., St. Louis, MO, USA.      
 
Gene cloning and mutant construction. Streptococcus pyogenes MEW123 was used 
as a source strain for DNA, Genbank CP014139.1 [12]. Bacterial strains and plasmid 
vectors are listed in Table 2.1. The primers used for PCR amplification and cloning are 
listed in Table 2.5. For cloning and routine DNA Sanger sequencing, the Phusion High-
Fidelity DNA Polymerase (New England Biolabs, Inc., Ipswich, MA, USA) was used. For 
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routine endpoint PCR amplification standard Taq DNA Polymerase was used (New 
England Biolabs, Inc.). Polymerase chain reaction products were digested with 
indicated restriction enzymes and ligated to pJRS233 or pGCP213 for in-frame 
deletions, pSPC18 for insertional mutations, or pJoy3 as a plasmid vector for 
transformation efficiency assays. In-frame deletion mutants and insertional mutants 
were constructed essentially as described [25, 26], [28], and [27], respectively. 
a) Construction of an in-frame deletion of SpyMEW123I gene cluster. The 
DRSM in-frame deletion allele was cloned by splice overlap extension (SOE) PCR [75]. 
Corresponding GenBank accession numbers for the MEW123 restriction endonuclease 
gene hsdR, specificity subunit hsdS, and the methyltransferase subunit hsdM, are 
AWM59_07895, AWM59_07900, and AWM59_07905, respectively. The upstream 
region of the gene cluster was PCR amplified using primers MEW123 Del-RSM F1 and 
MEW123 Del-RSM R2, producing a 1.02 kb amplicon. The downstream region of the 
gene cluster was PCR amplified using primers MEW123 Del-RSM F3 and MEW123 
Del-RSM R4, producing a 1.02 kb amplicon. These two amplicons contain 
complementary ends that anneal together and essentially will produce an in-frame 
deletion of the three-gene restriction endonuclease, specificity subunit, and DNA 
methyltransferase open reading frames. The two amplicons were mixed together as 
template and further amplified using primers MEW123 Del-RSM F1 and MEW123 Del-
RSM R4, the resulting amplicon was approximately 2.04 kb and contained a unique 
EcoRI site at the 5’ end and a unique HindIII site at the 3' end. The resulting amplicon 
was digested with EcoRI and HindIII, and inserted within same restriction sites of the E. 
coli to S. pyogenes temperature-sensitive vector for allelic replacements, pGCP213 
[26], producing plasmid pKJ24. The pKJ24 plasmid was confirmed by Sanger DNA 
sequencing using primers MEW M13 F and MEW M13 R, which bind just outside and 
flank the multiple cloning site region within pGCP213. Electrocompetent cells of 
MEW123 were prepared and transformation was performed essentially as previously 
described [76]. The pKJ24 plasmid carrying the RSM in-frame deletion was transformed 
into electrocompetent S. pyogenes MEW123 through electroporation with conditions as 
described above. Erythromycin-resistant transformants were handled according to the 
temperature-sensitive selection protocol as previously described [26]. Final clones of S. 
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pyogenes that had successfully replaced the full-length genomic RSM gene cluster with 
the in-frame deletion allele were screened by endpoint PCR and confirmed by Sanger 
DNA sequencing. The resulting strain containing the in-frame deletion allele (∆RSM) 
was identified as MEW513.  
b) Construction of ∆RSM strain complemented in trans with plasmid-encoded 
RSM operon. GenBank accession numbers for the MEW123 restriction endonuclease 
gene hsdR, specificity subunit gene hsdS, and the methyltransferase subunit gene 
hsdM, are AWM59_07895, AWM59_07900, and AWM59_07905, respectively. The 
operon was cloned by PCR using primers pJoy3_123_RSM_F and pJoy3 123 RSM R, 
producing an amplicon of approximately 6 kb. This fragment was inserted into plasmid 
pJoy3 linearized by digestion with EcoRI and SphI using the NEBuilder® HiFi DNA 
Assembly kit (New England Biolabs, Inc.), producing plasmid pEH01. This plasmid was 
transformed into electrocompetent S. pyogenes MEW513 through electroporation with 
conditions as described above. Chloramphenicol-resistant clones were selected and 
screened by endpoint PCR, with restoration of m6A methylation activity confirmed by 
dot blot. The resulting strain containing the plasmid encoded RSM operon for 
complementation (∆RSM/pRSM) was identified as strain MEW552.     
c) Construction of spectinomycin-cassette disruption mutant of restriction 
endonuclease gene, hsdR. The GenBank accession number for the restriction-
endonuclease subunit gene, hsdR, is AWM59_07895. A fragment of the endonuclease 
open reading frame was cloned by PCR using primers 123_7895 F and 123_7895 R, 
producing an amplicon of approximately 950 bp. This fragment was inserted into 
plasmid pSpc18 linearized by digestion with HindIII and BamHI using the NEBuilder® 
HiFi DNA Assembly kit (New England Biolabs, Inc.), producing plasmid pKJ19. This 
plasmid was transformed into electrocompetent S. pyogenes MEW123 through 
electroporation with conditions as described above. Spectinomycin-resistant clones 
were selected and screened by endpoint PCR, with final confirmation by Sanger DNA 
sequencing. The resulting strain containing the spectinomycin-resistance cassette 
insertion disrupting the restriction endonuclease gene hsdR (ΩRE) was identified as 
strain MEW489.            
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d) Construction of in-frame deletion of mga. The GenBank accession number for 
the MEW123 Mga protein, gene mga, is AWM59_08335. An in-frame deletion allele of 
mga was cloned by splice-overlap extension (SOE) PCR [75]. The upstream region of 
the mga gene was cloned using primers M28 Mga 5’ SalI and M28 Mga 5’ SOE R, 
producing an amplicon of approximately 420 bp. The downstream region of the mga 
gene was cloned using primers M28 Mga 3’ BamHI and M28 Mga 3’ SOE F, producing 
an amplicon of approximately 410 bp. The two amplicons are mixed together as 
template and amplified using the outside primers M28 MGA 5’ SalI and M28 Mga 3’ 
BamHI, producing an amplicon of approximately 830 bp. This amplicon was 
subsequently digested with BamHI and SalI and ligated into the E. coli to S. pyogenes 
temperature-sensitive vector for allelic replacements, plasmid pJRS233 [25], cut 
similarly with BamHI and SalI. The resulting plasmid of was named pIL01, with 
confirmation by Sanger DNA sequencing and PCR verification. Electrocompetent cells 
of MEW123 were prepared and transformation with plasmid pIL01 was performed 
essentially as previously described [76]. Erythromycin-resistant transformants were 
handled according to the temperature-sensitive selection protocol as previously 
described [26]. Final clones of S. pyogenes that had successfully replaced the full-
length genomic mga allele with the in-frame deletion allele were screened by endpoint 
PCR and confirmed by Sanger DNA sequencing. The resulting strain containing the in-
frame deletion allele (∆mga) was identified as MEW480.  
e)  Construction of spectinomycin-cassette disruption mutant of strain 
MEW123 scpA gene (ScpA protein). The GenBank accession number for the 
MEW123 scpA gene is AWM59_08315. A fragment of the scpA open reading frame 
was cloned by PCR using primers M28 ScpA SalI F and M28 ScpA SacI R, producing 
an amplicon of approximately 1.1 kb. The amplicon was digested with SalI and SacI and 
ligated into plasmid pSpc18 linearized with SalI and SacI, producing plasmid pIL09. This 
plasmid was transformed into electrocompetent S. pyogenes MEW123 through 
electroporation with conditions as described above. Spectinomycin-resistant clones 
were selected and screened by endpoint PCR, with final confirmation by Sanger DNA 
sequencing. The resulting strain containing the spectinomycin-resistance cassette 
insertion disrupting the scpA gene (ΩscpA) was identified as strain MEW380.                     
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f) Construction of spectinomycin-cassette disruption mutant of strain 
MEW123 emm28 gene (M28 protein). The GenBank accession number for the M28 
protein, gene emm28, is AWM59_08325. A fragment of the emm28 open reading frame 
was cloned by PCR using primers M28 Emm Hindlll F and M28 Emm BamHl R, 
producing an amplicon of approximately 1.1 kb. This amplicon incorporated unique sites 
for HindIII and BamHI, and the amplicon was accordingly restriction digested and 
ligated into plasmid pSpc18 opened with HindIII and BamHI, producing plasmid pIL03. 
This plasmid was transformed into electrocompetent S. pyogenes MEW123 through 
electroporation with conditions as described above. Spectinomycin-resistant clones 
were selected and screened by endpoint PCR, with final confirmation by Sanger DNA 
sequencing. The resulting strain containing the spectinomycin-resistance cassette 
insertion disrupting the emm28 gene (Ωemm28) was identified as strain MEW409.   
 
Transformation efficiency assay. Transformation efficiency was assessed by 
electroporation of electrocompetent S. pyogenes strains with 0.5 µg plasmid pJoy3 
conferring chloramphenicol resistance isolated from E. coli DH5α. Electroporation was 
performed using a Gene Pulser II system (BioRad, Hercules, CA, USA) under the 
following settings; Volts at 1.75 kV, capacitance at 400Ω, and resistance at 25 µf. 
Transformants were plated onto THY agar supplemented with chloramphenicol. In 
addition, a separate aliquot of the sample was plated onto THY agar with no antibiotics 
to determine the total viable cell count. Transformation efficiency was determined as the 
number of chloramphenicol resistant cells per total viable cell count.  
 
SMRT sequencing. Genomic DNA was purified from S. pyogenes strains MEW123 
(WT) and MEW513 (DRSM) using the Wizard Genomic DNA Purification Kit (Promega, 
Madison, WI). Genomic DNA preparation, library preparation, and sequencing of 
MEW123 was performed as previously described [12]. For MEW513, one Single 
Molecule Real-Time (SMRT) cell was used to sequence the library prepared with 5 kb 
mean insert size on the Pacific Biosciences RSII sequencer by the University of 
Michigan Sequencing Core (https://brcf.medicine.umich.edu/cores/dna-sequencing). 
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Modification and motif analysis was performed using 
RS_Modification_and_Motif_Analysis.1 version 2.3.0 using the published MEW123 
reference genome with an average reference coverage of 501 and 539 for MEW123 
and MEW513, respectively. Data generated in this analysis have been deposited in 
NCBI’s Gene Expression Omnibus [77] and are accessible through GEO Series 
accession number GSE130428 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130428).   
 
Dot blot assay for m6A modification. Genomic DNA was isolated from S. pyogenes 
strains MEW123 (WT) and MEW513 (DRSM), as described above. DNA was treated 
with RNAse during purification to remove any contaminating mRNA or rRNA potentially 
containing m6A base modifications. DNA was denatured by heating at 98oC for 10 min 
and then placed immediately on ice for 5 minutes. Denatured DNA or unmodified 
oligonucleotides as a negative control was then spotted at 500 ng per spot onto 
nitrocellulose membranes and allowed to air dry. Membranes were then placed onto 
Whatman paper soaked with PBS containing 0.5% Tween 20 (PBST), and DNA was 
cross-linked to the membranes using a Bio-Rad GS Genelinker using two 125 mJ 
delivery cycles. Membranes were blocked in 5% milk protein in PBS for 1 h at room 
temperature and then incubated with a dilution of anti-m6A primary rabbit antibody (2 
µg/mL) (EMD Millipore ABE572 Anti-N6-methyladenosine (m6A) Antibody) in 5% milk 
PBS overnight at 4oC. Primary antibody was removed and the membrane was washed 
three times with PBST for 5 minutes each wash. The membrane was then incubated 
with a 1:5,000 dilution of horseradish peroxidase-conjugated anti-rabbit secondary 
antibody in 5% milk PBS at room temperature for 1 hour. The secondary antibody was 
removed, and the membrane washed with PBST three times for 5 minutes each wash. 
Chemiluminescent substrate (Pierce SuperSignal West Femto HRP Substrate, 
ThermoFisher Scientific, Waltham, MA) was applied and the membrane was visualized. 
 
RNA-sequencing. Streptococcus from fresh overnight growth on THY agar plates was 
inoculated into 40 mL of C-media broth and grown statically to mid-log phase OD600nm of 
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0.6. RNA was then purified using the RiboPure RNA Purification Kit (Life Technologies), 
for bacteria according to the manufacturer’s recommendations. The University of 
Michigan Sequencing Core performed ribosomal rRNA depletion using the Ribo-Zero 
Magnetic Kit, bacteria and subsequent library preparation. Fifty-base single end reads 
were sequenced on the Illumina HiSeq 4000. Sequence alignment was performed using 
the Burrows-Wheeler Aligner (BWA) version 0.7.8-r455 to the MEW123 reference 
genome [12]. Subsequent differential expression analysis was performed using the  
limma package in R [78]. Differentially expressed genes were called as those that had a 
Benjamini-Hochberg adjusted p-value less than 0.05 and a log2 fold change greater 
than 1. Log2 CPM values were computed using edgeR and were subsequently used to 
construct the heatmap using the aheatmap function as part of the NMF package in R 
[79, 80]. Data generated in this analysis have been deposited in NCBI’s Gene 
Expression Omnibus [77] and are accessible through GEO Series accession number 
GSE130427 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130427).   
 
Real-time PCR for comparison of transcript expression. Based on results of the 
most significantly differentially expressed genes between WT (MEW123) and ∆RSM 
(MEW513), three genes were selected for independent reverse-transcription cDNA 
preparation and real-time PCR amplification for relative comparison of transcript 
expression; mga, emm28, and scpA. RNA was isolated as described above from strains 
grown in C-media broth to mid-log phase OD600nm of 0.6. Synthesis of cDNA was 
performed using the iScript™ cDNA Synthesis Kit (BioRad). Real time amplification of 
select genes was performed using an iCycler Thermocycler (BioRad) and iQ SYBR 
Green Supermix (BioRad). Sequences for RT-PCR primers are as shown in Table 2.5. 
Relative transcript levels were determined using the recA transcript as reference by the 
2(-DDCt) method [81]. All RNA was stored at -80ºC. All cDNA was stored at -20ºC or 
utilized directly for comparative RT-PCR analysis. For each experiment, three biological 
replicates were analyzed in duplicate. Statistical significance was examined using the 
paired t-test in Prism 6 (GraphPad).  
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Murine subcutaneous infection model. Inflammatory infection of murine 
subcutaneous tissue was conducted as described in detail [41]. On the day of infection, 
mice sedated by inhalation of isoflurane received a subcutaneous injection of 100 µl 
PBS containing 1 x 107 S. pyogenes into the shaved flank. Following infection, the 
resulting ulcers were photographed over several days and the areas of the irregular 
lesions were calculated using ImageJ software as described in detail elsewhere [82, 
83]. Skin biopsies were obtained from euthanized mice and homogenized in 1 mL ice 
cold PBS using a FastPrep-24 homogenizer (MP Biomedicals, LLC., Santa Ana, CA); 
tissue was homogenized in 2 mL conical screw top vials with 3.2 mm stainless steel 
beads (Fisher Scientific, Pittsburg, PA) with two FastPrep cycles of speed 6.0 for 45 
sec, with a 5 min ice incubation between pulses to prevent overheating.  
 
Murine tissue cytokine analysis. Samples of mouse skin and subcutaneous tissue 
homogenates were harvested at six-days post-infection. Cytokine protein 
concentrations were determined by a multiplex murine ELISA assay (EMD Millipore, 
Billerica, MA, USA) according to the manufacturer's protocol. 
 
Murine tissue histologic analysis. Murine skin biopsies were obtained at six-days 
post-infection and were fixed in 4% formalin and dehydrated up to 70% ethanol prior to 
paraffin embedding through the University of Michigan Pathology Core for Animal 
Research (PCAR). H&E staining and immunohistochemistry services were performed 
by the PCAR using commercially available anti-CD3 (T lymphocytes), and anti-F4/80 
(macrophages) antibodies (Abcam, Cambridge, MA, USA). Digital images were 
obtained with an EC3 digital imaging system (Leica Microsystems, Buffalo Grove, IL, 
USA) using Leica Acquisition Software (Leica Microsystems). Adjustments to contrast in 
digital images were applied equally to all experimental and control images. 
 
Human vaginal epithelial cell in vitro assays. Adherence of S. pyogenes strains was 
assessed to an established human vaginal epithelial cell line, VK2/E6E7, using methods 
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similar to those previously described [84-86]. The human vaginal epithelial cell line 
VK2/E6E7 was purchased from the American Type Culture Collection (ATCC, 
Manassas, Virginia), and cells were grown and maintained in media and conditions as 
recommended by ATCC. Human cells were grown to confluence in 12-well tissue 
culture-treated plates and washed with sterile PBS prior to inoculation with bacteria. S. 
pyogenes strains were grown in THY broth to early stationary phase (OD600nm 0.6), 
washed twice in sterile PBS, and adjusted to give an inoculum of ~5 x 106 CFU in 1 mL 
per well, for a multiplicity of infection (MOI) of ~5. Bacteria and human cells were 
incubated at 37oC in 5% carbon dioxide for 60 min, after which time the supernatants 
were removed and cells were washed four times with 2 mL sterile PBS to remove non-
adherent organisms. To recover S. pyogenes from the epithelial cells, each well was 
treated with 0.2 mL 0.25% Trypsin-EDTA (Invitrogen) and incubated at 37oC for 5 min, 
and then lysed by addition of 0.8 mL sterile water at pH 11. Lysis in water at pH 11 was 
shown to result in a more complete eukaryotic cellular breakdown with maximal 
recovery of bacteria from the surface in addition to intracellular reservoirs [87]. This 
method recovers all cell-associated streptococci, predominantly extracellular adherent 
cells with a relatively smaller amount of intracellular cells. The cell suspension was 
serially diluted in PBS and plated onto THY agar for determination of viable CFU count. 
The total cell-associated CFU percentage was calculated as (total CFU recovered from 
the well/CFU of the original input inoculum) x 100%.  
 
Murine vaginal colonization model. Experiments were performed as previously 
described [55]. To synchronize estral cycles, sedated mice were estrogen 
supplemented by intra-peritoneal injection with 0.5 mg b-estradiol 17-valerate (Sigma) 
dissolved in 0.1 mL sterile sesame oil (Sigma) 2 days prior to streptococcal inoculation 
and again on the day of inoculation (considered day #0). On day #0, sedated mice were 
inoculated with ~1 x 106 colony forming units (CFUs) instilled into the vaginal vault using 
a P20 micropipetter (Gilson, Inc., Middleton, WI) in a total volume of 20 µL PBS. At 
successive intervals over a 1-month period post-inoculation, the vaginal vaults of 
sedated mice were gently washed with 50 µL sterile PBS and serial dilutions in sterile 
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PBS were plated onto THY agar plates supplemented with 1000 µg/mL streptomycin to 
determine viable CFUs. This concentration of streptomycin suppressed growth of 
normal mouse vaginal flora but had no effect on the plating efficiency of the 
streptomycin-resistant S. pyogenes strains. For colonization experiments, between 5 to 
20 mice were tested per S. pyogenes strain, as indicated in the relevant figure legends.  
 
Human neutrophil bactericidal activity assay. Human neutrophils were purchased 
from a commercial supplier (Astarte Biologics, Bothell, WA, USA) and prepared 
according to supplier recommendations to a concentration of 5 x 106 cells/mL in room 
temperature Hank’s Balanced Salt Solution (HBSS). Neutrophil bactericidal assay was 
performed similar to that reported by Staali et al. [45]. Briefly, streptococcal strains were 
grown in fresh C-media to mid-log phase (OD600nm of 0.6) and were washed twice in 
HBSS with calcium and magnesium, but without Phenol Red (Sigma, St. Louis, MO, 
USA). Streptococci were counted using a hemocytometer and adjusted to a 
concentration of 5 x 107 CFU/mL in room temperature HBSS. Neutrophils and 
streptococci were mixed in a 1:10 ratio of neutrophils to bacteria, and were incubated 
together for 10 minutes at 37oC. Next, extracellular streptococci were eliminated by 
addition of gentamicin (100 µg/mL) and penicillin (5 µg/mL) in HBSS for 20 minutes at 
37oC. Next, cells were diluted in 1 mL of HBSS, centrifuged at 400g x 5 min, and 
washed with 1 mL fresh HBSS. The wash was repeated a second time in HBSS and the 
final cell pellet was resuspended in 50 µL of 2% saponin in distilled water at pH 11 and 
allowed to remain at room temperature for 20 minutes to lyse neutrophils and release 
viable intracellular streptococci. The cells were diluted in distilled pH 11 water and 
aliquots plated onto fresh THY agar media for CFU counts. Three biological replicate 
experiments for each strain were performed.      
 
Statistical analyses. Comparison of nonparametric data sets was performed using the 
Mann-Whitney U-test to determine significant differences. Differences between groups 
for recovery of CFU in vaginal washes were tested using a repeated measures analysis 
of variance. Differences in relative transcript levels were tested for significance with a 
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two-tailed paired t-test. Differences in VK cell adherence and in neutrophil bactericidal 
survival assays were compared using a non-paired t-test. For all tests, the null 
hypothesis was rejected for P < 0.05. Computation utilized the resources available in 
GraphPad Prism™ (GraphPad Software, Inc., San Diego, CA). 
  
	 67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.1. M.SpyMEW123I dependent m6A modifications in the S. pyogenes 
genome. A) Genomic organization of the SpyMEW123I Type I RM system gene cluster, 
hsdRSM, in strain MEW123 (WT) and the MEW513 in-frame deletion mutant ( RSM). 
B) Detection of genomic m6A base modifications (red line) in the MEW123 genome or 
the ∆RSM genome via PacBio SMRT sequencing. Modification quality values (modQVs) 
are indicated on the x-axis and the number of bases is indicated on the y-axis. ModQVs 
indicate if the polymerase kinetics at a position differs from the expected background, 
where a modQV of 30 corresponds to a p-value of 0.001. C) Dot blot with α-m6A 
antibody on genomic DNA isolated from the following strains: MEW123 (WT), restriction 
endonuclease hsdR antibiotic cassette-disruption mutant MEW489 (ΩRE), in-frame 
deletion of the hsdRSM gene cluster (∆RSM), the ∆RSM strain complemented with 
plasmid-encoded hsdRSM (∆RSM/pRSM), and unmodified DNA oligonucleotides 
serving as a negative control (Neg cont.) (500 ng DNA per spot).  
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Fig. 2.2. The Type I RM system, SpyMEW123I, is functional for endonuclease 
activity and influences transformation efficiency. A) Transformation efficiencies of 
WT (MEW123), the hsdRSM in-frame deletion (DRSM, MEW513), the hsdR single-gene 
disrupted mutant (ΩRE, MEW489), and the scpA insertional inactivation mutant (ΩscpA, 
MEW380). A Mann-Whitney U test was used to identify significant differences between 
groups for transformation efficiency; ** P < 0.01, *** P < 0.001, n = 3-7 replicates per 
point. B) Each SpyMEW123I RM site is represented on the plot where the position that 
the site occurs in the genome (from 0 Mb -1.8 Mb) is represented on the x-axis. The 
fraction of reads called as methylated from PacBio SMRT sequencing for each RM site 
is represented on the y-axis. RM sites that occur on the + and –  strand of the DNA 
duplex are represented by green triangles and red dots, respectively. 
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Fig. 2.3. Gene transcripts involved in immune evasion and adherence are down 
regulated in the ΔRSM strain compared to WT. A) Heatmap of differentially 
expressed genes between WT and ΔRSM strains. Replicates in triplicate are 
represented on the x-axis and published/putative gene functions are on the y-axis with 
gene references to the MEW123 genome. Relative expression is compared row-wise 
with more highly expressed replicates in red. B) Verification of RNA-Seq data using 
qRT-PCR with individual primer sets shown on the x-axis for the DRSM mutant (blue), 
complemented mutant strain ∆RSM/pRSM (green), hsdR single gene mutant ΩRE 
(orange), and the ∆mga mutant (purple). The y-axis indicates Relative Transcript Levels 
for individual transcripts compared to recA reference transcript. Each gene transcript 
was analyzed in triplicate. Shown is fold change compared to WT expression, with 
genes showing greater than two-fold change as significant. Genes extending lower than 
the x-axis were down-regulated several hundred-fold. 
 
 
  
	 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 71 
Fig. 2.4. Deletion of the MEW123 RSM gene cluster is associated with larger skin 
lesion formation in a murine subcutaneous infection model. C57BL/6J mice were 
inoculated subcutaneously at the shaved flank with 1x107 CFUs MEW123 (WT, red 
squares) or the DRSM mutant (blue squares) on Day 0. Lesions were photographed 
daily and lesion area was calculated using ImageJ software. A) Shown are individual 
mouse lesion area sizes with mean values (black bars) over Days Post-Infection (DPI). 
A Mann-Whitney U test was used to identify significant differences in lesion size 
between strains at each time point; ns, not significant,  * P < 0.05, *** P < 0.001. B) 
Representative images of mice skin lesions over time at days 2-, 4-, and 6-days post-
infection. Shown are skin lesions following infection with MEW123 (WT), MEW513 
(∆RSM), and the complemented strain MEW552 (∆RSM/pRSM). Black bars are 1 cm 
for reference. Black dashed lines highlight the area of tissue injury. C) Shown are 
individual mouse lesion area sizes from a representative experiment with mean values 
(black bars) over Days Post-Infection. Shown are lesions from mice infected with 
MEW123 (WT), MEW513 (∆RSM), the complemented strain MEW552 (∆RSM/pRSM), 
the in-frame deletion of Mga, MEW480 (∆mga), the cassette-insertion disruption mutant 
of emm28, MEW409 (Ωemm28), and the cassette-insertion disruption mutant of scpA, 
MEW380 (ΩscpA). A Mann-Whitney U test was used to identify significant differences in 
lesion size between strains at each time point; * P < 0.05.   
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Fig. 2.5. Deletion of the MEW123 RSM gene cluster increases the host 
inflammatory cytokine response in the murine subcutaneous infection model. 
C57BL/6J mice were inoculated subcutaneously at the shaved flank and resulting 
lesions were dissected on day 6 post-infection for cytokine analysis (panel A) and 
histology (panel B). A) Shown are ELISA results of homogenized murine skin biopsy 
specimens from mice previously inoculated with sterile phosphate buffered saline (PBS, 
black bars), 1x107 CFUs MEW123 (WT, red bars), or 1x107 CFUs of the DRSM mutant 
(DRSM, blue bars). Results are pooled from biopsies of 3 mice per group with mean and 
SEM cytokine concentrations. A Mann-Whitney U test was used to identify significant 
differences in cytokine concentration; ns, not significant,  * P < 0.05, ** P < 0.01. B) 
Representative images at 10X magnification of skin biopsies from mice inoculated with 
MEW123 (WT, upper row), or the DRSM mutant (DRSM, bottom row). Slides were 
stained with hematoxylin and eosin (H&E) for general neutrophil and overall 
inflammatory response, or specifically by immunohistochemistry for T cells (a-CD3) or 
macrophages (a-F4/80). Focal areas of intense inflammation were outlined with dashed 
lines for comparison.  
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Fig. 2.6. Deletion of MEW123 RSM gene cluster impairs resistance to human 
neutrophil bactericidal activity. Streptococcal resistance to human neutrophil 
bactericidal activity was examined using an in vitro assay. Human neutrophils were 
incubated with S. pyogenes strains in a 1:10 ratio for 10 min. Extracellular streptococci 
were eliminated with gentamicin and penicillin for 20 min. Neutrophil lysis and release of 
viable intracellular streptococci was performed with 2% saponin in pH 11 water for 20 
min. Surviving CFUs were plated onto THY agar. Shown are streptococcal strains 
HSC5 (M14) as a positive control, the HSC5 Ωemm (M14 Ωemm) as a negative control, 
MEW123 (M28), MEW123 Ωemm (M28 Ωemm), and the MEW123 RSM deletion mutant 
(M28 ∆RSM). Shown are mean ± SEM CFU counts performed in triplicate from a 
representative experiment. An non-paired t-test was used for statistical significance, 
comparing mutant to parent strain; * P < 0.05, *** P < 0.001. 
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Fig 2.7. Deletion of MEW123 RSM gene cluster impairs streptococcal adherence 
to human vaginal epithelial cells, but does not impact carriage duration in a 
murine vaginal colonization model. A) Confluent wells of VK E6E7 human vaginal 
epithelial cells were inoculated with 5x106 CFUs of S. pyogenes MEW123 (WT, red), the 
emm28 gene-disrupted mutant (Ωemm28, gray), or the RSM deletion mutant (DRSM, 
blue) (multiplicity of infection 5-10:1). Following 1h incubation, non-adherent 
streptococci were washed away with sterile PBS followed by lysis of the epithelial cells 
with pH 11 water, serial dilution, and determination of viable streptococci remaining. The 
% Cell Associated (mostly adherent plus few intracellular) is the percentage of the 
inoculum CFUs remaining detectable at 1h. Significant differences between groups 
were calculated by non-paired t-test (** P < 0.01, n = 6 replicates per point). B) 
Estrogenized female C57BL/6J mice were intravaginally inoculated with 1x106 CFU of 
S. pyogenes MEW123 (WT, red), or the RSM deletion mutant (DRSM, blue). Mice were 
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cultured by intravaginal washes with sterile PBS and plated onto selective media (THY 
supplemented with streptomycin 1000 µg/mL) for quantification. Shown are mean ± 
SEM Log10 CFU counts over time post-infection of 10 mice per group pooled from two 
separate experiments. A repeated-measures ANOVA was used for statistical 
significance; at no time point tested over the 28-day experiment were the two groups 
statistically significantly different. 
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Fig. 2.8. Growth curves of WT and ∆RSM mutant are similar in THY broth and C-
media, and in THY-broth containing penicillin, gentamicin, or erythromycin. 
Growth was monitored using a Synergy HTX plate reader (BioTek) in 96 well plates 
(Greiner Bio-One). Briefly, 4µl of overnight culture grown in THY broth was inoculated 
into 200µl of the described fresh media, with identical strains and conditions measured 
in at least triplicate. Growth was at 37oC, room air, in static conditions for 12 hours (time 
on X-axis) and OD620nm was measured every 3 seconds (Y-axis). Where indicated, 
antibiotic was added to THY broth at concentrations ranging from 0.05 µg/mL to 100 
µg/mL, with concentrations shown in the color-coded key on the right [µg/mL].  
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Fig. 2.9. Streptococcal CFU counts in skin lesions at day 4 post-infection. Skin 
lesions from infected mice were dissected on day#4 post-infection and homogenized in 
1 mL sterile PBS. The homogenate was serially diluted in sterile PBS and plated onto 
THY agar plates containing streptomycin (1000 µg/mL) to select for S. pyogenes strain 
MEW123 and its mutants. Each point represents the CFU counts from one mouse 
lesion, with black bars indicating mean CFU values for that group. Groups are MEW123 
(WT), MEW513 (∆RSM), MEW552 (∆RSM/pRSM), and MEW480 (∆mga). The Mann-
Whitney U-test was used to test for statistical significance, though none were 
statistically different from the WT strain.  
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Table 2.1. Strains used in this study. 
Strain/Plasmids Description Source 
Strains 
Escherichia coli 
DH5α Standard cloning vector, recA1 endA1 hsdR17 Invitrogen 
Streptococcus pyogenes 
MEW123 Streptomycin-resistant clone of pediatric throat isolate, serotype M28 [12] 
MEW380 MEW123 transformed by plasmid pIL09 to insertionally-inactivate scpA gene by spectinomycin resistance marker (ΩscpA) This study 
MEW409 MEW123 transformed with plasmid pIL03 to insertionally-inactivate M protein, emm gene, by spectinomycin resistance marker (Ωemm28) This study 
MEW480 MEW123 with in-frame deletion of mga (∆mga) by allelic exchange after transformation with plasmid pIL01  This study 
MEW489 MEW123 transformed with plasmid pKJ19 to insertionally-inactivate restriction endonuclease with spectinomycin resistance marker (ΩRE) This study 
MEW513 MEW123 with restriction-modification system in-frame deletion (ΔRSM) by allelic exchange after transformation with pKJ24 This study 
MEW552 MEW513 with RSM operon complemented in trans on plasmid pEH01 (∆RSM/pRSM) This study 
HSC5 Serotype M14 reference strain [23] 
HSC5 Ωemm HSC5 mutant with the M protein, emm14 gene, disrupted by spectinomycin resistance marker (Ωemm14) [24] 
Plasmids 
 
 
pJRS233 Low-copy E. coli to S. pyogenes temperature-sensitive vector for allelic replacement (erythromycin-resistant, ErmR) [25] 
pGCP213 High-copy E. coli to S. pyogenes temperature-sensitive vector for allelic replacement (ErmR) [26] 
pJoy3 E. coli to S. pyogenes shuttle vector (chloramphenicol-resistant, ChlorR) [27] 
pSpc18 integration vector containing aad9 (spectinomycin resistance gene from Enterococcus faecalis) (SpcR) [28] 
pIL01 pJRS233 with in-frame deletion of mga (ErmR) This study 
pIL03 pSpc18 with emm28 gene fragment disruption (SpcR) This study 
pIL09 pSpc18 with scpA gene fragment disruption (SpcR) This study 
pKJ19 pSpc18 with restriction endonuclease gene fragment disruption (SpcR) This study 
pKJ24 pGCP213 with in-frame deletion of restriction-modification gene cluster (ErmR) This study 
pEH01 pJoy3 with intact RSM operon cloned for complementation (ChlorR) This study 
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Table 2.2. Motif analysis of modified bases from PacBio SMRT sequencing in wild type S. 
pyogenes strain MEW123. 
Motif* Type Motifs in 
genome 
Mean modQV Mean 
coverage 
GCANNNNNNNTTYG m6A 412 332.64 245.02 
CRAANNNNNNNTGC m6A 412 282.18 237.32 
THTWGAAGA unknown 410 44.74 240.57 
ANDYVGCAD m6A 3502 86.17 241.02 
TNRRDDDG unknown 34390 44.88 235.68 
TNNNDNNH unknown 746710 47.81 235.15 
THRGCNTWNH unknown 3107 43.39 237.84 
AGNNAVNW m6A 32122 78.13 239.29 
TNNNCRV unknown 77468 45.11 235.03 
VAHNBAVYW m6A 27467 76.34 242.45 
THNNDVNG unknown 96451 43.43 237.89 
*modified base is bolded and underlined 
 
 
Table 2.3. Motif analysis of modified bases from PacBio SMRT sequencing in ΔRSM 
strain. 
Motif* Type Motifs in 
genome 
Mean modQV Mean 
coverage 
TYTWGARGR unknown 701 46.56 263.00 
DAGKBANYW m6A 5826 88.94 256.78 
ANNYRGYA m6A 8371 85.54 259.83 
GAHBBAACA m6A 499 125.47 268.90 
TNNNDNNH unknown 746710 49.02 251.20 
TNRRDDDG unknown 34390 45.12 251.97 
THRGCNTH unknown 5464 43.69 253.61 
TNNNCRV unknown 77468 45.81 251.94 
DTNRVCBNHNH unknown 29343 44.13 251.93 
AHSBAMYW m6A 9198 75.01 265.11 
THNNDVNG unknown 96451 44.13 256.11 
*modified base is bolded and underlined 
 
Table 2.4. Differentially expressed genes in ΔRSM strain compared to WT.  
Cluster MEW123 Locus  
Fold-Change 
(Log2) Ave Expr adj.P.Val Prob Product Annotation 
1 AWM59_00940 -3.88 1.98 0.00 1.00 hypothetical protein 
1 AWM59_00945 -3.16 1.30 0.00 0.98 hypothetical protein 
2 AWM59_02865 -1.14 6.80 0.01 0.89 cell surface protein 
2 AWM59_02875 -1.12 3.04 0.05 0.45 conjugal transfer protein 
2 AWM59_02880 -1.29 4.30 0.04 0.46 cell division protein (FtsK) 
2 AWM59_02900 -1.14 2.87 0.01 0.87 hypothetical protein 
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3 AWM59_07395 -1.23 6.09 0.03 0.55 hypothetical protein 
3 AWM59_07430 -4.12 5.14 0.00 1.00 hypothetical protein 
4 AWM59_07895 -10.73 4.10 0.00 1.00 Endonuclease hsdR 
4 AWM59_07900 -11.69 3.07 0.00 1.00 Specificity hsdS 
4 AWM59_07905 -10.79 3.98 0.00 1.00 Methyltransferase hsdM 
5 AWM59_08190 -5.60 5.26 0.00 0.99 Collagen-like surface protein A (SclA) 
5 AWM59_08310 -2.38 6.45 0.00 0.99 LPXTG anchor domain surface protein 
5 AWM59_08315 -4.32 5.53 0.00 1.00 peptidase C5 (ScpA) 
5 AWM59_08325 -8.65 5.31 0.00 1.00 M28 protein (M28) 
5 AWM59_08330 -8.01 6.54 0.00 1.00 emm-like protein 
5 AWM59_08335 -1.24 6.39 0.04 0.45 Trans-Acting Positive Regulator (Mga) 
6 AWM59_08385 -4.57 6.93 0.00 1.00 fibronectin-binding protein (SfbX) 
6 AWM59_08390 -5.11 7.31 0.00 1.00 Serum Opacity Factor (SOF) 
6 AWM59_08395 -6.47 3.57 0.00 1.00 hypothetical protein 
 
Table 2.5. Primers used in this study. 
Primer Sequence 5'-3' (restriction sites underlined) 
MEW123 Del-RSM F1  ATATGAATTCGGTTTTTTGGTAAAAAACTTTTTTAGCA 
MEW123 Del-RSM R2  TTTTTTGGTCTTTTTTAATCCCCATTCGACATGATA 
MEW123 Del-RSM F3  TGGGGATTAAAAAAGACCAAAAAACACCACAGTAGA 
MEW123 Del-RSM R4  ATATAAGCTTTTAATTTAACAAATATTTCTAAAGAAAATGGATTGG 
pJoy3 123 RSM F ACCATTATTGTGAGGAACTGCGTTACCGATCCCTTAAAAG 
pJoy3 123 RSM R ACCGATAGCACCCGCGCATGGATGAGATGATTCTATTTTGATTTATAG 
123_7895 F TAAAACGACGGCCAGTGCCAATCTCTTAGAAACAGGTGAAAG 
123_7895 R ATTCGAGCTCGGTACCCGGGAGATATCATTTTGCGCATAG 
M28 Emm Hindlll F CCCAAGCTTATAAACAGTATTCGCTTAGAAAATTAAAAACAGG 
M28 Emm BamHI R CGCGGATCCGTTAGCTGCTTCGCCTGTTGACGGTAACG 
M28 ScpA SalI F CCCGTCGACCTCAATGCACAATCAGACATTAAAGC 
M28 ScpA SacI R CCCGAGCTCTCAATATCGCCACGTTCAATAAGG 
M28 Mga 5’ SalI CCCGTCGACTGACAATAATGTCACAGAT 
M28 Mga 5’ SOE R TTGTTGGCTAGTAAACAATTTACTTACATGC 
M28 Mga 3’ SOE F GTTTACTAGCCAACAAGCAACATCATCATAGGATTTCAGACG 
M28 Mga 3’ BamHI CGCGGATCCCGCTCTTCGAATACTTTGTT 
Emm28 RT-PCR F CAGACTTAGCAGAAGCAAATAGC 
Emm28 RT-PCR R CAGCTTGTTTAGCCAATTGCTC 
Mga RT-PCR F CTTATCTACCCTCAAACGCCTC 
Mga RT-PCR R CGAATTTGCCTCTCATCTCCTG 
ScpA RT-PCR F CACTGATTTTGATGTGATTGTAGACAA 
ScpA RT-PCR R ATGCAAGTGTCAAACGACGATCT 
recA RT-PCR F ATTGATTGATTCTGGTGCGG 
recA RT-PCR R ATTTACGCATGGCCTGACTC 
MEW M13 F CAGGGTTTTCCCAGTCACGAC 
MEW M13 R GAGCGGATAACAATTTCACACAGG 
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CHAPTER III 
 
Methyltransferase DnmA is Responsible for Genome-wide 
N6-methyladenosine Modifications at Non-palindromic Recognition Sites in 
Bacillus subtilis 
 
 
  
Abstract 
The genomes of organisms from all three domains of life harbor endogenous base 
modifications in the form of DNA methylation. In bacterial genomes, methylation occurs 
on adenosine and cytidine residues to include N6-methyladenine (m6A), 5-
methylcytosine (m5C), and N4-methylcytosine (m4C). Bacterial DNA methylation has 
been well characterized in the context of restriction-modification (RM) systems, where 
methylation regulates DNA incision by the cognate restriction endonuclease. Relative to 
RM systems less is known about how m6A contributes to the epigenetic regulation of 
cellular functions in Gram-positive bacteria. Here, we characterize site-specific m6A 
modifications in the non-palindromic sequence GACGmAG within the genomes of 
Bacillus subtilis strains. We demonstrate that the yeeA gene is a methyltransferase 
responsible for the presence of m6A modifications. We show that methylation from 
YeeA does not function to limit DNA uptake during natural transformation. Instead, we 
identify a subset of promoters that contain the methylation consensus sequence and 
show that loss of methylation within promoter regions causes a decrease in reporter 
expression. Further, we identify a transcriptional repressor that preferentially binds an 
unmethylated promoter used in the reporter assays. With these results we suggest that 
m6A modifications in B. subtilis function to promote gene expression. 
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Introduction 
DNA methylation is pervasive across all three domains of life. In eukaryotes, 5-
methylcytosine (m5C) modifications have been shown to function in development and 
the regulation of gene expression, with aberrant methylation implicated in human health, 
including cancer, autoimmune diseases, and metabolic disorders [for review, (1,2)]. 
m5C in promoter regions has been linked to the repression of downstream gene 
transcription, whereas gene body methylation has been positively correlated with gene 
expression [for review (3)]. A lesser-studied modification in the genomes of eukaryotes 
is N6-methyladenine (m6A). Recent studies have identified m6A in the genomes of 
Chlamydomonas, Caenorhabditis elegans and Drosophila melanogaster (4-6). In 
contrast to promoter m5C, m6A modifications appear to function in gene activation in 
the algae Chlamydomonas (4) and promoter m6A is also important in early Drosophila 
development (5). Further, m6A was positively correlated with gene expression in a 
diverse set of fungi (7). Thus, there is a growing recognition that m6A is critical for the 
regulation of gene expression in a broad range of eukaryotic organisms.   
Bacterial genomes are known to harbor N4-methylcytosine (m4C) in addition to 
m5C and m6A [(8) and references therein]. All three modifications impart consequences 
to bacterial cells when methylation is lost (9). The most well understood example of 
DNA methylation in eubacteria is in the context of restriction-modification (RM) systems 
[for review (10,11)]. RM systems function as a bacterial host defense mechanism to 
prevent the invasion of foreign DNA, including phages and other mobile genetic 
elements (10,11). In organisms with RM systems, unmethylated foreign DNA is targeted 
for site-specific cleavage by a restriction endonuclease while the host chromosome is 
protected at the recognition sequence by site-specific DNA methylation (12). 
Methylation is achieved through the activity of DNA methyltransferases (MTases). 
MTases catalyze the transfer of a methyl group from the donor S-adenosylmethionine 
(SAM) to adenosine or cytidine residues in DNA (13,14). MTases that lack a cognate 
endonuclease and do not function in RM systems are referred to as ‘orphan MTases’ 
(15). In a limited set of Gram-negative bacteria, orphan MTases have been shown to 
function in critical processes including cell cycle control (16), origin sequestration 
(17,18), DNA mismatch repair (19-21), and the regulation of gene expression [for review 
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(22)]. DNA methylation from orphan and RM-based MTases has also been shown to 
establish epigenetic inheritance through phase variation primarily in Gram-negative 
pathogens (23-25). While much work has been done to characterize RM and orphan 
MTases from Gram-negative bacteria, much less is known about how m6A contributes 
to the regulation of the cell cycle or gene expression in Gram-positive bacteria (26).  
Until recently, tools for unbiased detection and functional characterization of DNA 
methylation were limited. Available tools for detection, such as methylation-sensitive 
restriction endonuclease treatment and bisulfite sequencing, are limited to the sequence 
context and modification type that can be detected (27). The recent development of the 
Pacific Biosciences (PacBio) Single Molecule, Real-Time (SMRT) sequencing platform 
allows for detection of modifications without a priori knowledge of their existence (28). 
SMRT sequencing enables the analysis of real-time DNA polymerase kinetics for 
inference of DNA base modifications. Base modifications in the template strand result in 
changes in DNA polymerase kinetics compared to their unmodified counterparts, 
allowing for reliable, sequence-context specific detection of methylated bases during 
sequencing reactions (29). While differences in kinetic signatures for 5mC modified 
cytidine residues are modest, SMRT sequencing is adept for m6A and m4C detection 
(29). 
Using the SMRT sequencing platform, a recent study of 230 diverse prokaryotes 
detected base modifications in 93% of the genomes surveyed (8). Of the genomes with 
detected modifications, 75% of the modifications were m6A, which is due in part to the 
robust signal of m6A modifications in SMRT sequencing relative to other modifications 
(29). Given the high percentage of prokaryotic genomes with m6A detected and the 
contribution of m6A to the regulation of eukaryotic gene expression, it seems unlikely 
that the prevalent m6A modifications in prokaryotes are used exclusively in the context 
of regulating DNA cleavage by RM systems.  As mentioned above, in Escherichia coli 
and Caulobacter crescentus m6A from orphan MTases occurs in palindromic 
recognition sequences and has been shown to mediate protein-DNA interactions (9,30), 
regulating important cellular processes including gene expression (31-34). Deletion of 
Dam methyltransferase (dam), which is responsible for m6A at GATC sites in E. coli, 
has severe pleiotropic effects (35,36). In C. crescentus deletion of the CcrM 
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methyltransferase, which catalyzes the formation of m6A at GA(N)TC sites, is lethal 
when the CcrM-deficient strain is grown in rich media (16,37).  
Much less is known about how m6A regulates cellular functions in Gram-positive 
bacteria. Recent work in Streptococcus pyogenes found that m6A from an active Type I 
RM system regulates virulence gene expression in a clinical isolate, suggesting that 
m6A could have important roles for regulating gene expression in Gram-positive 
systems (26).Therefore, the importance of m6A in E. coli and C. crescentus and the 
pervasive occurrence of m6A in prokaryotes (8) highlights the importance of 
understanding how m6A regulates cellular functions in the numerous and diverse set of 
bacterial genomes that contain the modification. 
Here, we characterize m6A modifications in the Gram-positive bacterium Bacillus 
subtilis strains PY79 and NCIB 3610. Using SMRT sequencing, we show that m6A is 
present at non-palindromic GACGmAG sites throughout the B. subtilis chromosome. 
Further, we characterize the methyltransferase, referred to herein as DnmA, as 
responsible for detectable m6A modifications in the B. subtilis genome of both strains. 
We found that DnmA does not function as part of an active, canonical Type I or Type II 
RM system. Moreover, we show that the promoter regions for a subset of genes contain 
the consensus sequence and that loss of methylation in these cis regulatory elements 
results in a decrease in gene expression. Further, we show that the transcriptional 
repressor ScoC preferentially binds a promoter region that is unmethylated. Together, 
our results show that m6A can function as an epigenetic signal in B. subtilis. 
 
Results 
Characterization of B. subtilis PY79 and NCIB 3610 methylomes. It was previously 
published that B. subtilis does not have m6A at the E. coli Dam MTase recognition site, 
GATC, and that ectopic expression of Dam in B. subtilis induced the DNA damage 
response (44,45). However, until recently it remained unknown if B. subtilis contains 
m6A in another sequence context because the detection of m6A without a priori 
knowledge of the sequence context would require a new experimental approach. 
PacBio SMRT sequencing was used to determine if DNA modifications were present in 
the genome of several B. subtilis 
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available web resource REBASE maintained by New England Biolabs. This resource 
reports m6A occurring in various sequence motif contexts in 19 of 23 B. subtilis strains 
where SMRT sequencing was used. Among the B. subtilis strains analyzed, methylation 
at GACGmAG sites was reported in four of the 23 strains (http://rebase.neb.com). 
Previously, our group performed PacBio sequencing on the widely used B. subtilis 
laboratory strain PY79 for whole-genome assembly (41). As part of our effort to study 
DNA methyltransferases, we used PacBio sequencing to characterize the PY79 
methylome.  We purified genomic DNA from the wild type (WT) B. subtilis strain PY79 
and analyzed our results using the SMRT sequencing platform, allowing for genome-
wide base modification detection in sequence-specific contexts (29).  
 SMRT sequencing of the B. subtilis PY79 chromosome showed that the second 
adenosine residue within the sequence context 5'-GACGmAG showed high modification 
quality values (modQVs), which indicates a statistically significant difference in DNA 
polymerase kinetics from the expected background at particular loci (Fig 3.7, Table 
3.1). The interpulse duration (IPD) ratios, which are a comparison of DNA polymerase 
kinetics at a base within a particular sequence context compared to an unmethylated in 
silico control, were far higher for the second adenosine residue in the GACGmAG motif 
compared to any other modified motifs in the B. subtilis chromosome (Table 3.1, Fig 
3.7). Thus, we identify m6A	in the sequence context 5'-GACGmAG in the chromosome 
of B. subtilis PY79, herein referred to as the m6A motif.  
We found that 99.7% of m6A motifs (1215/1219) were called as methylated in the 
PacBio SMRT sequencing analysis at the 3'-adenosine during exponential growth in 
defined minimal medium. While our sequencing analysis identified other motifs in the B. 
subtilis PY79 chromosome, the average modQVs, IPD ratios, and the percentage of 
motifs called as modified were far lower compared to m6A identified within the 
GACGmAG sequence (Table 3.6 and Fig 3.8). It is likely that most of the other motifs 
called represent DNA secondary structures that affect DNA polymerase kinetics or 
sequencing noise instead of genuine nucleic acid modifications (Table 3.6).  For 
completeness we chose to report all motifs called during analysis of the SMRT 
sequencing data (Table 3.6). 
Of the 1,219 m6A motifs that occur in the B. subtilis PY79 genome, 1,118 
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(91.7%) occur in protein coding regions. Intergenic regions, which compose 11.2% of 
the genome, contain 7% (85 motifs in 76 regions) of the m6A motifs. With the exception 
of only a few sites, the majority of m6A sites had greater than 75% of sequencing reads 
called as methylated independent of genome position or occurrence on the plus or 
minus strand of the chromosome (Fig 3.8 and Table 3.6). 
B. subtilis PY79 is a commonly used laboratory strain, however selection in the 
lab has caused PY79 to lose many of the robust phenotypes associated with ancestral 
strains of B. subtilis (46). To determine whether m6A is present in the ancestral strain, 
we purified genomic DNA from B. subtilis strain NCIB 3610 (40) for SMRT sequencing 
and found m6A within the same GACGAG sequence context (Fig 3.7B and Table 3.1). 
In NCIB 3610 94.7% (1208/1275) of m6A sites were called as methylated in the PacBio 
SMRT sequencing analysis. The chromosome of the ancestral strain is considerably 
larger than PY79 and harbors an 84-kb plasmid, both of which account for the increased 
number of m6A motifs (40). The decrease in the percentage of motifs called as modified 
between PY79 and NCIB 3610 (99.7% à 94.7%) could be the result of biological 
variation, such as an increase in protein binding or other factors that may occlude 
methylation of recognition sites.  The decrease in motifs called could also be due to 
technical variation in sequencing reactions. We note that we also detected many 
additional motifs in the ancestral strain that did not appear in the lab strain PY79, with 
each motif called listed in supplementary Table 3.6. Further, m6A at GACGAG 
sequences has also been reported for three B. subtilis strains other than PY79 and 
NCIB 3610 on REBASE.   
 In addition to m6A modifications, SMRT sequencing of the PY79 genome 
identified cytidine modifications in the sequence mCTCGARB (where R represents a 
purine and B either a cytidine or a guanosine). These results are described in the 
supplementary results section, where we show using methylation-sensitive restriction 
digest that m5C formation occurs in the B. subtilis PY79 genome through the BsuMI RM 
system (Fig 3.9) previously described for B. subtilis Marburg (47).  
 
Distribution of m6A sites across the B. subtilis genome shows enrichment on the 
lagging strand of the left chromosomal arm. To begin to understand the function of 
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m6A in B. subtilis, we used the motif enrichment program DistAMo (42) to determine the 
location of m6A sites on the B. subtilis chromosome. This was done to determine if m6A 
sites are uniform or showed areas of enrichment and de-enrichment throughout the 
chromosome (Fig 3.1). We present the analysis using sliding windows of 50 kb to 500 
kb over the length of the chromosome by the rings from outside (large) to inside (small) 
scaling in 50 kb increments. Over (red) and under (blue) enrichment are colored by z-
scores in the scale as shown. From the analysis we determine that the locations of m6A 
sites are certainly not uniform across the chromosome and instead show patterns of 
enrichment in particular regions.  We find that several areas are largely devoid of m6A 
sites, including the terminus region and the origin of replication (Fig 3.1). Analysis of 
enrichment shows that locations in the B. subtilis chromosome with high z-scores 
includes the right and left chromosomal arms with the largest enrichment on the lagging 
strand of the left chromosomal arm (Fig 3.1C). With these results we suggest that m6A 
is unlikely to function in origin sequestration or DNA mismatch repair as described for 
Dam methylation in E. coli (17,18) due to our finding that the origin does not contain 
m6A sites and because m6A is non-palindromic and not uniform across the B. subtilis 
chromosome. To be certain, we empirically test if m6A contributes to replication timing, 
mutagenesis, or recombination in the supplementary results and show no effect (Fig 
3.10, 3.14 and Table 3.7).  
 
Methyltransferase YeeA is necessary for m6A formation in vivo. DNA methylation 
is catalyzed by DNA methyltransferases (MTases) (48). To identify putative MTase(s) 
responsible for the observed m6A modification, we searched all protein coding 
sequences for the conserved DNA m6A MTase catalytic motif (D/N/S)PPY (48). This 
search yielded two uncharacterized MTases, coded for by the genes yabB and yeeA 
(dnmA) (41). We created clean deletions of the ΔyabB and ΔyeeA (dnmA) coding 
regions as well as a ΔyabBΔyeeA double deletion. Each of these strains was viable and 
none of the deletions conferred a growth defect on B. subtilis under the conditions used 
here (Fig 3.3A, described later in the results).  
To identify the MTase responsible for genomic m6A, DNA was harvested from 
each strain when cultures reached an OD600 of ~0.7 followed by SMRT sequencing. 
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Subsequent methylation analysis revealed that chromosomal DNA from ΔyeeA (dnmA) 
cells lost all detectable methylation at the m6A motif previously identified in WT cells in 
both PY79 and NCIB 3610 strain backgrounds (Table 3.2, Fig 3.11, and Table 3.8). 
Expression of yeeA (dnmA) from an ectopic locus in the ΔyeeA (dnmA) background 
restored methylation at the m6A site (Fig 3.11C and Table 3.2). Computational analysis 
from sequencing data posted on REBASE also predicted YeeA (DnmA) as the MTase 
responsible for m6A detected in strains of B. subtilis with modifications at the m6A motif 
described here.  
Genomic DNA from ΔyabB cells retained the methylation at m6A sites (Fig 3.12, 
Table 3.9) whereas detectable modifications at the m6A site were lost in the double 
deletion strain (Fig 3.12B, Table 3.9). Interestingly, while methylation is maintained at 
the m6A site in the ΔyabB strain, we noticed additional motifs not present in the WT or 
ΔyeeA (dnmA) strains that were detected upon loss of yabB in the single or double 
deletion strains (Table 3.9). These additional motifs are likely to result from sequencing 
noise and/or DNA secondary structure given the low IPD ratios (Table 3.9).  With these 
results we show that yeeA (dnmA) is necessary for genomic m6A formation in the 
sequence context GACGmAG in vivo and we refer to YeeA herein as DNA 
methyltransferase A (DnmA), with the formal name of M.BsuPY79I and M.Bsu3610I for 
strains PY79 and NCIB 3610, respectively. For simplicity, we will collectively refer to 
M.BsuPY79I and M.Bsu3610I as DnmA in the work presented below. 
 
DnmA is sufficient for methylation of m6A sites in double stranded (ds)DNA in 
vitro. DNA MTases typically use SAM to catalyze the transfer of a methyl group to a 
DNA base (9). DnmA (M.BsuPY79I), YabB, and a DnmA catalytically inactive variant 
(Y465A) were purified (Fig 3.2A). In addition to the predicted ~120-kDa band 
corresponding to the DnmA monomer, a high molecular weight species was observed in 
the DnmA purifications. The slower migrating protein was analyzed by mass 
spectrometry identifying it as multimer of DnmA. We speculate that the DnmA multimer 
is caused by irreversible disulfide bonding or another crosslink that forms between two 
purified DnmA monomers during isolation (Table 3.10).  
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A time course methylation experiment was performed to determine if DnmA is 
sufficient to catalyze methylation of the m6A motif in DNA (Fig 3.2B). The purified 
proteins were incubated with tritiated SAM and an oligonucleotide sequence from the B. 
subtilis addA locus containing the m6A (target) motif. Incorporation of the labeled methyl 
group over time indicates that DnmA is indeed sufficient for methylation at m6A motifs in 
dsDNA (Fig 3.2B). With the results from the time course methylation experiment we 
suggest that purified DnmA does not have significant activity on single-strand (ss)DNA. 
As a control we show that the Y465A catalytically inactive variant was unable to 
methylate the substrate indicating that the MTase activity we detect is specific to DnmA.  
 With the in vitro methylation assay established, we tested the activity of DnmA 
and YabB on DNA containing the target sequence and whole cell RNA extracted from a 
ΔdnmAΔyabB double mutant strain by assaying for incorporation of methylation from 
tritiated SAM. As expected, DnmA showed activity on the dsDNA substrate with the 
target sequence, but had minimal activity when whole cell RNA was used as a substrate 
(Fig 3.2C). In support of the in vivo results, we show that purified YabB had very little 
activity on a DNA substrate, whereas YabB did show incorporation when whole cell 
RNA was used as a substrate. With these results we suggest that YabB may function as 
an RNA methyltransferase (Fig 3.2C). To test if the m6A motif was necessary for DnmA 
methylation in vitro, the 3'-adenosine residue was substituted with thymidine (non-target 
sequence) and incubated with DnmA and tritiated SAM. As shown in Fig 3.2D, there 
was no appreciable incorporation of the methyl group by DnmA to the non-target 
sequence, demonstrating that methylation is specific for the target sequence (m6A 
motif). We also tested DnmA for methylation of dsRNA, ssDNA, and ssRNA bearing the 
target sequence. The results show little to no methylation for any of these substrates 
with the exception of ssDNA, which yielded only weak methylation activity relative to 
dsDNA (Fig 3.2D). Together, these results provide strong evidence that DnmA is 
specific for dsDNA containing the m6A motif.  
To determine if the lack of methylation at the non-target sequence was caused 
by an inability of DnmA to bind DNA, an electrophoretic mobility shift assay (EMSA) was 
performed on 5' end-labeled target (GACGAG), non-target (GACGTG), and a 
degenerate sequence where the entire target sequence had been removed. Incubation 
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of DnmA with the target, non-target, and degenerate sequences each resulted in a shift, 
indicating that the methylation specificity is not due to a loss of DNA binding at other 
sequences (Fig 3.13). Additionally, the Y465A catalytically inactive variant still bound 
the target sequence, suggesting that this variant is only dysfunctional for 
methyltransferase activity (Fig 3.13). We conclude that DnmA is necessary and 
sufficient to methylate dsDNA that carries the GACGAG sequence in vivo and in vitro 
and that Y465 is an important residue for activity.  
  
DnmA does not function as part of an active RM system. We next asked if DnmA 
functions as part of an active RM system. DnmA shares 38% identity and 57% similarity 
with the MmeI enzyme, which is a bifunctional protein with a methyltransferase domain 
and a PD-ExK endonuclease motif in the amino terminal domain. MmeI belongs to a 
subgroup of Type II RM systems that use DNA hemi-methylation for host chromosome 
protection (49). DnmA was included in a set of MmeI homologs that lack the 
endonuclease motif in the amino terminal domain but are flanked by conserved genes 
similar to yeeB and yeeC, which are immediately downstream of dnmA (49). It was 
found that under the conditions tested for other MmeI homologs DnmA lacked 
endonuclease activity, however it is important to note that the downstream yeeB and 
yeeC gene products are annotated as a putative helicase and an endonuclease, 
respectively (49). Deletion of dnmA does not result in a growth defect (Fig 3.3A), which 
would suggest that yeeB lacks endonuclease activity associated with typical Type II RM 
systems, where endonuclease activity is achieved independent of the MTase.  
It has been suggested that DnmA, along with YeeB and YeeC, comprise a Type 
I-like RM system, where restriction endonuclease activity requires the MTase subunit 
and DNA cleavage would not occur efficiently in the absence of DnmA (49). To test this 
possibility, we performed a transformation efficiency assay in WT and ΔdnmA cells with 
the plasmid pHP13, which is a 4.7 kb plasmid containing three m6A sites as the donor 
DNA (Fig 3.3B). Plasmid purified from E. coli cells was used to transform competency 
deficient (ΔcomK), hyper-competent (Δrok), WT and ΔdnmA strains followed by 
selection for transformants conferring resistance to chloramphenicol. We found that 
compared to ΔcomK and Δrok strains, with transformation efficiencies of < 1 x10-8  and 
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177 x10-5 (SE 13.2 x10-5), respectively, the transformation efficiencies of WT [7.33 x10-5 
(SE 3.30 x10-6)] and ΔdnmA [9.44 x10-5 (SE 1.25 x10-5)] were nearly indistinguishable 
(Fig 3.3C). We show that DnmA, YeeB, and YeeC do not function to restrict DNA 
update during natural genetic competence. Based on the transformation results and the 
conservation of these three genes clustering together, we suggest that DnmA, YeeB, 
and YeeC could be part of an inactive or inefficient Type I-like RM system or perhaps a 
noncanonical RM system. We also cannot exclude the possibility that restriction activity 
could be measured under some other circumstance, such as phage predation. 
 
Proximity of m6A sites to -35 boxes of housekeeping sigma factor 
SigA regulates promoter activity. Due to the enrichment of m6A within particular 
genomic locations (Fig 3.1), we considered a role for m6A in regulating gene 
expression. Several prior studies have shown that DNA methylation from RM systems 
can also regulate gene expression (23,25,26). Accordingly, DNA MTase targets that 
occur within promoter or operator regions have the potential to influence transcription 
(50). Thus, we hypothesized that DnmA-dependent methylation might exhibit a similar 
function in B. subtilis.    
  To identify genes that might be affected by DnmA-dependent methylation, we 
used the list of transcribed regions 5' of B. subtilis 168 open reading frames (ORFs) 
reported previously (51) to prioritize the subset of promoters in B. subtilis with m6A sites 
located on the left chromosomal arm where we observed m6A enrichment. The 
promoters chosen for analysis included those of non-coding and anti-sense RNAs as 
well as promoters embedded inside transcriptional units, and we excluded promoters 
where the target site occurs downstream of the transcriptional start site (Table 
3.11).  B. subtilis PY79 contains 32 transcribed regions 5' of ORFs with the m6A motif in 
the vicinity of known or predicted sigma factor binding sites (Table 3.11). To examine if 
m6A in promoter regions influences gene expression in B. subtilis, we constructed a 
series of transcriptional fusions where a gfp allele was introduced downstream of the 
respective m6A motif-containing promoter (Fig 3.4A). All transcriptional fusions 
were introduced at the ectopic amyE locus to separate the promoter from other potential 
cis-acting regulatory elements or chromosome structure contexts that could affect 
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expression (Fig 3.4B). Promoter activity was monitored in WT and ΔdnmA strains using 
fluorescence as a reporter in single cells during mid-exponential growth by flow 
cytometry (please see Materials and Methods).    
  We found that loss of m6A in a subset of B. subtilis promoters, specifically 
those that contain an m6A motif in or slightly downstream of the -35 region of the SigA-
binding box (PscpA, Phbs, PrnhC, PyumC, PzapA), consistently resulted 
in decreased activity from the unmethylated promoter relative to the methylated 
counterpart (Fig 3.4C and D). The m6A sites in the promoter region for PscpA, Phbs, 
PrnhC, PyumC, PzapA in PY79 are identical to the promoter regions in B. subtilis strain 
NCIB 3610.  
We did not observe this trend for the promoter fusions that contained m6A sites 
away from the -35 box. For example, the activation level of the SigB-inducible rsbV-
rsbW-sigB-rsbX promoter (PrsbV), with an m6A site directly upstream of the -10 box, 
was not influenced by the presence of methylation during normal growth or even after 
stressing the cells with 4% ethanol for 1-hour as described (52) (Fig 3.4C and D). 
Similarly, we did not observe differences in gfp expression with the PcomEA, PwprA, or 
PyloA fusions in the ΔdnmA background relative to WT.   
The m6A motif was present just upstream and overlapping the -35 region of the 
SigA binding box for PzapA (transcription unit: zapA-yshB-polX-mutSB-yshE) and 
PyumC, respectively, and both reporters showed a decrease in activity in ΔdnmA cells 
relative to WT (Fig 3.4C and D). ZapA is involved in FtsZ ring assembly and YumC is 
an essential ferrodoxin/flavodoxin reductase (53,54). The m6A site for the remaining 
three promoter fusions that showed decreased expression upon loss of m6A, PscpA 
(transcription unit: scpA-scpB-ypuI), Phbs (transcription unit: S861-hbs), and PrnhC, 
was located just downstream of the -35 region of the SigA binding box. Interestingly, the 
gene products for two of the differentially expressed promoter regions, scpA and hbs, 
have important roles in chromosome segregation, chromosome structure, and 
organization (55-60). The changes in Phbs activity were mild, which is likely due to the 
fact that Phbs contains two SigA-binding boxes, of which the m6A-positive box is the 
least dominant of the two promoters (61).  Another promoter fusion that exhibited a 
DnmA-dependent increase in expression was PrnhC, which codes for RNase HIII, an 
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enzyme important for cleavage of RNA-DNA hybrids (62,63). One type of RNA-DNA 
hybrid is an R-loop, which could affect local chromosome structure and transcription 
(64). Together, decreased expression from PscpA, Phbs, and PrnhC could have 
impacts on global chromosome structure, altering the expression of other genes.  
To further investigate how m6A methylation affects transcription, the m6A site 
within the PscpA-GFP promoter was mutated to GACGCG, ensuring loss of methylation 
at this site in both the WT and ΔdnmA backgrounds.  The GACGCG containing 
promoter adopted the same activity as observed in the ΔdnmA strain, indicating that 
m6A at the fifth position of the motif stimulates gene expression (Fig 3.5A and B). 
Interestingly, an AàT at the fifth position of the m6A site (GACGTG) made PscpA-GFP 
behave as if it were m6A (GACGmAG) in both WT and ΔdnmA backgrounds (Fig 3.5A 
and B middle panel). The reason for how thymidine in the fifth position of the motif 
stimulates gene expression to the same extent as m6A is unclear.  To further test how 
integrity of the motif modulates PscpA activity, the motif was subsequently changed to 
GACGAC so that the fifth position was unchanged but the DnmA recognition site was 
lost. The promoter adopted the same activity as quantified in the ΔdnmA strain, 
indicating that m6A or T at the fifth position of the motif stimulates gene expression for 
the scpA promoter (Fig 3.5A and B). With these data we suggest that m6A is capable of 
regulating gene expression when located near the -35 binding site for SigA with 
methylation promoting gene expression from a subset of promoters in B. subtilis.  
 
Transcriptional repressor ScoC binds GACGAG sites. The mechanism for m6A-
dependent promotion of gene expression could be explained by an increase in SigA 
binding at methylated promoter regions or a less direct mechanism, such as competition 
for SigA binding with a methylation-sensitive transcriptional regulator. To determine if 
proteins in B. subtilis differentially associate with unmethylated DNA, we performed a 
pull-down in cell extracts using two different oligos. We amplified biotinylated oligos 
corresponding to the PscpA promoter region containing the GACGAG site. We could 
not obtain complete methylation of the substrate in vitro using purified DnmA. Therefore, 
we amplified the region and introduced a mutation in the m6A motif to GACGTG, which 
behaved like the WT methylated promoter in our reporter assay using the same 
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promoter region (Fig 3.5A-B, middle panel). We isolated protein lysates from 
exponentially growing B. subtilis cells, incubated the lysates with our biotinylated oligos, 
performed a streptavidin pull-down, and visualized the proteins from each pull-down 
experiment via SDS-PAGE. We noted differences in the protein bands for the GACGAG 
relative to GACGTG oligo in the 20 and 40 kDa molecular weight range. These regions 
were excised from the gel and the proteins identified using mass spectrometry. Of the 
top four most abundant proteins across the samples, the transcriptional regulator of the 
transition state, ScoC (65,66), was the only protein that did not appear in both pull-down 
experiments (Fig 3.6A). We found that ScoC was only present in the pull-down with the 
oligo that contained the GACGAG site, representing the unmethylated promoter state. 
No peptides corresponding to ScoC were identified in the pull-down of the GACGTG 
control site (Fig 3.6A).  
To directly test if ScoC binding is affected by the AàT mutation, we purified 
ScoC (Fig 3.6B) and performed electrophoretic mobility shift assays (EMSAs). We used 
labeled oligos representing the PscpA promoter that only differed in the GACGAG and 
GACGTG sites, which overlap the -35 box but occur just outside of the ScoC consensus 
binding site (Fig 3.6C). The intensity of the shifted band was quantified and normalized 
to a no protein control for three independent experiments across a range of protein 
concentrations and the percent band shifted was compared at 250 nM and 500 nM 
ScoC.  Consistent with the results from our pull-down experiment, we observed a 33.4% 
(S.E. ±2.6) and 14.7% (S.E. ±1.1) percent band shift at 250 nM ScoC for the GACGAG 
and GACGTG oligos, respectively (Fig 3.6D-E). We also observed percent band shifts 
of 70.6% (S.E. ±9.0) and 45.7% (S.E. ±5.1) at 500 nM ScoC for the GACGAG and 
GACGTG oligos, respectively (Fig 3.6D-E). The increased binding of ScoC to the oligo 
with the GACGAG site compared to the oligo with the GACGTG site (Fig 3.6E) and the 
decrease in expression we observed from the GACGAG promoter region compared to 
the GACGTG or GACGmAG promoter (Fig 3.5) supports the model that ScoC is a 
transcriptional repressor (65,66) and that ScoC shows preferential binding to an 
unmethylated promoter with the m6A site proximal to the ScoC binding site. With these 
results we suggest that ScoC binds to unmethylated GACGAG sites in promoter regions 
repressing transcription. When the GACGAG site overlaps or is adjacent to the ScoC 
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binding site we suggest that methylation or AàT mutation at the fifth position could 
weaken ScoC binding leading to an increase in gene transcription.  
 
Discussion 
We report that DnmA (M.BsuPY79I or M.Bsu3610I) is responsible for 
endogenous m6A modifications that promote gene expression in B. subtilis strain PY79. 
We have shown that m6A in B. subtilis occurs at non-palindromic GACGmAG sites in 
the chromosome with enrichment on the left chromosomal arm. In B. subtilis PY79 there 
are only 1,219 chromosomal m6A sites in contrast to the ~20,000 and ~4,500 
palindromic m6A sites in E. coli and C. crescentus, respectively (67,68). While non-
palindromic sites have been described (8) and have been shown to affect gene 
expression (25), the palindromic nature of m6A sites in E. coli and C. crescentus is 
necessary for function in DNA mismatch repair, origin sequestration, and cell cycle 
control (67). During these processes, protein binding or activity is dictated by full versus 
hemi-methylated states of m6A motifs, which determines the downstream regulatory 
role (67,69). Here, we have shown that loss of m6A at the non-palindromic GACGmAG 
sites in B. subtilis also affects the regulation of gene expression, with loss of methylation 
resulting in decreased expression of genes, including scpA and hbs, which code for 
proteins important for chromosome structure, organization, and maintenance (55-60) 
(Fig 3.4C and D).  Our data indicate that the presence of m6A promotes the expression 
of a subset of genes in PY79 that could have important downstream effects on gene 
expression and chromosome structure.  
 One mechanism by which m6A regulates gene expression is through dictating 
transcription factor binding to promoter regions. In prototypical E. coli the methylation 
state of recognition sites for Dam methyltransferase in promoter regions has been 
shown to affect expression of a subset of genes, including virulence factors (67,69). 
One such example is the agn43 promoter, where methylation at the promoter blocks 
binding of the redox sensitive repressor OxyR, thereby stimulating production of Agn43, 
which is important for non-fimbrical adhesion (70). Also, uropathogenic E. coli use 
phase variation to evade the host immune system by altering the expression of the 
pyelonephritis-associated pilus (pap) in a Dam methylation dependent manner (24). In 
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the Gram-negative pathogen Neisseria meningitidis non-palindromic m6A sites from an 
active Type III RM system also function in phase variation (25). The Gram-negative 
bacterium C. crescentus has a transcriptional activator, GcrA, which associates with 
RNA polymerase-σ70 and recognizes a subset of promoter regions that are methylated 
at palindromic recognition sites by the CcrM MTase (71). 
Here we have demonstrated that m6A regulated promoters in B. subtilis PY79 
contain the methylation site at or slightly downstream of the -35 region of the 
housekeeping SigA binding site (72). We have shown that, in the absence of 
modification at the m6A site, we observe increased binding of the transcriptional 
repressor ScoC in the promoter region for the gene scpA (Fig 3.6A-E).  The increased 
binding of the transcriptional repressor ScoC at the scpA promoter containing a 
GACGAG site relative to the GACGTG site supports our reporter results, showing that 
the GACGTG site phenocopied the higher expression levels in a wild type strain relative 
to the ΔdnmA strain (Fig 3.5A-B). We speculate that increased binding of the ScoC 
repressor to unmethylated GACGAG sites is responsible for the decreased gene 
expression we observe from the scpA promoter, representing one mechanism by which 
m6A could regulate gene expression in B. subtilis PY79.  
While m6A-mediated binding of ScoC represents one mechanism by which m6A 
regulates gene expression, we find it likely that many other mechanisms exist. The 
methylation-responsive promoters identified in the current study do not share an 
obvious ScoC consensus binding sequence. Future work will be necessary to determine 
the additional regulatory mechanism(s) that result in increased gene expression at 
methylated promoter regions in B. subtilis PY79 and 3610.  
 Each of the promoter fusions tested was ectopically expressed at the amyE 
locus, which allowed us to assay for the effect of promoter methylation status 
independent of the effects of chromosomal location and local chromosome architecture. 
This experimental design allows for identification of promoter region activities that were 
affected by loss of methylation at the m6A site but did not account for other factors. 
Interestingly, as shown (Fig 3.4B), the genes for many of the downregulated promoter 
fusions occur toward the terminus (hbs, scpA, rnhC, and zapA) and on the left arm of 
the chromosome, whereas the amyE locus is origin proximal and occurs on the right 
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arm of the chromosome. Thus, we are able to conclude that methylation at the m6A site 
in B. subtilis PY79 promotes gene expression for a subset of genes but we cannot rule 
out other factors that control gene expression at the endogenous loci or indirect 
regulatory functions of m6A elsewhere in the chromosome. 
In addition to its direct regulatory function at select promoter regions, m6A may 
have indirect effects on gene expression. It has been shown that m6A can increase the 
curvature of the DNA that may, in turn, influence protein binding and chromosome 
architecture (73,74). Alternatively, m6A might directly influence the expression of DNA 
binding proteins that contribute to chromosome architecture. Consistent with this 
hypothesis, we observe slight but significant downregulation of the hbs gene, which 
codes for the essential and highly abundant histone-like protein HBsu (Fig 3.4C). A 
potential decrease in HBsu levels concomitant with the preference of HBsu for highly 
curved regions of DNA creates the possibility for an m6A-dependent mechanism for 
changes in overall DNA topology and chromosome architecture. Thus, loss of m6A may 
affect protein occupancy throughout the chromosome to influence chromosome 
architecture in such a way that results in more changes to gene expression. It is 
important to note that both direct and indirect models of m6A-dependent changes are 
possible and that they are not mutually exclusive 
Genomic m6A from orphan and active RM system MTases has been shown to 
function in the regulation of gene expression [e.g. (23-26)]. Here we demonstrate that 
loss of MTase DnmA does not affect the natural transformation efficiency of foreign 
methylated DNA from a plasmid with multiple recognition sites in competent cells. 
Therefore, we suggest that DnmA is an MTase from an inefficient or inactive RM 
system.  We have also discovered that DnmA-dependent m6A in the promoter regions 
of a subset of genes promotes gene expression in B. subtilis PY79 and we show that 
transcriptional repressor ScoC binds unmethylated DNA. In addition to influencing ScoC 
binding, we find it interesting that m6A promotes expression of several genes involved 
in chromosome structure and maintenance, which could in turn have effects on the 
expression of other genes. In total, we have shown that DNA methylation from DnmA 
has an effect on gene expression, prompting further investigation of RM systems and 
their possible regulatory contribution outside of DNA restriction. 
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Materials and Methods 
General Bacteriology: The antibiotic concentrations used in this study are as follows: 5 
μg/mL chloramphenicol, 0.5 μg/mL erythromycin, 100 μg/mL spectinomycin. Unless 
otherwise indicated, strains were grown in either LB (10 g/L tryptone, 5 g/L yeast 
extract, 10 g/L NaCl) or defined S750 minimal media supplemented with 1% glucose (1x 
S750 salts diluted from 10x S750 salts (104.7 g/L MOPS, 13.2 g/L ammonium sulfate, 6.8 
g/L monobasic potassium phosphate, adjusted to pH 7 with potassium hydroxide), 0.1% 
potassium glutamate, 1% glucose, 40 μg/mL phenylalanine, 40 μg/mL tryptophan, 2 mM 
MgCl2, 0.7 mM CaCl2, 50 μM MnCl2, 1 μM ZnCl2, 1 μg/mL thiamine-HCl, 20 μM HCl, 
and 5 μM FeCl3) at 30°C with shaking at 200 rpm. 
 
Strain construction: The strains, plasmids and oligos used in this study can be found 
in Supplementary Tables 3.3, 3.4, and 3.5. Individual strain and plasmid construction 
can also be found in the Supplemental Materials and Methods. Deletions were created 
by ordering Bacillus subtilis 168 strains from the Bacillus Genetic Stock Center 
(http://www.bgsc.org/) where the respective genes were replaced with a loxP flanked 
erythromycin (erm) resistance cassette (BKE strains). Genomic DNA from the BKE 
strains was purified and used to transform B. subtilis strain PY79, and the erm 
resistance cassette was subsequently removed with Cre recombinase (38). 
Overexpression strains and all promoter GFP fusions were integrated in the PY79 amyE 
locus via double crossover (39).  Three colonies containing the crossover were selected 
and colony purified on LB plates containing 100 µg/mL spectinomycin. Successful 
integration of the constructs was verified by PCR, Sanger sequencing, and screening 
for the ability to utilize starch.  
 
Chromosomal DNA purification: Genomic DNA for Pacific Biosciences SMRT 
sequencing was purified as follows. Strains were struck out on LB and grown overnight 
at 30°C. 500 mL LB cultures were inoculated at OD600 0.05 and grown at 37°C.  During 
mid-exponential phase (OD600 0.6-0.8) an equal volume of methanol was added to each 
culture and centrifuged at 4,000 rpm for 30 minutes. The supernatant was discarded 
and cells were resuspended in 12.5 mL of 10% sucrose Tris/HCl pH 8 buffer and 
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transferred to Oakridge tubes. Resuspensions were then treated with 310 μL lysozyme 
(40 mg/mL in 10% sucrose Tris/HCl pH 8 buffer) for 30 minutes at 37°C and mixed 
every 5 minutes. 1.25 mL of 0.5 M EDTA was added to each tube and incubated on ice 
for five minutes followed by addition of 10 mL of freshly prepared lysis solution (0.1% 
Triton X-100, 62.5 mM EDTA, 50 mM Tris/HCl pH 8). Solutions were centrifuged at 
15,000 rpm for 30 minutes and decanted into chilled graduated cylinders. To each 
lysate 0.95 g/mL of cesium chloride (CsCl) was added and dissolved followed by a 1/10 
volume addition of 10 mg/mL ethidium bromide. Solutions were balanced and 
centrifuged at 44,000 (131,600 x g) rpm for 24 hours. Chromosomal DNA was extracted 
and subjected to a second round of CsCl purification as described above. Solutions 
were centrifuged at 44,000 rpm (131,600 x g) for 48 hours. Ethidium bromide was 
removed by extraction 4x with water-saturated butanol. The aqueous phase was 
transferred to an Oakridge tube and 1 volume of water and 2 volumes ethanol were 
then added. The solution was centrifuged at 15,000 rpm for 20 minutes and the 
supernatant was aspirated. The pellet was washed with 70% ethanol and resuspended 
in 1 mL TE buffer. 
In all other experiments, frozen strains were struck out and grown at 30°C. The 
plates were washed in S750 minimal media and 25 mL cultures were inoculated at an 
OD600 0.05 and grown at 37°C with shaking to mid-exponential growth phase (OD600 
0.6-0.8). Genomic DNA was purified via phenol chloroform extraction method. 
 
PacBio SMRT sequencing and methylation analysis: Chromosomal DNA was 
prepared for sequencing as described above. Library preparation and subsequent 
sequencing was performed as previously described (40,41).  Modification and motif 
analyses were performed using	RS_Modification_and_Motif_Analysis.1 version 2.3.0 
with the appropriate B. subtilis reference genomes. The initial parameters used for 
modification analysis were performed using  0.75 minimum high quality reads, 50 bps 
minimum length, and a minimum ModQV call of 30. We also increased minimum high 
quality reads to >0.85 and minimum length to >1000 bps in subsequent analysis. 
Modification graphs were generated using functions from BaseModFunctions.v2.1.R 
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available at: https://github.com/PacificBiosciences/Bioinformatics-
Training/tree/master/basemods. 
 
Motif Distribution Analysis: Motif distribution analysis was performed using the 
DistAMo web based server (42) available at http://computational.bio.uni-
giessen.de/distamo searching the GACGAG motif for the Bacillus subtilis PY79 genome 
via accession number NC_022898.1. 
 
Protein Purification (DnmA, DnmA (Y645A), and YabB): Recombinant proteins were 
purified from E. coli BL21DE3 cells containing a pE-SUMO vector with the B. subtilis 
gene inserted (dnmA, dnmA (Y465A), or yabB). Cultures were grown in 4 L of terrific 
broth (2.4% yeast extract, 1.2% tryptone, 0.4% glycerol, 250 mM (NH4)2SO4, 500 mM 
KH2PO4, 1x metals (1,000x metals: 2.5 mM FeCl3, 1 mM CaCl2, 0.5 mM ZnCl2, 0.1 mM 
CoCl2, 0.1 mM CuCl2, 0.1 mM NiCl2, 0.1 mM Na2MoO4, 0.1 mM Na2SeO3, 1 mM 
H3BO3), and 25 µg/mL kanamycin) at 37ᵒC with orbital rotation for 2 hours until reaching 
an OD600 of ~0.7. Overexpression was induced by adding IPTG to 1 mM and the 
cultures were grown for 3 additional hours 37ᵒC. Cells were then pelleted by 
centrifugation and frozen in liquid nitrogen to be stored at -80ᵒC. Once thawed, the 
pellet was resuspended in lysis buffer (50 mM Tris-HCl pH 8, 300 mM NaCl, 10% 
sucrose, 10 mM imidazole, 1x protease inhibitors (Roche 11873580001)) and cells were 
sonicated on ice. Cell debris was pelleted by centrifugation. Supernatant was then 
poured through a 3 mL Ni2+-NTA agarose gravity-flow column. The column was washed 
with wash buffer (20 mM Tris-HCl pH 8, 10% glycerol, 20 mM imidazole, 2 M NaCl) and 
eluted with elution buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 400 mM imidazole). 
SDS-PAGE was performed to confirm the presence of desired protein. The sample was 
then dialyzed into anion exchange start buffer (50 mM Tris-HCl pH 8, 25 mM NaCl, 5% 
glycerol, 1 mM β-mercaptoethanol) and the sample was applied to a Q column (GE: 
17115301) using an elution gradient of 50-750 mM NaCl. SDS-PAGE was performed 
and fractions containing desired protein were pooled and incubated with ULP1 protease 
at 25°C for 30 minutes. The digestion product was applied to another 3 mL Ni2+-NTA 
gravity-flow column, washed, and eluted using the same buffers as above. SDS-PAGE 
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was again performed to confirm the SUMO tag was removed and the protein was 
concentrated and buffer exchanged into protein storage buffer (50 mM Tris-HCl pH 8, 
150 mM NaCl, 50% glycerol), aliquoted, flash frozen in liquid nitrogen, and stored at -
80°C. 
 
ScoC purification: Primers oTMN62 and 63 were used to amplify scoC from the B. 
subtilis chromosome and were subsequently combined with the pE-SUMO expression 
vector via Gibson assembly. Recombinant proteins were purified from E. coli BL21DE3 
cells grown in 2 L of LB with 25 µg/ml kanamycin at 37ᵒC with orbital rotation until an 
OD600 of 0.7 was reached. Overexpression was induced by adding 0.5 mM IPTG 
followed by culture growth for an additional three hours at 37ᵒC with orbital rotation and 
cultures were subsequently pelleted via centrifugation and stored at -80ᵒC. The pellet 
was re-suspended in lysis buffer and sonicated on ice as described for DnmA and 
YabB. Subsequent to centrifugation, the supernatant was applied to a 4 mL Ni2+-NTA 
agarose gravity-flow column. The column was washed with wash buffer (50 mM Tris-
HCl pH 8, 25 mM imidazole, 2 M NaCl, 5% glycerol) and eluted with elution buffer (50 
mM Tris-HCl pH 8, 400 mM imidazole, 150 mM NaCl, 5% glycerol). Following elution, 1 
mM DTT and SUMO ULP1 protease were added to the elution fraction and incubated 
for 2 hours at room temperature. The sample was then dialyzed into storage buffer (50 
mM Tris-HCl pH 8, 150 mM NaCl, 5% glycerol) overnight at 4°C.  The dialyzed sample 
was then applied to another 4 mL Ni2+-NTA gravity-flow column to separate the 
recombinant protein from the SUMO tag. SDS-PAGE was performed to confirm the 
SUMO tag was removed. Glycerol was added to 25% and the protein was aliquoted and 
flash frozen for storage at -80ᵒC 
 
Methylation Assays: All methylation reactions were performed in a buffer containing 
50 mM Tris-HCl pH 8, 50 mM NaCl, and 200 µM MgSO4. The following substrates were 
annealed in the same buffer at 2.5 µM concentration by heating primers to 100 °C for 30 
seconds and then cooling to room temperature on the bench top: dsDNA target 
(oTNM38, oTMN39); dsDNA non-target (oTMN40, oTMN41); and dsRNA (oJR270, 
oJR271). The H3-SAM (Perkin Elmer: NET155H001MC) was used at a concentration of 
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1 µM in solution. The purified DnmA, YabB, or DnmA (Y465A) was added to a 
concentration of 1 µM and all substrates were used at 0.25 µM in solution. The proteins 
were added in excess to determine if there was any off target methylation activity at 
higher protein concentrations. The total reaction solution came to 10 µL. All reactions 
were incubated at 37ᵒC for 150 minutes unless otherwise specified. Reactions were 
stopped using 450 µL of 10% TCA and placed on ice. The samples were filtrated using 
Glass microfiber filters (GE: 1822-025), washed with cold 70% ethanol, dried, and 
placed in a scintillation counter to measure mmol incorporation.  
 
Growth Curves: Strains were plated on LB and grown overnight at 30°C. Plates were 
washed in LB and diluted to an OD600 of 0.05 in 10 mL of LB in side-armed flasks. 
Cultures were grown in shaking water baths at 37°C and optical density was measured 
using a Klett meter every half hour through late stationary phase. Growth curve 
experiments were done in triplicate and data was subsequently fit to a Gompertz growth 
(43) model {𝑦 = 𝐴𝑒𝑥𝑝{− 𝑒𝑥𝑝 )!!	×	$" 	(𝜆 − 𝑡) + 11} (where the parameters A, μm, and λ 
represent the time (t) when the growth rate equals zero (asymptote), the maximum 
growth rate, and the lag time, respectively), to obtain growth rate estimates (μm) for 
each strain. 
 
Transformation efficiency assays: Strains were plated on LB and grown overnight at 
30°C. Plates were washed with phosphate buffered saline (PBS) pH 7.4 and the cells 
were pelleted, the supernatant was aspirated, and a second PBS wash was completed 
before the cells were resuspended in PBS. The cells were used to inoculate a culture at 
an OD600 of 0.05 into 1 mL of 1x MC media (10x MC media: 615 mM K2HPO4, 380 mM 
KH2PO4, 1.11 M dextrose anhydrous, 30 mM sodium citrate dihydrate, 840 µM ferric 
ammonium citrate, 0.5 g casein hydrolysate, and 125 mM sodium aspartate 
monohydrate, to 50 mL with ddH2O and filter sterilize) with 3 µL of 1M MgSO4 and 
grown at 37°C with aeration for 4 hours. After 4 hours 3 µL of 1M MgSO4 and 300 ng of 
pHP13 purified from E. coli MC1061 cells was added to 300 µL of cells and grown for an 
additional 1.5 hours at 37°C. 10x serial dilutions were performed into PBS and 
appropriate dilutions were plated onto LB plates for colony forming unit (CFU) counts 
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and chloramphenicol plates for transformation forming unit (TFU) counts. 
Transformation efficiencies were calculated as TFU/CFU and the average 
transformation efficiency for replicates performed over three separate days was plotted 
along with the corresponding standard errors.  
 
Flow Cytometry: Cells were grown overnight at 30°C on LB plates containing 100 
µg/mL spectinomycin. Exponentially growing colonies were washed from the plates 
using S750 medium, and washed two more times to remove residual LB agar before 
diluting the cells in pre-warmed S750 medium to an OD600 of 0.05. Cells were grown to 
an OD600 of 0.4 at 30°C after which fluorescence of 200,000 cells was measured using 
an Attune™ NxT Acoustic Focusing Cytometer (ThermoFisher Scientific) using the 
following settings: Flow rate, 25 µL/min; FSC voltage, 200; SSC voltage, 250; BL1 
voltage, 250. 
 
Streptavidin pull-down: 5' biotinylated primers were used to amplify the 233 bp region 
of the scpA promoter via PCR using genomic DNA from strains LVG087 and LVG102 
as a template, which correspond to the GACGAG and GACGTG promoter, respectively. 
To obtain total cell lysate, 4 L of strain TMN85 (ΔdnmA) was grown in S750 medium at 
37°C with shaking until the culture reached an OD600 of 1.0. After the cells were 
harvested the pellets were washed with 1x PBS (pH 7.5) and then subsequently 
washed with Pull- Down Binding Buffer (PDBB; 50 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 
100 mM NaCl, 0.01% (v/v) Triton X-100, 25% (v/v) glycerol, and 1 mM DTT) and 
resuspended in ice-cold 20 mL PDBB supplemented with one tablet of cOmplete™, 
EDTA-free Protease Inhibitor Cocktail (Roche, Mannheim, Germany). The cell 
suspensions were sonicated on ice (10s on, 40s off, 70 Hz) until the solutions cleared.  
Cell debris was removed from the lysate by two subsequent washing steps and the 
protein content of the supernatant was estimated using a Bradford assay (~20 mg/mL 
protein).  For each pull-down experiment, 100 µL of Dynabeads™ M-270 Streptavidin 
magnetic bead slurry (ThermoFisher Scientific) was washed three times with 500 µL 
Pull-Down Wash Buffer (PDWB; 10 mM Tris-HCl pH 7.5, 1 mM EDTA, and 1 M NaCl). 
The beads were re-suspended in 250 µL PDWB, mixed with 200 pmol biotinylated 
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probe DNA dissolved in 250 µL nuclease-free water, and incubated for 30 min at 25°C 
with gentle rotation. The DNA-coated beads were washed three times with PDBB before 
100 mg protein and 100 µg salmon sperm DNA (Millipore Sigma) were mixed and 
added to the DNA-bound beads. After 2 hrs of incubation at room temperature with 
gentle rotation, the beads were separated and washed once with PDBB, once with 
PDBB plus 100 µg salmon sperm DNA, and again with PDBB. Bound proteins were 
eluted using Pull-Down Elution Buffer (PDEB; 50 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 1 
M NaCl, 0.01% (v/v) Triton X-100, 25% (v/v) glycerol, and 1 mM DTT). The eluted 
proteins were desalted and concentrated using TCA precipitation and separated on a 4-
20% Mini-PROTEAN TGX precast protein gel (Bio-Rad, Hercules, USA). Bands in the 
20 and 40 kDa size range were excised from the gel followed by protein identification 
using mass spectrometry through the University of Michigan Proteomics Resource 
Facility, project PRF-2019-L-SIMM-29. 
 
ScoC EMSA: 5' IR dye end-labeled substrates oTN67/oTN68 and oTN70/oTN71, 
corresponding to the GACGAG and GACGTG oligos, respectively, were annealed at a 
concentration of 50 nM by heating at 95°C for 1 minute and then snap-cooled on ice. 
Care was taken to avoid subjecting the IR dye labeled oligos to light. Annealed oligos 
were mixed at a final concentration of 5 nM with indicated concentrations of purified 
ScoC in 1x EMSA reaction buffer (5x EMSA reaction buffer: 250 mM Tris-HCl pH 8, 5 
mM EDTA, 150 mM KCl, 10 mM MgCl2, 5 mM DTT, 1% Tween 20, 125 μg/mL sheared 
salmon sperm DNA) to a final volume of 10 μL. Reactions were incubated at 37°C for 15 
minutes and subsequently loaded onto and resolved via 6% Native-PAGE, which was 
performed covered and on ice for 60 minutes at 100V. The samples were visualized 
with the LI-COR Odyssey imager. The intensity of the shifted band was normalized to 
the no protein control for each sample to calculate the percent band shifted. Three 
replicates were completed and quantified across separate days and the average and 
standard errors for percent band shifted was reported in 3.6. 
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Fig. 3.1.  Motif enrichment analysis for m6A sites in the B. subtilis PY79 
chromosome. Motif enrichment analysis was performed using the DistAMo web based 
server tool (42). Sliding windows of 50 kb to 500 kb are represented by the rings from 
outside (large) to inside (small) rings scaling in 50 kb increment increases. Over (red) 
and under (blue) enrichment are represented by z-scores in the scale indicated. (A) 
m6A motif enrichment for all motifs with ori and ter regions indicated; (B) m6A motif 
enrichment on the leading strand; (C) m6A motif enrichment on the lagging strand. 
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Fig. 3.2. DnmA is sufficient for methylation of dsDNA at 5'GACGAG sites.  
(A) SDS-polyacrylamide gel of purified catalytically inactive DnmA variant Y465A, WT 
DnmA (M.BsuPY79I), and YabB. (*) indicates DnmA multimer. (B) DnmA (M.BsuPY79I) 
incorporation of tritiated SAM into dsDNA and ssDNA substrates carrying the GACGAG 
sequence over time. Y465A (indicated in blue) is a DnmA (M.BsuPY79I) catalytically 
inactive variant. (C) Incorporation of tritiated SAM into DNA and RNA substrates by 
uncharacterized MTases DnmA (M.BsuPY79I) and YabB. (D) DnmA (M.BsuPY79I) 
incorporation of tritiated SAM onto indicated substrates. The DnmA catalytically inactive 
variant is indicated.  
 
  
0
10
20
30
dsDNA
target
dsDNA
nontarget
dsRNA ssDNA ssRNA
Y465A
M
et
hy
l 3
H
 m
m
ol
 in
co
rp
or
at
io
n 
0
10
20
30
0 50 100 150
time (min)
substrate
dsDNA
ssDNA
Y465A/
dsDNA
M
et
hy
l 3
H
 m
m
ol
 in
co
rp
or
at
io
n 
dsDNA
target
A B
D
0
5
10
15
20
25
DNA RNA DNA RNA DNA RNA
M
et
hy
l 3
H
 m
m
ol
 in
co
rp
or
at
io
n
DnmA YabB
C
No protein
15
25
120
190
60
Y4
65ADn
mA
Yab
B 
DnmA
YabB
*
DnmA
	 115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3. Loss of DnmA does not affect growth rate or transformation efficiency of 
foreign methylated DNA. (A) Growth curves for WT, ΔdnmA, ΔyabB, and 
ΔdnmAΔyabB were performed in triplicate and fit to a Gompertz growth model (43) to 
calculate growth rate. Growth rate and the corresponding 95% confidence interval for 
each strain are indicated. (B) Plasmid map of pHP13 with the location of each m6A site 
shown. The orange carrots indicate the relative position and strand orientation for each 
site. (C) Transformation efficiency assays were performed using pHP13 plasmid purified 
from E. coli as donor DNA in WT, ΔdnmA, Δrok, and ΔcomK recipient strains. The 
average transformation efficiency and standard error for each strain is indicated.    
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Fig. 3.4. Methylation of DnmA motifs in proximity of -35 boxes affects 
downstream gene expression. (A) Schematic overview of the promoter regions 
containing DnmA sites that were selected for analysis using transcriptional GFP fusions. 
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Indicated are the locations of the predicted sigma factor -35 and -10 boxes with respect 
to the DnmA motifs. U numbers correspond to the transcribed regions 5' of 
ORFs identified by Nicolas et al (51). (B) The location of the studied promoters on the 
PY79 chromosome map with respect to the amyE site used for integration and analysis 
of the promoter-GFP constructs. (C) Histograms depicting the GFP fluorescence 
in 200,000 WT (blue) or ΔdnmA (red) cells in three biological replicates that were grown 
in S750 medium to an OD600 of 0.5 at 30°C and measured using flow cytometry. For 
U0374/PsigB, an additional experiment was performed in which the cells were treated 
with 4% EtOH an hour before analysis with flow cytometry. The standard deviations are 
represented as shaded areas. Promoter regions that appear methylation sensitive are 
shown in green. (D) Scatter dot plots, with indicated mean and standard deviation, 
depicting the median fluorescence of each strain taken from the histograms shown in 
(C) and appended with similar measurements taken on at least one different day. A 
standard T-test was performed to evaluate differential GFP expression between WT and 
ΔdnmA for each promoter. p-values: * = p < 0.05, ***  = p < 0.005, **** = p < 0.001. 
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Fig. 3.5. Mutating the DnmA recognition motif is sufficient for differential gene 
expression in the PscpA promoter. (A) Analysis of the effect of mutating WT 
GACGAG to GACGCG (first graph), GACGTG (second graph), or GACGAC (third 
graph) on the activity of PscpA-GFP in WT (teal) and ΔdnmA (orange) cells.  (B) Scatter 
dot plots, with indicated mean and standard deviation, of the median GFP fluorescence 
of each strain taken from the histograms shown in (A) and appended with 
measurements from a similar experiment taken on a separate day. The median values 
were tested against each other, including the median values from the strain expressing 
PscpA-GFP in WT cells, for differential expression using a one-way ANOVA post-hoc 
Tuckey test. p-values: * = p < 0.05, ***  = p < 0.005, **** = p < 0.001, ns = not 
significant. 
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Fig. 3.6. Transcription factor ScoC binds the scpA promoter with an unmodified 
GACGAG site. (A) Top protein hits identified in the pull-down of the biotinylated scpA 
promoter regions with GACGAG and GACGTG sites. The #PSMs indicates the total 
number of peptide spectra identified for each protein using the indicated oligo in the 
lysate pull-down assay. (B) SDS-polyacrylamide gel of ScoC overexpressed and 
purified from E. coli and stained with Coomassie. (C) Schematic of the scpA promoter 
region. The ScoC binding consensus sequence is shown in blue, the m6A site is in red, 
and the -35 box is also indicated. (D) ScoC binding to 5' IR dye end-labeled scpA 
promoter region containing a GACGAG or GACGTG site was determined via EMSA. 
Representative electrophoretic mobility shift assay (EMSA) of ScoC binding to scpA 
promoter regions is shown. The concentration of ScoC is shown with (-) indicating the 
absence of ScoC from the reaction. Oligos containing the GACGAG or GACGTG site 
are also indicated at the top of the gel. The DNA substrates used in the reaction are 
otherwise identical. (E) Quantification of the percent band shifted using 250 nM and 500 
nM concentrations of ScoC for the GACGAG and GACGTG oligos as indicated on the 
graph. The percent band shifted was normalized to the no protein control for each 
substrate. Three replicates were completed with the error bars representing the 
standard error between reactions. 
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Fig. 3.7. The genome of B. subtilis strains contain m6A modifications. (A) PacBio 
SMRT sequencing of genomic DNA isolated from WT PY79 cells. Modification quality 
values (modQVs) indicate if the kinetics of the DNA polymerase differs from the 
expected background at a particular locus, where a modQV of 30 represents a p-value 
of 0.001. ModQVs are indicated on the x-axis and the number of bases is indicated on 
the y-axis. Each line represents the modification quality values for a particular 
nucleotide. (B) PacBio SMRT sequencing of genomic DNA isolated from the WT 
ancestral strain NCIB 3610.  
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Fig. 3.8. GACGmAG sites have high modification scores throughout the B. subtilis 
PY79 genome. (A) Representative boxplot of interpulse duration (IPD) ratio values at 
GACGAG sites throughout the genome in WT cells. The median IPD ratio value is 
indicated. (B) The genomic location of each GACGmAG site (x-axis) and the 
corresponding fraction of reads that were called as methylated at that position (y-axis) 
from PacBio SMRT sequencing is plotted. Sites that appear on the plus strand are 
indicated as a green triangle and those that appear on the minus strand are indicated as 
red dots. (C) Representative boxplot of the IPD ratio values at GACGAG sites 
throughout the genome in ΔdnmA (M.BsuPY79I) cells. Median IPD ratio value is 
indicated.   
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Fig. 
3.9. Deletion of the BsuMI RM system eliminates m5C from the B. subtilis 
chromosome. Clean deletions were made for the coding regions of both subunits of the 
putative methyltransferase (ydiOP) in conjunction with separate deletions for each gene 
in a nearby operon coding for a putative restriction endonuclease (ydiR, ydiS, ydjA). 
DNA purified from these strains was subjected to 6 hours of treatment with a 5-
methylcytidine and 5-hydroxymethylcytidine specific endonuclease MspJI. (-) indicates 
no treatment, (+) indicates treatment with MspJI. 
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Fig. 3.10. Origin firing in B. subtilis is not regulated m6A. (A-E) Representative 
images of fluorescence microscopy for (A) WT, (B) ΔdnmA, (C) yabA::cat, (D) dnaAN 
depletion, and (E) ΔyabB strains expressing spo0J::spo0J-gfp, respectively. White bar = 
10 μm. (F) Quantification of Spo0J-GFP foci for strains A-E.  
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Fig. 3.11. Bacillus subtilis m6A modifications are dependent on methyltransferase 
DnmA. (A) PacBio SMRT sequencing of genomic DNA isolated from the ΔdnmA PY79 
strain. (B) PacBio SMRT sequencing of genomic DNA isolated from the ancestral strain 
NCIB 3610 with a dnmA deletion. (C) PacBio SMRT sequencing of genomic DNA 
isolated from ΔdnmA cells ectopically expressing dnmA from the amyE locus with 0.2 
mM IPTG.  
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Fig. 3.12. Genomic m6A is present in a yabB deletion strain. (A) PacBio SMRT 
sequencing of genomic DNA isolated fromPY79 ΔyabB cells. (B) PacBio SMRT 
sequencing of genomic DNA isolated from PY79 ΔdnmAΔyabB cells. 
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Fig. 3.13. DnmA binds DNA without the m6A motif. DnmA (M.BsuPY79I) substrate 
binding was determined by electrophoretic mobility shift assay (EMSA) with purified 
DnmA and varying substrates. 5' IR-labeled substrates include: target substrate 
(GACGAG), non-target substrate (GACGTG) and a degenerate sequence substrate, 
which are indicated at the bottom. The (-) indicates the absence of DnmA from the 
reaction, (+) indicates addition of DnmA to the reaction. As indicated, the final lane 
includes the DnmA catalytic inactive variant (Y465A) incubated with the target 
substrate. 
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Fig. 3.14.  Loss of m6A does not cause an increased susceptibility to genotoxic 
stress. WT and ΔdnmA cells were tested for their sensitivity to several DNA damaging 
agents and replication fork stress caused by hydroxyurea (HU). Cells were grown to 
mid-exponential growth phase, serially diluted, and plated on LB agar plates with the 
following concentrations of DNA damaging agents:  100 ng/mL phleomycin (phleo), 10 
ng/mL mitomycin C (MMC), 1 mM hydrogen peroxide (H2O2), 100 μg/mL methyl 
methanesulfonate (MMS), and 5 mM hydroxyurea (HU). Cells with a recA::loxP 
disruption were used as a control. 
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Table 3.1. Relevant modified motifs detected in B. subtilis by PacBio SMRT sequencing. 
Motifa Type %Detected Mean QV Mean Cov. Mean IPD Ratio 
WT PY79 
GACGAG m6A 99.7 388 286 6.72 
CTCGARB m5Cb 70.8 74 270 1.89 
WT 3610 
GACGAG m6A 94.7 362 313 4.84 
aAll motif calls by SMRT sequencing are reported in Table 3.6. 
bModification type confirmed via methylation sensitive restriction endonuclease digest as described in the 
supporting document. 
 
Table 3.2. Relevant modified motifs detected in B. subtilis by PacBio SMRT sequencing. 
Motifa Type %Detected Mean QV Mean Cov. Mean IPD Ratio 
ΔdnmA WT PY79 
CTCGARB m5Cb 46.7 51 120 2.00 
ΔdnmA WT 3610 
Nonec    358  
ΔdnmA, amyE::Pspac dnmA PY79 
GACGAG m6A 99.7 213 152 6.32 
CTCGARB m5C 52.7 59 149 2.00 
aAll motif calls by SMRT sequencing are reported in Table 3.8. 
bModification type confirmed via methylation sensitive restriction endonuclease treatment as described in 
the supporting document. 
cGACGAG and CTCGARB were not detected in NCIB 3610 ΔdnmA. All other motifs called are reported in 
Table 3.8. The average coverage is reported for each spurious motif detected.  
 
Table 3.3. Strains used in this study 
Strain Genotype Source 
JWS10  PY79 (90) 
JWS261 ΔydiOP, ΔydiR This work 
JWS262 ΔydiOP, ΔydiS This work 
JWS263 ΔydiOP, ΔydjA This work 
TMN1 ΔyabB This work 
TMN5 ΔdnmA (M.BsuPY79I) This work 
TMN7 ΔdnmA,  ΔyabB This work 
DK1042 NCIB 3610 comIQ12I (91) 
TMN47 NCIB 3610, ΔdnmA (M.Bsu3610I) This work 
TMN16 ΔdnmA, amyE::PspacdnmA This work 
JWS259 spo0J::spo0J-gfp  
JWS260 ΔdnmA, spo0J::spo0J-gfp This work 
TMN80 ΔyabB, spo0J::spo0J-gfp This work 
AK42 yabA::cat, spo0J::spo0J-gfp Lab stock 
LAS254 PspacdnaAN::cat, spo0J::spo0J-gfp (81) 
BTS13 ΔmutSL::spc (92) 
LVG066 amyE::PrbsV-GFP This work 
LVG067 ΔdnmA, amyE::PrbsV-GFP This work 
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LVG068 amyE::PwprA-GFP This work 
LVG069 ΔdnmA, amyE::PwprA-GFP This work 
LVG070 amyE::PyloA-GFP This work 
LVG071 ΔdnmA, amyE::PyloA-GFP This work 
LVG072 amyE::PzapA-GFP This work 
LVG073 ΔdnmA, amyE::PzapA-GFP This work 
LVG074 amyE::PrnhC-GFP This work 
LVG075 ΔdnmA, amyE::PrnhC-GFP This work 
LVG079 amyE::PcomEA-GFP This work 
LVG080 ΔdnmA, amyE::PcomEA-GFP This work 
LVG081 amyE::PezrA-GFP This work 
LVG082 ΔdnmA, amyE::PezrA-GFP This work 
LVG087 amyE::PscpA-GFP This work 
LVG088 ΔdnmA, amyE::PscpA-GFP This work 
LVG102 amyE::PscpA mut1-GFP This work 
LVG103 ΔdnmA, amyE::PscpA mut1-GFP This work 
LVG105 amyE::Phbs-GFP This work 
LVG106 ΔdnmA, amyE::Phbs-GFP This work 
LVG108 ΔdnmA operon, amyE::PscpA-GFP This work 
LVG109 ΔdnmA operon, amyE::PscpAmut1-GFP This work 
LVG118 amyE::PscpA mut2-GFP This work 
LVG119 ΔdnmA operon, amyE::PscpAmut2-GFP This work 
LVG120 amyE::PscpA mut3-GFP This work 
LVG121 ΔdnmA operon, amyE::PscpAmut3-GFP This work 
 
 
Table 3.4. Plasmids used in this study 
Plasmid Vector Insert Source 
pJS146 pminiMAD ydiOP  
pTN02 pE-SUMO dnmA (M.BsuPY79I)  
pTN03 pDR110 dnmA (M.BsuPY79I)  
pAS2 pE-SUMO dnmA (Y465A) (M.BsuPY79I)  
pTN12 pE-SUMO yabB  
pTN13 pE-SUMO scoC  
pLVG1 pDR111_GFP(Sp) w/o lacI (79) 
pLVG1-0374 pLVG1 PrsbV/U0374  
pLVG1-0868 pLVG1 PwprA/U0868  
pLVG1-1292 pLVG1 PyloA/U1292  
pLVG1-1995 pLVG1 PcomE/U1995  
pLVG1-2292 pLVG1 PezrA/U2292   
pHP13  None 
BGSC 
(http://www.bgsc.org) 
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Table 3.5. Oligonucleotides used in this study 
Oligo name Oligo sequence 
oAS1 CCAAGAGCCGGTGGATTACCAAAAACATATACTTCTTC 
oAS2 CCACCGGCTCTTGGTTCAAAAAAACAAAACAAAGAACATAAATC 
oAS9 /5IRD700/GTGCAGCGTATCCGGACAATGACGAGACGGAAACAGAGCTGCTGCTG ATC 
oAS10 /5IRD700/GTGCAGCGTATCCGGACAATGACGTGACGGAAACAGAGCTGCTGCTGATC 
oAS11 /5IRD700/ATATAAACATACATACATACATTATTATATAAACATACATACATACATTA 
oTMN5 GGCTCACCGCGAACAGATTGGAGGTATGGCGCTCATTGATTTAGAAGA TAAAATTGC 
oTMN7 TGGTGGTGGTGGTGGTGCTCGACTACCGTTCTGTCATTTCTTGATACAA TTTAAGCAATAC 
oTMN36 CACCGCGAACAGATTGGAGGTATGGTTTCATTACATGATGATGAAAGATTAGATTA 
oTMN37 TGGTGGTGGTGGTGCTCGATTATTTGTCTCCATATAAAATGGTCCTGATTTC 
oTMN38 GTGCAGCGTATCCGGACAATGACGAGACGGAAACAGAGCTGCTGCTGATC 
oTMN39 GATCAGCAGCAGCTCTGTTTCCGTCTCGTCATTGTCCGGATACGCTGCAC 
oTMN40 GTGCAGCGTATCCGGACAATGACGTGACGGAAACAGAGCTGCTGCTGATC 
oTMN41 GATCAGCAGCAGCTCTGTTTCCGTCACGTCATTGTCCGGATACGCTGCAC 
oTMN62 CACCGCGAACAGATTGGAGGTATGAATCGAGTGGAACCGCCCTATG  
oTMN63 GGTGGTGGTGGTGGTGCTCGATTAACTGTTTACAGGTTCGAGCTCTTCAG  
oTMN67 /5IRD700/CA AAACAGGATATGAAATAGTATTGGACGAGAGCTTTTTGGTGGCTTATACTATAG  
oTMN68 /5IRD800/CTATAGTATAAGCCACCAAAAAGCTCTCGTCCAATACTATTTCATATCCTGTTTTG  
oTMN70 /5IRD700/CAAAACAGGATATGAAATAGTATTGGACGTGAGCTTTTTGGTGGCTTATACTATAG  
oTMN71 /5IRD800/CTATAGTATAAGCCACCAAAAAGCTCACGTCCAATACTATTTCATATCCTGTTTTG  
oJR269 TAATGTATGTATGTATGTTTATATAATAATGTATGTATGTATGTTTATAT 
oJR270 GUGCAGCGUAUCCGGACAAUGACGAGACGGAAACAGAGCUGCUGCUGAUC 
oJR271 GAUCAGCAGCAGCUCUGUUUCCGUCUCGUCAUUGUCCGGAUACGCUGCAC 
oLVGLS023A GCTAGCTGATTAACTAATAAGGAGGACAAAC 
oLVGLS023B GAGAGTCGAATTCCTGCAGC 
oLVGLS024A CCGGGATCCGATGACCTCGTTTCCACCGAATTAGC 
oLVGLS024B CCGGGATCCGCAGGCCATGTCTGCCCGTATTTC 
oLVGLS034 CGTATCACGAGGCCCTTTCG 
oLVGLS042A GAAATAGTATTGGACGTGAGCTTTTTGGTGGCTTATAC 
oLVGLS042B GCCACCAAAAAGCTCACGTCCAATACTATTTCATATCCTG 
oLVGLS044A GAAATAGTATTGGACGCGAGCTTTTTGGTGGCTTATAC 
oLVGLS044B GCCACCAAAAAGCTCGCGTCCAATACTATTTCATATCCTG 
oLVGLS045A GAAATAGTATTGGACGACAGCTTTTTGGTGGCTTATAC 
oLVGLS045B GCCACCAAAAAGCTGTCGTCCAATACTATTTCATATCCTG 
oKWJ89 TTCTTCGCTTGGCTGAAAAT 
oKWJ90 CACCAGGTTTTTGGTTTGCT 
oLVG52A 5’Biotin-CTGCAGGAATTCGACTCT 
oLVG52B 5’-Biotin-CCTTATTAGTTAATCAGCTAGC 
oLVG_U0374F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCCCTGATCTGCAGAAGCTCATTG 
oLVG_U0374R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCCTTCAAATCACTAGTTGCTTTATAC 
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oLVG_U0868F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGGTCTGCATTTGCCAATTG 
oLVG_U0868R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCAAAATAATGAATCTCCTTGAAGG 
oLVG_U1292F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGTTAATCCTTGTTTCATGGACG 
oLVG_U1292R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCTCTCATTCTTCCTGCATTCGAT 
oLVG_U1995F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGCGTGACAGCTGATTTTACGG 
oLVG_U1995R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCCGCAGTGAAAAAGCAGTTTC 
oLVG_U2292F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCCGGAAGTATTGAAGTCGAG 
oLVG_U2292R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCCGGAGTATCTATTCTTCCATTG 
oLVG_U1780F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGAATCATAAACGAAGGCTCTGG 
oLVG_U1780R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCGTAGAGTAACACATATAAAAAGCCAT 
oLVG_U1815F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCCTCTAGTGCTTCTTAGAAAGG 
oLVG_U1815R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCTCACTCTCATTGCCGGAAAAAC 
oLVG_U2212F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGTAAGTGAACCGCTGTACG 
oLVG_U2212R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCATTCCGCGAGAATCCTAG 
oLVG_U2213F  CGCCATTCGCCAGGGCTGCAGGAATTCGACTCTCGTGAAGTGCTGGCCGTAAATG 
oLVG_U2213R  CATGTTTGTCCTCCTTATTAGTTAATCAGCTAGCACTTTTCGCTGTATATACCAGTG 
Oligo sequences in red represent RNA. /5IRD700/ indicates 5' infrared dye label with excitation at 700 
nm. 
 
Table 3.6. Modified motifs detected in B. subtilis by PacBio SMRT sequencing. 
Motif Type %Detected Mean QV Mean Cov. Mean IPD Ratio 
WT PY79 
GACGAG m6A 99.7 388 286 6.72 
VTTCGAGNR NA 79.2 75 284 1.90 
CTCGARB m5C* 70.8 74 270 1.89 
VTTVGAGNBY NA 40.1 55 283 1.67 
GGNB NA 5.6 41 290 1.67 
WT 3610 
GACGAG m6A 94.7 362 313 4.84 
RAWKYAGYA m6A 28.7 98 309 1.66 
DTNRADDDG NA 22.8 61 305 1.78 
DTWTWGAAG NA 21.4 57 327 1.71 
AGCNMAAAWH m6A 15.8 107 322 1.53 
TNNNDNNH NA 12.6 61 303 1.78 
DTSNVCNTWNH NA 11.7 58 304 1.75 
TWGCNNNG NA 10.6 58 313 1.75 
TNRGCYNH NA 10.1 56 309 1.72 
TNNNCRVH NA 9.6 58 304 1.76 
TSNNNNNG NA 6.1 57 305 1.75 
AGDNNNNW m6A 4.3 104 325 1.71 
*Modification type confirmed via methylation sensitive restriction endonuclease digest. 
The motifs shown in this table are comprehensive to those presented in Table 3.1. 
 
 
Table 3.7. Cells with ΔdnmA are wild type for mutation rate 
Strain No. of 
cultures 
Mutations per 
culture 
Mutation rate (Mutations per 
generation 10-8 + [95%CI] 
Relative 
mutation rate 
Wild Type 20 0.60 1.7 [0.95-1.68] 1 
	 133 
ΔdnmA 22 0.72 1.8 [0.94-2.2] 1.05 
ΔmutSL 22 41.3 120.8 [109-131] 71.1 
Mutagenesis assays were done as described using rifR as an indicator. Mutation rate and 
mutations per culture were calculated using the Ma-Sandri-Sarkar Maximum Likelihood 
Estimator with the web-based tool FALCOR (76). 
 
 
Table 3.8. Modified motifs detected in B. subtilis by PacBio SMRT sequencing. 
Motif Type %Detected Mean QV Mean Cov. Mean IPD Ratio 
ΔdnmA WT PY79 
VTTCGAGNR NA 62.5 53 118 2.00 
CTCGARB m5C* 46.7 51 120 2.00 
ΔdnmA WT 3610 
VATATRGCA m6A 54.0 88 363 2.00 
RAHKYAGYA m6A 31.0 110 357 1.67 
DDTNRGCNTHNH NA 20.4 60 356 1.72 
DNNDTGYAADNG NA 20.3 65 348 1.81 
DTNRVDDDG NA 15.2 61 355 1.73 
TNNNDNNH NA 12.3 62 353 1.74 
TNNNCRVH NA 9.4 60 359 1.72 
AGNNMRNA m6A 9.1 109 359 1.55 
TNNSCBDH NA 7.2 58 363 1.68 
TSNNBNNG NA 6.4 58 361 1.71 
AGNNDNNW m6A 3.4 101 365 1.54 
ANDNNNNH m6A 0.8 98 367 1.53 
ΔdnmA, amyE::Pspac dnmA PY79 
GACGAG m6A 99.7 213 152 6.32 
VTTCGAGNR NA 67.2 59 146 1.98 
CTCGARB m5C 52.7 59 149 2.00 
MNGACGAWCC NA 47.3 58 152 2.20 
VTTCGAGBB NA 38.1 53 157 1.82 
WAGACGAWB NA 21.7 53 148 2.19 
GGNNB NA 6.6 40 168 1.86 
*Modification type confirmed via methylation sensitive restriction endonuclease treatment. 
The motifs shown in this table are comprehensive to those presented in Table 3.2. 
 
Table 3.9. Modified motifs detected in B. subtilis by PacBio SMRT sequencing. 
Motif Type %Detected Mean QV Mean Cov. Mean IPD Ratio 
ΔyabB 
GACGAG 
ATATRGCA 
m6A 
m6A 
96.9 
74.0 
304 
80 
240 
238 
5.15 
2.09 
ADGYACYTV 
ADKYASYA 
AGCNAAAAWH 
GANNBNRCA 
TNNNNNNH 
DTVVVNNDG 
ANVBANYW 
AGDNVDNW 
TBNNDNNG 
AGBB 
m6A 
m6A 
m6A 
m6A 
NA 
NA 
m6A 
m6A 
NA 
m6A 
34.7 
29.8 
17.3 
13.7 
12.2 
11.1 
6.4 
5.4 
5.2 
2.7 
85 
88 
95 
98 
46 
44 
78 
87 
43 
99 
238 
238 
237 
241 
234 
234 
238 
236 
235 
238 
2.01 
1.88 
1.58 
1.90 
1.69 
1.67 
1.81 
1.81 
1.67 
2.02 
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ΔdnmA ΔyabB  
VTTCGAGNR NA 71.9 60 166 1.92 
CTCGARB NA 57.3 57 168 1.91 
VTTCGAGBY 
GG 
NA 
NA 
33.2 
3.1 
46 
39 
181 
185 
1.70 
1.77 
 
Table 3.10. Identification of protein species in DnmA protein purification 
Identified Protein Accession Number Molecular Weight Total Spectrum Count 
YEEA_BACSU 101 kDa 190 
SMT3_YEAST 12 kDa 42 
K2C1_HUMAN 66 kDa 34 
HORN_HUMAN 282 kDa 34 
TRYP_PIG 24 kDa 18 
K1C10_HUMAN 59 kDa 19 
K22E_HUMAN 65 kDa 21 
K1C9_HUMAN 62 kDa 15 
K2C5_HUMAN 62 kDa 4 
CYTA_HUMAN 11 kDa 3 
K1C14_HUMAN 52 kDa 8 
ALBU_HUMAN 69 kDa 2 
ARGI1_HUMAN 35 kDa 3 
ANXA2_BOVIN (+8) 39 kDa 2 
FABP5_HUMAN 15 kDa 2 
SBSN_HUMAN 61 kDa 2 
Mass spectrometry was completed by the University of Michigan Core on the high molecular 
weight species, confirming the presence of DnmA (YeeA). The SMT3_Yeast contaminant is 
likely the result of trace SUMO-tagged DnmA from the protein purification process (see 
Materials and Methods). 
 
Table 3.11. Promoter upshifts containing the m6A motif 
Upshift Sequence context Downstream TU 
U374 cgatgattttacgttaattgttttgcggagaaaGGTTTAAcgtctgtcagacgaGGGTATAAAGCAACTAGTGatttgaaggaaaatttgaggtgatacga rsbV, rsbW, sigB, rsbX 
U868 atattccaaatcatttaaaataaccttaaaattccctgtaagcggtatctcgtcctatgaaatTATGATACCTTCAAGGAGATtcattattttgcaggagg wprA 
U1292 gctctcttatagagatatcactctataagcatgcttaTTCTGActcgtcccatttCATGCTATAATTATCGAATGcaggaagaatgagagggtgtattgca yloA 
U1780 aaaaaaggaatattcgttcggtaaatcaccttaaatcCTTGACgagcaagggattgacgCTTTAAAATGCTTGATATGGctttttatatgtgttactctac S861, hbs 
U1815 ctgtacaaactccttcaaaacaggatatgaaatagTATTGGACgagagctttttggTGGCTTATACTATAGGGTAGccagtttttccggcaatgagagtga scpA, spcB, ypuI 
U1995 taaaacgatggttttttaaaatgcttttttatgCTTTTGCAgtacagacgaacgTATGACATACTCGTCTACACatgaaactgctttttcactgcggaaat S963, comEA-EC, S962, holA 
U2212 tgtatataccagtgtatcataacagcgggaggctcgtcTTTCCATTcatttaataaaCGTGTTATGATAAGAACTAGgattctcgcggaatggaggagaaa 
yshA (zapA), yshB, S1080, polX, 
mutSB 
U2213 gttcttatcataacacgtttattaaatgaatggaaagacgagcctcccgctgtTATGATACACTGGTATATACagcgaaaagtgtaaaaaaaggagattat rnhC 
U2292 aatttttggacgagtgtgatgtgaccgactcttttTGGCTTATaaacgccgagaGATGCTACAATGGAAGAATAgatactccggtaatattgttcatatac S1127, S1125, ezrA 
U2511 acggatgggcacgttagatccttacgattttttctgctgacTCGTCAATttgaacggcaaTATGGTATAATTAATAACAAttttcatttaggaggcaattt yumC 
U624 cactaaagttgatcaaatgacctaagtgcgccaaacgtGTTACGggacgagctatctCATGGTATAAATGGAATTGTaaacgttatcaaggaggtcgtcat malA, malR-Q 
U792 atattcagctcagtcctttttgatgcgtctttcccgCACATAactcgtctcattcccGCATATGGTTAAGAATAAAgaatctatgcaaagggggaggagcc yhaL 
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U1042 agcggtctgaggctttttattagataaaagacctaattgttctaTGAAACTTTCtgacgagatatCCGTATATCATACAGAttgacatcattcacatcaga S462, S461 
U1293 tacaccctctcattcttcctgcattcgataattatAGCATGaaatgggacgagtcaGAATAAGCATGCTTATAGAgtgatatctctataagagagcagggg yloB, S571, yloC, ylzA, gmk, rpoZ 
U1406 atgtgttcataaaaaactaaaaaaaaTATTGAAAatactgacgaggttATATAAGATGAAAATAAGTTagtttgtttaaacaacaaactaataggtgatgt S634, xylA, S635, xylB, S636 
U1861 ctttcccgtcatataaactgctcaaatgaaccgcttttgtcaaacaTTTCTGTATAATAGACGAGAaatcagtttatttttcagtatagaagcatttttat yqjN 
U2116 atcaagggaataaagatcgtttttatgacgagccaaaagggtgaccatAACATAtcaagcataaaaaagACATAGACTGTTAACAGAAccagcaaacaaat S1041, glnQ, glnH, glnM, glnP 
U2235 gtgtattggctttgcggaaaaaagggtggaacCacgattccgtttattcaaCCTCGTCCCTttcatagggggcggggtttttatatgcaaaaaaaggagtg thrS 
U2676 cttactttaaaaagccacgcaacacggttctCGtcacagacgaaggagccgcAaagaagttattaagggatgaataatccctcaatataaatatctctcac 
gapA, S1301, S1300, pgk, tpiA, pgm, 
eno 
U3059 gcgaaacacacatgttctccactaaaaaagAGTATAtccggtatagatagaCGAGAAACTGAAAGGGAAAcctcattcgtttacatattggcttcagcgga aldY 
U75 cctgatttccaaatcatttgcggatcgcctgaacTGCttgtcagcaaaaagggcAAGCTATTAGAGACGAGACcgattgcgggcacccgttccagagggaa secondary internal pabB upshift 
U568 aaaagagtatctcgtatagaacataagaagaatgacgagttttttaAGATTAtcatcaattatgtgaGAATAAAATATTATAAGGGaaaatgaaggctgtc S257 - as-fecF 
U797 ctatttttctttttttgcagatgattgGCAGGACATggatgactttaTGTACAAATAAAATAACGAcgagcaaaccgccgaataaagatacatattcatcg as-yhaJ; secondary yhaI upshift 
U809 tttgctgcggaagacatatacagataaagaacagccATAATGacatagacgagaagcGCATACATATAAACAGATTggaaaacaaaataaagaacgagtgt as-ecsB (ecsB internal) 
U895 aagaaggtccgtattaatttttcccaCTCATAAaccttactttacccCACCATACTATTgaagacgactcatctcgtcaaagtatggaagggggcagtctc S397, yizC 
U911 tcctgagaaggttttaacaaatcatgatcttgaaaaaatggtTGAAACTTCTgacgagtggatTCGTACAAGAACAGGAatagaagaaagaagaatcgcag secondary internal fabHA upshift 
U936 ataaaacattctaaaggcggtgtttccgacggcttcggctcgtcgccaAGCATCtcaaataaaatttctTCATATACATCATATGAGTagctgccaggaac S416 - as-spxH 
U1010 cgggtagccgaccttcggattatcaAACTTGACgagcagcggcatcACGGCCACACTTGTGATAAAcaaggcgccaagtgatccgatttggcggaacgtcg as-yjmB 
U1122 gttcttaacggttatatgaaccaattcattcgaaaagacaCCTTTACAaacatacgttcgttaAATTATAATAAAACAGACGAgctgccatccagcatccc S498; independent transcript 
U1389 ttgttgttgatattcttgaataaaaaaacccggtttctCGCGAtgaggagccgggtttttttatGAGACGCTCGTCCCCGTCtcggctatgattctaggat S623 - as-cwlC 
U1429 gaatgtaggtctctttgaggctttagcacgaattctctcgtcctccttgttaaatttttgttaaattcaCAATATTATAtaccattagcccgggcgctgtt 
S653 - secondary internal surA 
upshift 
U1984 aaatattttattcaaagtcagccagtcgacgagTATTTAAacgcactcgaacaGGAAATGATAAAtacaatagcaaaaaccgggcagcctgatctcaaaac secondary hrcA-grpE-dnaK upshift 
U2466 tcatttcttttggcgttacgtcattcatcctcgtcatggcctttcgcgcttatcaggaattgaaatcggacgatatggatcaaatgaggggaaatgatcaa secondary mrpD-G upshift 
U1405 ttcatcttatataacctcgtcagtattttcaatattttttTTAGttttttatgaacacATTAGATATAATAAAGGGAAgattcgctatgtactatgttgat S633, xylR 
U1996 ttttacctgacgagtttgtaaaaaatatttttcatattACACctgagaaattaaaggAACGAAATGTAAAAGGAAttattactgacctggataatacgctt 
yqeH, aroD, yqeI, nadD, yqeK, yqeL, 
yqeM 
U2030 gagattttggatatagacgaggctcttggttcacGAATTCACCAgatgtgccgtgatTACATAGTGATTATTAGAGGcgatcgaatgcaattaaatcatag yqzO, yqaN, S982, yqaO, S980 
U2255 cctcctctcgtcagcatgtcctattttttatatgTATTCACGCtgcggctgaataTGAATACATTCATCTTAAAGgagggatggcatgtgtttacacaagc ytwI 
U2486 cggaggcaggatgacgagccacagccctctgttGGTTTGAtcgctctcctgagaGGGAAAACTGAAAGAAACGcggtcatccggcagatcgtataccatcc S1225; as-yukBC 
U3058 ttcagtttctcgtctatctataccggatatactctttttTAGTGGAGaacatgtgtgtttCGCCTTATACTGAATATACAgatccttacataagagaggag yxkF, S1490, msmX 
U3138 agacgaggtttcttataagcctttTTCATccttttcCCTCCTTCCTTGTAAaaaaataggctatcacgcacaactaaatattataatcctctgataattct yxbC 
U3060 agatagacgagaaactgaaagggaaacctcattCGTTTACatattggcttcagcGGAAATAGAAGAAGACATGcaggaccaaaggagggtcatcttatgag aldY 
U118 tttgaaaataaaaaatttaattttcctCTTTACAAacagggggtgacctGTATATAATAACTTTTGTCAgctcgacgagaacacaacggcccgttggtcaa 
trnSL-Glu2, -Val1,-Thr1, -Tyr1, -Gln2, 
S67 
U301 cagcagcgatcgcggcctatgcgaatcaaaacGGATTACttttgctgacagcGGGAATTAACGGTAATATCatccgctttttgacaccgctcgtcatctca secondary gabD upshift 
U902 atcagactcttttgtcacctcactttctgctaaaattggaTTCCCCCTtcgctttttgTATGGTATGATAACTTTTAGaatagaatgagaaggacgaggtg yjzD, S399 
U934 acaacctctatgcttaatgttcatatttttgtcacaaAACATAacgaagtgcattcacTCATATCCTTATAAGGAAAaaggacgaggaggaccgccatgat yizD 
U1428 agcttacttttcataaattcaaaaatgagaagAACAGCGCCCgggctaatggtatATAATATTGTGAATTTAACAaaaatttaacaaggaggacgagagaa S654, yndL, S657, fosB, S658, S659 
U1534 tatagatcagaacaaaagttcgatgtaaatgttggtaataaaatataaaggtcaataatgaTATCCGTAGTATTAATAAAGgagagattcttttcgacgag yozM 
U1794 atttcgagcttttcacttgaactgaaaaaGGTTTGatgcgtcgggtaattGTAAATACTGTTAACGACAttgcctttttcgatgacgagggcatcaatgcc S869 - sporulation sRNA - as-ypdA 
U1806 taaggctcttttttagttgctattcatataatagaaATTTtcaaaaaaaagttgTACGTGTATAATAAAACAAGgtaaagattgaaaggatttgagacgag aroC 
U1860 cagcaattcgtccttcgtctgccaattcattgattccgcccctcctaTGAATAAaaatgcttctataCTGAAAAATAAActgatttctcgtctattataca yqjM 
U2140 tgtaagaaaaaccgattgcatttcacaaagcttttaCGTCTAattcatgggataaggGAATACATTTTTACAAAGAcgagccatcagcatgtctgacggtt yrzE 
U2221 aattgttaaaatgcgtgatatttcatcagtattCCTCGGAGCAatcacggcatcaGGCATAGACTGATACTGAGGcgtcgcatcatatgaatagacgagac S1083; as-ysfB 
U2256 aaacacatgccatccctcctttaagatgaatgtaTTCATAttcagccgcagcgtGAATACATATAAAAAATAGgacatgctgacgagaggaggaccgtttt ytvI 
U2654 tgtttctctttctatattttatcaatcacgctTGCATGCCctccctcgttattTGCGTTATAATAGTGACAGAcgaggtgaaaagtatgaaccaatcagaa yvaP, S1288, yvaQ 
U3003 tacggacaattcagagcatattggctcttcattgcgCCTTTtctttcaatatttgaTGCGTTAAAATGGTAACCGTgtgaaaagatgctagacgaggaaaa S1473, S1472, S1471, qoxA-D 
	 136 
U3203 gaaggtggtcttcaaggaaaaaacgagcaggtgctcgaacagatagagcaggaaatgctagcttcggggcttgatatagaggaacaggacgaggagaaggt internal yzzI upshift 
Subset of transcribed regions 5' of ORFs identified in Nicholas et al. (51) that contain the m6A 
motif (indicated in red). Capitalized letters and underscores indicate predicted sigma factor 
binding sites. Downstream transcriptional units are listed. 
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Supporting Text 
 
Supplementary Results 
m5C modifications function as part of the BsuMI restriction-modification system. 
The analysis of SMRT sequencing detected cytidine methylation in the PY79 genome 
(Table 3.1). In B. subtilis Marburg the BsuMI RM system was first found to recognize 5' 
YTCGAR sites and later refined using analysis of transformation efficiency to recognize 
5' CTCGAG (47). This work showed that in B. subtilis Marburg the ydiO-ydiP operon 
codes for the methyltransferase (MTase) responsible for m5C modifications of the 
BsuMI RM system and that an adjacent operon, ydiR-ydiS-ydjA, codes for the cognate 
endonuclease (47). Given the sequence similarity between the mC motif detected in the 
WT strain PY79, 5' CTCGARB, and the site identified in the Marburg strain, 5' 
CTCGAG, we decided to test whether YdiO-YdiP was responsible for cytidine 
methylation in PY79. Because PacBio does not robustly detect m5C methylation, we 
experimentally determined the modification type by treating DNA with the m5C- and 5-
hydroxymethylcytosine-specific endonuclease, MspJI (Fig 3.9). We created PY79 
strains with deletions of ydiO-ydiP and each subunit of the putative endonuclease, ydiR, 
ydiS, or ydjA. DNA was purified from each of these strains in addition to WT and a strain 
with a deletion of N6-methyladenosine methyltransferase DdnmA, as controls. DNA 
from WT, ΔdnmA, and strains lacking ydiO-ydiP plus the respective restriction 
endonuclease subunits were treated with MspJI, recognizes 5- 5hmC and m5C at 5' 
mCNNR sites, followed by electrophoresis on an agarose gel. Smearing in WT and 
ΔdnmA strains indicates the presence of m5C modifications whereas distinct bands in 
ΔydiOPΔydiR, ΔydiOPΔydiS, ΔydiOPΔydjA strains indicates loss of m5C modifications, 
implicating ydiOP as the MTase responsible for all m5C methylation in the B. subtilis 
genome (Fig 3.9). The results we present here confirm the BsuMI RM recognition site 
as 5'CTCGARB in B. subtilis strain PY79. The m5C motif identified in PY79 was not 
detected as modified in NCIB 3610 by PacBio SMRT sequencing (Table 3.1). 
 
B. subtilis m6A does not function in replication timing. We sought to determine the 
consequence of m6A loss in B. subtilis cells. In the Gram-negative bacterium E. coli, 
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GATC-specific m6A functions in origin sequestration (17,18,35), DNA mismatch repair 
(20,21), and the regulation of gene expression (69). The methylation status of 
palindromic GATC sites in the E. coli origin of replication regulates the binding of SeqA, 
which inhibits origin firing by sequestering the origin region (17,18,35). Whereas GATC 
sites are enriched in the E. coli origin, as discussed in the main text the m6A motif is not 
present in the B. subtilis replication origin, although a high density of m6A sites flank the 
origin on the left arm (Fig 3.1). To empirically determine if m6A sites located in the 
origin proximal region on the left arm influence origin duplication, we assessed the 
origin proximal copy number in exponentially growing WT and ΔdnmA (M.BsuPY79I) 
cells using Spo0J-GFP (parB-gfp) as a marker for origin copy number as done 
previously (80,81). We show that in WT, ΔdnmA, ΔyabB cells, 65%, 64%, 66% of cells 
showed two Spo0J-GFP foci, respectively. As controls we used a deletion of yabA, a 
negative regulator of origin firing (82), and show that 74% of cells have four or more foci 
as expected (81). As a hypo-initiation control we used an IPTG regulated promoter 
(PspacdnaAN) to deplete the replication initiation protein dnaA and the replication sliding 
clamp dnaN. We show a near 8-fold increase in the percentage of cells with a single 
Spo0J-GFP focus, demonstrating an inhibition of DNA replication initiation (81) (Fig 
3.10). With these results we show no difference in origin proximal copy number between 
WT, ΔdnmA, or ΔyabB cells as determined by fluorescence microscopy and we 
conclude that m6A does not contribute to the regulation of DNA replication initiation. 
 
B. subtilis m6A does not function in DNA mismatch repair. In addition to origin 
sequestration, methylation at GATC sites in E. coli also functions in strand 
discrimination during DNA mismatch repair, thereby ensuring removal of mismatched 
bases from the nascent strand (20). Both the loss of adenosine methylation at GATC 
sites and hyper-methylation of the chromosome by overexpression of Dam resulted in 
an increase in spontaneous mutation rate (83,84). m6A sites are non-palindromic in B. 
subtilis and occur far less frequently (~1,200 sites relative to ~20,000 GATC sites in E. 
coli). The lack of an even distribution on the leading and lagging strands across the 
genome and the low number of sites does not support a contribution of m6A to strand 
discrimination during mismatch repair. To be certain, we conducted rifampin resistance 
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assays as a measure for mutation rate (75,85,86) in WT and ΔdnmA strains. No 
difference in mutation rate between these strains was observed as compared to a 
mismatch repair deleted control (Table 3.11). These results indicated that the presence 
or absence of m6A does not influence spontaneous mutagenesis in B. subtilis (87,88). 
Furthermore, because the m6A sites occur multiple times at the addA locus and AddA is 
important for recombinational repair (89), we performed spot titer assays to determine if 
ΔdnmA cells were more sensitized to DNA damaging agents relative to WT cells and 
found no increase in sensitivity (Fig 3.14).  
 
Supplementary Materials and Methods 
Chromosomal DNA digestion by MspJI: Genomic DNA was purified from PY79, 
ΔdnmA, ΔydiOPΔydiR, ΔydiOPΔydiS, and ΔydiOPΔydjA strains as described above 
and treated for six hours with MspJI according to the manufacturer’s recommendations 
(New England BioLabs). For each control the reaction was set up exactly like the 
experimental group with an equivalent amount of water added instead of MspJI. Each 
reaction was then loaded on a 0.7% agarose gel and electrophoresed, stained with 
ethidium bromide, and visualized by illumination with UV.  
 
DnmA (M.BsuPY79I) Y465A: A PCR reaction was performed using specially designed 
primers to create two overlapping blocks of DNA coding for dnmA with an alanine in the 
place of the tyrosine usually found in the NPPY catalytic motif. The 5' block was created 
by PCR using oTMN5 and oAS1 with B. subtilis genomic DNA as the template. The 3' 
block was created by PCR using oAS2 and oTMN7 with B. subtilis genomic DNA as the 
template. PCR products were gel extracted, purified, and combined with pE-SUMO 
vector via Gibson assembly to create pAS2. The resulting plasmid was used to 
transform E. coli MC1061 cells and plated on LB agar containing 25 µg/ml kanamycin. 
Resulting colonies were PCR screened for presence of the dnmA gene using oTMN5 
and oTMN7 and further verified by Sanger sequencing. BL21DE3 cells containing this 
plasmid were then tested for their ability to overexpress the mutant protein with addition 
of 200 µM IPTG.  
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Electrophoretic Mobile Shift Assay (EMSA): EMSAs were performed using 1 µM 
DnmA and 5' IR dye labeled substrates at 0.62 µM in a buffer containing 100 mM Tris-
HCl pH 8, 250 mM NaCl, and 1 mM MgSO4. The substrates were annealed in the same 
buffer by heating to 100°C for 30 seconds and then allowed to cool back to room 
temperature on the bench top. Substrates included the target sequence (oAS09, 
oTMN39), non-target (oAS10, oTMN41), and a degenerate sequence (oAS11, oJR269). 
A no protein control was used for each substrate and catalytically inactive DnmA 
(Y465A) was assayed with the target sequence. These assays were performed at 30°C 
for 15 minutes. Samples were then loaded onto, and resolved via 6% native-PAGE 
electrophoresed on ice at 100V and visualized with a LI-COR Odyssey imager. 	
Spot titer assays: The indicated strains were struck from frozen stocks onto LB agar 
plates and incubated overnight at 30°C. Single colonies were inoculated into 2 mL of LB 
media and grown in a rolling rack at 37°C to an OD600 of 0.6-0.8. Strains were then 
diluted to an OD600 of 0.5 and subsequent 10-fold serial dilutions were performed in 
0.85% saline solution. The dilutions (4 μL) were then spotted on LB agar and LB agar 
plus the indicated concentrations of exogenous DNA damaging agent or HU.  Spots 
were allowed to dry, and the plates were incubated at 30°C overnight. 	
Mass Spectrometry: Mass spectrometry was performed by The University of Michigan 
Proteomics & Peptide Synthesis Core, project number MS976/M1516-086. Briefly, the 
band of interest was excised from SDS-PAGE and placed in 50 µl of distilled water. The 
band was then digested with trypsin and analyzed using LC/MS/MS on a ThermoFisher 
Orbitrap mass spectrometer. Resulting data was searched against the NCBI protein 
database and presented in Supplementary Table 3.10. 
 
Spontaneous mutagenesis assay: Protocol was followed essentially as described 
(75). Briefly, frozen strains were struck out on LB and grown at 30°C overnight. Single 
colonies were inoculated into 3 mL of LB media and grow at 37°C to an OD600 between 
1 and 1.2. At this point, 1.5 mL of culture was pelleted by centrifugation and the 
supernatant was aspirated. Cells were resuspended in 0.85% saline and two 1,000-fold 
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serial dilutions were performed in 0.85% saline. 100 μL of the original solution was 
plated on LB plates containing 100 μg/mL rifampin and grown at 30°C overnight and 
100 μL from the 10-6 dilution was plated on LB and grown at 30°C overnight.  The 
number of single colonies on each plate was counted the next morning and mutation 
rate was calculated using the Ma-Sandri-Sarkar Maximum Likelihood Estimator Method 
through the FALCOR fluctuation analysis calculator (76).  All strains were independently 
grown and plated on at least three different days. 
 
Live cell microscopy: Protocol was followed essentially as described (77). Frozen 
strains were struck on LB plates and grown overnight at 37°C.  Plates were washed with 
defined S750 minimal media and diluted back to an OD600 of 0.05 in 2 mL of defined 
S750 minimal media and grown at 37°C to mid-exponential growth phase (OD600 
between 0.6-0.8). 1 mL aliquots were then treated with 1 μL of FM4-64, the vital 
membrane strain, and spotted onto 1% agarose pads containing 1X Spizizen’s salts. 
Fluorescence microscopy was performed with an Olympus BX61 microscope. The 
Olympus 100X oil immersion 1.45 numerical aperture (NA) total internal reflection 
fluorescence microscopy (TIRFM) objective lens was used for all imaging and all strains 
were independently imaged on at least three different days.  
 
Strain construction 
JWS261 (ΔydiOP, ΔydiR): PY79 was transformed with genomic DNA from BKE06090 to 
make strain JWS245. JWS245 was transformed with pDR224 to make JWS248. 
JWS248 was transformed with pJS146. 
 
JWS262 (ΔydiOP, ΔydiS): PY79 was transformed with genomic DNA from BKE06100 to 
make strain JWS246. JWS246 was transformed with pDR224 to make JWS249. 
JWS249 was transformed with pJS146. 
 
JWS263 (ΔydiOP, ΔydjA): PY79 was transformed with genomic DNA from BKE06110 to 
make strain JWS247. JWS247 was transformed with pDR224 to make JWS250. 
JWS250 was transformed with pJS146. 
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TMN1 and TMN2 (ΔyabB):  PY79 was transformed with genomic DNA from BKE00340 
to make strain JWS230. JWS230 was transformed with pDR224. 
 
TMN5 and TMN6 (ΔdnmA): PY79 was transformed with genomic DNA from BKE06760 
to make strain JWS230. JWS230 was transformed with pDR224. 
  
TMN16 (ΔdnmA, amyE::Pspac dnmA): TMN5 was transformed with pTN003. 
 
TMN47 (ΔdnmA in NCIB 3610): DK1042 was transformed with genomic DNA from 
JWS230. JWS230 was transformed with pDR224. 
 
JWS260 (ΔdnmA, spo0J::spo0J-gfp): TMN5 was transformed with genomic DNA from 
JWS259. 
 
TMN80 (ΔdnmA, spo0J::spo0J-gfp): TMN2 was transformed with genomic DNA from 
JWS259. 
 
LVG066 (amyE::PrbsV-GFP): PY79 was transformed with plasmid pLVG1-374. 	
LVG067 (ΔdnmA, amyE::PrbsV-GFP): TMN06 was transformed with plasmid pLVG1-
0374. 
 
LVG068 (amyE::PwprA-GFP): PY79 was transformed with plasmid pLVG1-0868. 
 
LVG069 (ΔdnmA, amyE::PwprA-GFP): TMN06 was transformed with plasmid pLVG1-
0868. 
 
LVG070 (amyE::PyloA-GFP): PY79 was transformed with plasmid pLVG1-1292. 
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LVG071 (ΔdnmA, amyE::PyloA-GFP): TMN06 was transformed with plasmid pLVG1-
1292. 
 
LVG072 (amyE::PzapA-GFP): PY79 was transformed with Gibson assembled fragment 
fLVG-2213. 	
LVG073 (ΔdnmA, amyE::PzapA-GFP): TMN06 was transformed with Gibson 
assembled fragment fLVG-2213. 
 
LVG074 (amyE::PrnhC-GFP): PY79 was transformed with Gibson assembled fragment 
fLVG-2212. 
 
LVG075 (ΔdnmA, amyE::PrnhC-GFP): TMN06 was transformed with Gibson assembled 
fragment fLVG-2212. 
 
LVG079 (amyE::PcomEA-GFP): PY79 was transformed with plasmid pLVG1-1995. 	
LVG080 (ΔdnmA, amyE::PcomEA-GFP): TMN06 was transformed with plasmid pLVG1-
1995. 
 
LVG081 (amyE::PezrA-GFP): PY79 was transformed with plasmid pLVG1-2292. 
 
LVG082 (ΔdnmA, amyE::PezrA-GFP): TMN06 was transformed with plasmid pLVG1-
2292. 
 
LVG087 (amyE::PscpA-GFP): PY79 was transformed with Gibson assembled fragment 
fLVG-1815. 
 
LVG088 (ΔdnmA, amyE::PscpA-GFP): TMN06 was transformed with Gibson assembled 
fragment fLVG-1815. 
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LVG108 (ΔdnmA operon, amyE::PscpA-GFP): TMN17 was transformed with Gibson 
assembled fragment fLVG-1815. 
 
LVG102 (amyE::PscpAmut1-GFP): PY79 was transformed with Gibson assembled 
fragment fLVG-1815mut1. 
 
LVG103 (ΔdnmA, amyE::PscpAmut1-GFP): TMN06 was transformed with Gibson 
assembled fragment fLVG-1815mut1. 
 
LVG109 (ΔdnmA operon, amyE::PscpAmut1-GFP): TMN17 was transformed with Gibson 
assembled fragment fLVG-1815mut1. 
 
LVG105 (amyE::Phbs-GFP): PY79 was transformed with Gibson assembled fragment 
fLVG-1780. 
 
LVG106 (ΔdnmA, amyE::Phbs-GFP): TMN06 was transformed with Gibson assembled 
fragment fLVG-1780. 
 
LVG118 (amyE::PscpAmut2-GFP): PY79 was transformed with Gibson assembled 
fragment fLVG-1815mut2. 
 
LVG119 (ΔdnmA operon, amyE::PscpAmut2-GFP): TMN17 was transformed with Gibson 
assembled fragment fLVG-1815mut2. 
 
LVG120 (amyE::PscpAmut3-GFP): PY79 was transformed with Gibson assembled 
fragment fLVG-1815mut3. 
 
LVG121(ΔdnmA operon, amyE::PscpAmut3-GFP): TMN17 was transformed with Gibson 
assembled fragment fLVG-1815mut3. 
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Plasmid construction 
General cloning techniques 
All pLVG1-derived plasmids and amyE-containing linear fragments were assembled 
using Gibson assembly (78). Enzymatic assembly of overlapping DNA fragments, or 
overlap extension PCR. Gibson assemblies consisted of 30-80 ng of each PCR product 
and 1X Gibson assembly mastermix (0.1 M Tris pH 8.0, 5% PEG-8000, 10 mM MgCl2, 
10 mM DTT, 0.2 mM dNTPs, 1 mM NAD+, 4 units/mL T5 exonuclease, 25 units/mL 
Phusion DNA polymerase, 4,000 units/mL Taq DNA ligase) in a total reaction volume of 
10-12 µL. The reactions were incubated at 50°C for 90 minutes. Gibson-assembled 
plasmids were used to transform  E. coli MC1061. Gibson-assembled linear fragments 
were purified using spin columns, re-amplified using Phusion polymerase and used to 
transform PY79 or PY79 derivatives.  For overlap extension PCR, 500 ng of each PCR 
product was mixed and standard PCR cycling was performed using end primers and Q5 
polymerase (NEB). PCR fragments were routinely obtained using Phusion polymerase 
(NEB) or Q5 polymerase (NEB) and gel-purified before Gibson assembly or overlap 
extension PCR. 
 
Individual plasmid (p) construction 
pJS146: The regions 500 base pairs upstream and downstream of the ydiOP operon 
were amplified from PY79 genomic DNA using primers oJS650 and oJS651 (upstream 
region) and oJS653 and oJS657 (downstream region). The fragments were then 
combined with the pminiMAD vector using Gibson assembly. 
 
pTN02: The dnmA gene was cloned from PY79 genomic DNA using primers oTN3 and 
oTN8 with overlapping regions to the pDR110 vector. The pDR110 vector and insert 
were combined using Gibson assembly. 
pTN03: The dnmA gene was cloned from PY79 genomic DNA using primers oTN5 and 
oTN7 with overlapping regions to the pE-SUMO vector. The pE-SUMO vector and insert 
were combined using Gibson assembly. 
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pAS2: Overlap PCR was used to make the YàA substitution. The 5' block was created 
by using oTMN5 and oAS1 with PY79 genomic DNA as a template. The 3' block was 
created by using oTMN7 and oAS2 with PY79 genomic DNA as a template. PCR 
products were gel purified and combined with the pE-SUMO vector using Gibson 
assembly. 
 
pTN12: The yabB gene was cloned from PY79 genomic DNA using primers oTN36 and 
oTN37 with overlapping regions to the pE-SUMO vector. The pE-SUMO vector and 
insert were combined using Gibson assembly. 
 
pTN13: The scoC gene was cloned from PY79 genomic DNA using primers oTN62 and 
oTN63 with overlapping regions to the pE-SUMO vector. The pE-SUMO vector and 
insert were combined using Gibson assembly.	
 
pLVG1: To remove the lacI gene from pDR111_GFP(Sp) (79), the plasmid was 
amplified using primers oLVGLS024A and oLVGLS024B, restricted with BamHI and 
self-ligated with T4 DNA ligase. 	
pLVG1-0374: The backbone of pLVG1 without Pxyl was amplified with primers 
oLVGLS023A and oLVGLS023B and combined with a DNA fragment containing U0374 
(PrsbV), amplified from PY79 genomic DNA using primers oLVG_U0374F and 
oLVG_U0374R.  	
pLVG1-0868: The backbone of pLVG1 without Pxyl was amplified with primers 
oLVGLS023A and oLVGLS023B and combined with a DNA fragment containing U0868 
(PwprA), amplified from PY79 genomic DNA using primers oLVG_U0868F and 
oLVG_U0868R.  	
pLVG1-1292: The backbone of pLVG1 without Pxyl was amplified with primers 
oLVGLS023A and oLVGLS023B and combined with a DNA fragment containing U1292 
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(PyloA), amplified from PY79 genomic DNA using primers oLVG_U1292F and 
oLVG_U1292R. 	
pLVG1-1995: The backbone of pLVG1 without Pxyl was amplified with primers 
oLVGLS023A and oLVGLS023B and combined with a DNA fragment containing U1995 
(PcomEA), amplified from PY79 genomic DNA using primers oLVG_U1995F and 
oLVG_U1995R. 	
pLVG1-2292: The backbone of pLVG1 without Pxyl was amplified with primers 
oLVGLS023A and oLVGLS023B and combined with a DNA fragment containing U2292 
(PezrA), amplified from PY79 genomic DNA using primers oLVG_U2292F and 
oLVG_U2292R. 	
Individual DNA fragment (f) construction 
fLVG-1780: An upstream DNA fragment was amplified from pLVG1 using primers 
oLVGLS023C and oLVGLS023A. A downstream DNA was amplified from pLVG1 using 
primers oLVGLS023B and oLVGLS023D. A DNA fragment containing U1780(Phbs) 
was amplified from PY79 genomic DNA using primers oLVG_U1780F and 
oLVG_U1780R. The three fragments were assembled using Gibson assembly and the 
correct construct was enriched using end primers oLVGLS034 and oKJW090. 	
fLVG-1815: An upstream DNA fragment was amplified from pLVG1 using primers 
oLVGLS023C and oLVGLS023A. A downstream DNA was amplified from pLVG1 using 
primers oLVGLS023B and oLVGLS023D. A DNA fragment containing U1815 (PscpA) 
was amplified from PY79 genomic DNA using primers oLVG_U1815F and 
oLVG_U1815R. The three fragments were assembled using Gibson assembly and the 
correct construct was enriched using end primers oLVGLS034 and oKJW090. 	
fLVG-1815mut1: To replace 5'-GACGAG with 5'-GACGTG in the scpA promoter, an 
upstream and downstream DNA fragment was amplified from LVG087 genomic DNA 
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using primer pair oLVGLS042A/oKJW89 and oLVGLS042B/oKJW090, respectively. The 
fragments were assembled by overlap extension PCR. 	
fLVG-1815mut2: To replace 5'-GACGAG with 5'-GACGCG in the scpA promoter, an 
upstream and downstream DNA fragment was amplified from LVG087 genomic DNA 
using primer pair oLVGLS044A/oKJW89 and oLVGLS044B/oKJW090, respectively. The 
fragments were assembled by overlap extension PCR. 	
fLVG-1815mut3: To replace 5'-GACGAC with 5'-GACGAC in the scpA promoter, an 
upstream and downstream DNA fragment was amplified from LVG087 genomic DNA 
using primer pair oLVGLS045A/oKJW89 and oLVGLS045B/oKJW090, respectively. The 
fragments were assembled by overlap extension PCR. 	
fLVG-2212: An upstream DNA fragment was amplified from pLVG1 using primers 
oLVGLS023C and oLVGLS023A. A downstream DNA was amplified from pLVG1 using 
primers oLVGLS023B and oLVGLS023D. A DNA fragment containing U2212 (PrnhC) 
was amplified from PY79 genomic DNA using primers oLVG_U2212F and 
oLVG_U2212R. The three fragments were assembled using Gibson assembly and the 
correct construct was enriched using end primers oLVGLS034 and oLVGLS090. 	
fLVG-2213: An upstream DNA fragment was amplified from pLVG1 using primers 
oLVGLS023C and oLVGLS023A. A downstream DNA was amplified from pLVG1 using 
primers oLVGLS023B and oLVGLS023D. A DNA fragment containing U2213 (PzapA) 
was amplified from PY79 genomic DNA using primers oLVG_U2213F and 
oLVG_U2213R. The three fragments were assembled using Gibson assembly and the 
correct construct was enriched using end primers oLVGLS034 and oKWJ90. 
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CHAPTER IV 
 
RnhP is a Plasmid-borne RNase HI that Contributes to Genome Maintenance in 
the Ancestral Strain Bacillus subtilis NCIB 3610 
 
  
 
Abstract 
RNA-DNA hybrids form throughout the chromosome during normal cell growth and 
under stress conditions. When left unresolved, RNA-DNA hybrids can slow replication 
fork progression, cause DNA breaks, increase mutagenesis, and reduce gene 
expression. To remove hybrids, all organisms use ribonuclease H (RNase H) to 
specifically degrade the RNA portion. Here we show that, in addition to chromosomally 
encoded RNase HII and RNase HIII, Bacillus subtilis NCIB 3610 encodes a previously 
uncharacterized RNase HI protein, RnhP, on the endogenous plasmid pBS32. Like 
other RNase HI enzymes, RnhP incises Okazaki fragments, ribopatches, and a 
complementary RNA-DNA hybrid. We show that while chromosomally encoded RNase 
HIII is required for pBS32 hyper-replication, RnhP compensates for loss of RNase HIII 
activity on the chromosome. Consequently, loss of RnhP and RNase HIII impairs 
bacterial growth. We show that the decreased growth rate can be explained by laggard 
replication fork progression near the terminus region of the right replichore, resulting in 
SOS-dependent inhibition of cell division. We conclude that B. subtilis NCIB 3610 
encodes functional RNase HI, HII, and HIII, and pBS32 encoded RNase HI contributes 
to replication fork progression and chromosome stability while RNase HIII is important 
for chromosome stability and plasmid hyper-replication.  	
 The contents of this chapter are being submitted for publication by Taylor M. Nye, Emma K. McLean, Andrew M. 
Burrage, Devon D. Dennison, Daniel B. Kearns, and Lyle A. Simmons. DDD contributed Fig 4.1C. EKM performed 
experiments for Fig 4.4B-F and Fig 4.5. AMB designed and performed experiments for Fig 4.3 and Fig 4.8. I 
designed, performed, and analyzed data for the remaining experiments. LAS and I wrote the manuscript. LAS, DBK, 
AMB, and I edited the manuscript.	
	 156 
Introduction 
For all organisms, faithful replication of the chromosome is essential to ensure daughter 
cells receive an accurate and complete copy of their genetic material. Over the last 
decade there has been a growing recognition that RNA is often incorporated into 
genomic DNA, either through hybridization with or covalent linkage to DNA (1-3). These 
incorporation events can have severe consequences for cell physiology, leading to 
replication fork stress, genome instability, and adverse effects on transcription (4-8). 
RNA-DNA hybrids form through a variety of processes throughout each phase of 
bacterial growth, with each type of hybrid impacting genome integrity in a different way.  
In exponentially growing cells a common type of RNA-DNA hybrid occurs in the 
form of Okazaki fragments (9, 10). During DNA replication, Okazaki fragments on the 
lagging strand begin with RNA primers generating an RNA-DNA hybrid with a covalent 
RNA-DNA junction (11, 12). These RNA primers are later removed and replaced with 
DNA through the activity of several DNA repair proteins.  A second type of RNA-DNA 
hybrid occurs during replication by DNA polymerase error, where an rNTP is used in 
place of the cognate dNTP, resulting in a sugar error (4, 6, 14). Sugar errors tend to be 
single replicative DNA polymerase errors and have the potential to occur every few 
thousand base pairs in exponentially growing cells (6, 14). In states of slow growth, it 
has been proposed that translesion DNA polymerases could use rNTPs in place of 
scarce dNTPs in a process termed ribopatch repair (15). Ribopatch repair would 
generate relatively short polymers of RNA nested in double stranded DNA to provide a 
temporary solution for sites in need of repair (15). RNA polymers covalently joined to 
DNA can impact genome integrity because the 2'OH of the ribose sugar can facilitate a 
nucleophilic attack on the 3' PO4-, resulting in a 2', 3' cyclic phosphate at the rNMP and 
a 5' OH at the adjacent nucleotide (16). The resulting nick in the phosphodiester 
backbone is refractory to ligation and unable to function in further DNA synthesis (4, 17, 
18). Failure to heal the end and repair the nick would then result in a double strand 
break during the next round of DNA replication.  
RNA-DNA hybrids in the form of Okazaki fragments and DNA polymerase 
incorporation events are similar in that the RNA is covalently linked to DNA through a 
phosphodiester bond (9, 10). Another prevalent RNA-DNA hybrid forms during 
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transcription when mRNA transcripts are base-paired with the transcribed DNA strand, 
displacing the coding strand as ssDNA to form an R-loop [for review (1)]. In the case of 
R-loops, RNA hybridized to DNA lacks a covalent RNA-DNA junction. Persistent R-
loops can impair progression of replication forks and DNA synthesis while also 
decreasing gene expression from the DNA template subsequent to R-loop formation (7, 
19, 20). Transcription is required during all growth phases, suggesting that R-loop 
formation could be prevalent during the entire life cycle of a bacterium. All cells need to 
resolve each class of RNA-DNA hybrid that occurs in vivo to maintain genome integrity 
and efficient gene expression throughout bacterial growth.  
To reduce the detrimental consequences that RNA-DNA hybrids impose on 
genome integrity and transcription, organisms have enzymes dedicated to hybrid 
resolution (21, 22). The RNase H family of endoribonucleases binds to and cleaves the 
RNA component of RNA-DNA hybrids, resolving all classes of hybrids that occur in vivo 
(21, 22). RNase H enzymes are highly conserved, with family members present in 
bacteria, archaea, eukaryotes and retroviruses, including HIV-1 (23-26). Bacterial 
RNase H enzymes are grouped into two general types based on amino acid sequence 
similarity: type I, which includes RNase HI, and type II, which includes RNase HII and 
HIII (27). RNase HI and RNase HIII enzymes act on both ribopatches (four or more 
embedded rNMPs) and hybrids lacking a covalent RNA-DNA junction, but are unable to 
cleave at a single rNMP embedded in DNA (9, 10, 28). Unlike RNase HI and HIII, 
RNase HII enzymes are adept for cleavage at single embedded rNMPs and ribopatches 
participating in ribonucleotide excision repair (RER), yet show very poor activity on 
hybrids that lack a covalent RNA-DNA junction (24, 29). All three enzymes are active on 
the RNA primer portions of an Okazaki fragment, suggesting that all three bacterial 
enzymes could have overlapping functions during lagging strand processing and 
maturation (9, 10, 30). In addition to their important contribution to chromosomal 
replication, evidence suggests that RNase H enzymes function in the regulation of 
endogenous plasmid replication (31) and in regulatory aspects of transcription (3, 7). 
 Comparative sequence analysis of over 300 genomes found that 80% of 
bacterial genomes contain RNase HI and RNase HII (27). Approximately 17% of 
bacterial genomes, including the Firmicutes phylum, which includes a group of 
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important Gram-positive pathogens from Streptococcus, Staphylococcus, and 
Enterococcus species, lack RNase HI and instead encode RNase HII and RNase HIII 
(27). Importantly, Firmicutes were the only group with some representatives that 
appeared to encode all three RNase H genes (9, 27). One Firmicute that seemed to 
encode all three RNase H enzymes is the soil bacterium Bacillus subtilis (9, 27). The 
RNase HII and HIII enzymes from the lab strain B. subtilis PY79 are active and have 
been characterized in vitro and in vivo (4, 9, 10, 30). Functional studies of the putative 
RNase HI-like genes from B. subtilis have shown that these genes lack the residues 
involved in substrate binding and do not possess nuclease activity in vitro (9, 27). 
Furthermore, prior work also showed simultaneous deletion of both RNase HII (rnhB) 
and RNase HIII (rnhC) is lethal (32) or results in a mutator phenotype with accumulation 
of compensatory mutations (10), suggesting that the putative RNase HI-like genes are 
unable to compensate for loss of both RNase HII and RNase HIII in vivo. Of the small 
subset of bacteria that contain putative RNase HI, HII, and HIII proteins there is no 
experimental evidence to support the coexistence of functional RNase HI and RNase 
HIII in the same genome (27).  
 B. subtilis NCIB 3610 (referred herein as 3610) is considered a “wild” ancestral 
strain that has maintained many of the wild motility and social behaviors associated with 
B. subtilis strains isolated from the soil (33-36). In addition to the 4.2 Mbp chromosome, 
3610 contains an endogenous 84 Kbp plasmid, pBS32 (37). Plasmid pBS32 encodes 
102 genes, many of which include a large contiguous set of genes that appear to 
encode for a cryptic prophage (38).  Other genes on the plasmid control host cell 
physiology, such as the inhibitor of biofilm formation RapP, the inhibitor of natural 
competence for DNA uptake ComI, and the cell death promoting sigma factor SigN (38, 
39).  The remaining genes on pBS32 are of unknown function, including zpdC (rnhP), 
which encodes a putative RNase HI.  If zpdC encodes a functional RNase HI enzyme 
this, to the best of our knowledge, would suggest that B. subtilis 3610 is the first 
reported bacterium to encode active RNase HI, HII, and HIII enzymes. Moreover, if 
ZpdC is an active RNase H it is unknown whether ZpdC activity is important for pBS32 
plasmid maintenance, integrity of the B. subtilis chromosome, or some other DNA 
maintenance function.  
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 Here we show that ZpdC (named here as RnhP) is capable of cleaving all 
substrates typical of RNase HI proteins. Deletion of rnhP does not affect pBS32 
maintenance, although deletion of rnhC results in loss of the pBS32 hyper-replication 
phenotype. We demonstrate that deletion of rnhP and rnhC results in a 2-fold increase 
in doubling time, which is attributed to cell filamentation and induction of the SOS 
response. Together, our data show that both the plasmid encoded RNase HI (RnhP) 
and the chromosomally encoded RNase HIII (RnhC) are important for genome 
maintenance in the ancestral strain of B. subtilis NCIB 3610, demonstrating that 
bacteria can indeed maintain all three RNase H proteins with each enzyme contributing 
to genome stability.    
 
Results 
RnhP is an active RNase HI enzyme. The endogenous 84 Kbp plasmid, pBS32, of the 
ancestral strain B. subtilis NCIB 3610 contains several uncharacterized genes that 
encode proteins with sequence homology to bacterial DNA replication and repair 
proteins (38, 47, 48). One such gene, zpdC (rnhP), shares 38.5% primary structure 
identity and 50.3% primary structure similarity to the RNase HI protein from Escherichia 
coli (Fig 4.1A). Importantly, all of the catalytic residues involved in metal coordination 
are conserved between the two sequences as are residues within the a-helix 3 basic 
protrusion handle, which is involved in substrate binding (49), suggesting that ZpdC 
might have RNase H activity (Fig 4.1A). As part of our ongoing effort to determine how 
RNA-DNA hybrids impact genome stability and transcription, we began by purifying 
ZpdC (RnhP) and a variant with D73N, which has been shown to render E. coli RNase 
HI catalytically inactive (49) (Fig 4.1B).  
 To assay for RNase H activity, we ordered an oligonucleotide labeled with an IR 
dye at the 5’ end that contained four embedded rNMPs flanked by DNA on either side. 
This labeled oligonucleotide was annealed to a complementary DNA strand, creating a 
double stranded RNA-DNA chimeric substrate as previously described (10). We used 
this substrate because prior work showed that bacterial RNase HI, HII, and HIII are all 
active on this substrate (9, 10, 30). We incubated ZpdC (RnhP) and the catalytically 
inactive variant with this substrate for 10 minutes at 37°C in buffers that mimic in vivo 
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relevant metal concentrations (1 mM MgCl2, 10 μM MnCl2,) as described (10). The 
substrate was also exposed to alkaline hydrolysis in a separate reaction to create a 
ladder corresponding to the positions of each embedded rNMP. The products of the 
reaction were separated by electrophoresis on denaturing urea PAG to measure 
substrate cleavage. Incubation of the substrate with low (4 nM) and high (50 nM) 
concentrations of protein results in complete cleavage of the substrate, whereas the 
catalytically inactive variant did not show any cleavage at either concentration (Fig 
4.1C).  
To determine if ZpdC (RnhP) has strict RNase H activity, such that it is only 
capable of cleaving the RNA portion of RNA/DNA hybrids, we tested the ability of ZpdC 
(RnhP) to cleave double stranded RNA and DNA substrates. We incubated 4 nM and 
50 nM ZpdC (RnhP) with an RNA oligo labeled at the 5’ end with an IR dye hybridized 
to a complementary RNA oligo and a DNA oligo labeled at the 3’ end with an IR dye 
hybridized to a complementary DNA oligo under the same buffer and incubation 
conditions described above for the RNA-DNA chimera substrate. Unlike the RNA-DNA 
chimera substrate, we did not observe any cleavage of the RNA or DNA substrates 
when incubated with low or high concentrations of ZpdC (Fig 4.1D and E).  From these 
data we conclude that ZpdC is an active and strict RNase H enzyme. Having 
established that ZpdC is a plasmid encoded RNase H, we rename zpdC to RNase H 
from pBS32 (rnhP).  
 
RnhP is active with various metals and at varying temperatures. To determine the 
parameters of activity for RnhP we assayed for cleavage over a range of temperatures 
and metal concentrations relevant to B. subtilis growth (50). RnhP cleaved the RNA-
DNA chimeric substrate with four embedded rNMPs when incubated at 25°C, 30°C, and 
37°C for 10 minutes with no appreciable difference in activity observed between the 
three temperatures (Fig 4.8A). We also tested the activity of RnhP on the four 
embedded rNMP substrate with various metals, holding all other reaction and buffer 
conditions the same between samples (see Materials and Methods). RnhP appeared to 
be most active when incubated with 10 μM Mn2+ as a metal cofactor (Fig 4.8B). RnhP 
also showed activity when incubated with Mg2+, Zn2+, and Co2+, although RnhP was less 
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active when compared with activity in the presence of Mn2+. We note a reduction in 
RnhP activity when incubated with 1 mM MgCl2 and 10 μM MnCl2, compared to the 10 
μM MnCl2 alone condition, which could be explained by competition of Mn2+ with Mg2+ 
for binding to the RnhP active site (Fig 4.8B). We conclude that RnhP is active both 
under relevant growth temperatures and with various metal cofactors. We note that, 
compared to the other cofactors tested here, Mn2+ supports the most activity. 
 
RnhP cleaves RNA-DNA covalent chimeras in a different location when compared 
with B. subtilis RNase HII and RNase HIII. Most bacteria encode a functional RNase 
HII enzyme and either RNase HI or RNase HIII (27). Further, it has been hypothesized 
that RNase HI and HIII are mutually exclusive (27). RNase HII is classically 
characterized as having unique activity on a single embedded rNMP within DNA and 
polymers of rNMPs that are covalently linked to DNA including embedded 
ribonucleotide polymers (i.e. “ribopatches”) and Okazaki fragments (51). RNase HI and 
HIII recognize substrates that contain four or more embedded rNMPs that are covalently 
linked to DNA and RNA-DNA hybrids that interact through hydrogen bonding, such as 
R-loops (9, 10, 51). To empirically determine the cleavage patterns of RNase H 
enzymes, we purified RnhP, RnhC (RNase HIII), and RnhB (RNase HII) to examine 
their activities and cleavage patterns on a variety of RNA-DNA hybrid substrates in vitro. 
The purification of RnhC and RnhB has already been described (4, 9, 10). 
 We began by testing the activities of all three enzymes using a substrate labeled 
with an IR dye at the 5’ end that contained one rNMP flanked by DNA on both sides 
annealed to a complementary DNA strand (oJR209 and oJR145). Consistent with 
previously published results (4), we found that only RnhB (RNase HII) had activity on 
this substrate under the conditions tested here (see Materials and Methods) (Fig 4.2A).  
We next assayed for activity on the four embedded rNMP substrate. While all three 
enzymes were capable of incising the substrate at 4 nM and 50 nM protein 
concentrations, we found that the enzymes differed in their incision patterns. RnhB 
cleavage yielded a longer product, indicating cleavage between the third and fourth 
ribonucleotide from the 5' IR-dye end label as expected, whereas RnhC cleavage 
resulted in a shorter product, with cleavage within the middle of the embedded RNA. In 
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contrast to functional redundancy with RnhC, RnhP appeared to cleave the four 
embedded rNMP substrate more similarly to RnhB (RNase HII), resulting in a longer 
product than RnhC with cleavage between the third/fourth and second/third rNMPs from 
the 5' IR-dye end label (Fig 4.2B). 
Both the single and quadruple embedded rNMP substrates are intended to 
represent misincorporation events that can occur when DNA polymerases erroneously 
add rNTPs during replication or ribopatch repair, accounting for as many as 2,000 
rNMPs incorporated into the E. coli genome per round of replication (14). Significantly 
more rNMPs (~23,000) are expected to be incorporated into the genome in the form of 
Okazaki fragments during lagging strand synthesis (1). In B. subtilis, these primers are 
removed and replaced with dNMPs through the combined action of RNase HIII, DNA 
polymerase I, and YpcP (10). To test how RnhP activity compared to RnhC (RNase 
HIII) and RnhB (RNase HII) on an Okazaki fragment substrate, we constructed an oligo 
with rNMPs at the 5' end covalently linked to a stretch of DNA with a 3' IR-dye end label. 
This oligo was hybridized to another oligo that was complementary to the 5' end of the 
molecule but was significantly longer to generate a 3' overhang (oJR339 and oJR340). 
We incubated this substrate, as previously described (9, 10), with RnhB, RnhC, and 
RnhP to measure activity.  Consistent with previous work, we observe substrate 
cleavage for both RnhB and RnhC (9, 10). Furthermore, we show that RnhP has activity 
on the Okazaki fragment substrate, with multiple cleavage sites and some sites of 
incision overlapping with that of RnhC (Fig 4.2C).   
 
RnhP cleaves RNA-DNA hybrids differently than RNase HIII. A defining feature of 
the RNA-DNA hybrids tested thus far is that each substrate contains a covalent RNA-
DNA junction. The single rNMP substrate, the polymer of four embedded rNMPs, and 
the Okazaki fragment-like substrate each have an RNA-DNA covalent linkage. In 
contrast, an R-loop represents a different type of RNA-DNA hybrid, which is produced 
during transcription when RNA hybridizes with complementary DNA in the template 
strand, displacing the DNA coding strand (3, 52). This substrate differs in that it does 
not contain a covalent RNA-DNA linkage. To determine if RnhP, like other RNase HI 
enzymes, is capable of cleaving substrates without a covalent RNA-DNA linkage we 
	 163 
began by testing activity on a substrate labeled at the 5’ end with an IR dye that 
contains an all RNA strand hybridized to a complementary DNA strand (oJR227 and 
oJR145). Consistent with previously published results, we observed cleavage when the 
complementary RNA-DNA hybridized substrate was incubated with RNase HIII but not 
RNase HII (9, 10). We then tested RnhP and demonstrate that RnhP does indeed have 
activity on an RNA-DNA hybridized substrate lacking an RNA-DNA covalent junction. 
However, the site of incision differs between RnhP and RNase HIII (RnhC) (Fig 4.2D). 
This result, along with the results described above, shows that RnhP recognizes the 
same substrates as canonical RNase HI (51) and RnhP often cleaves at a different 
location than RNase HIII.  
 
RNase HIII is required for plasmid hyper-replication. We initially hypothesized that 
RnhP would be important for replication of pBS32 in 3610 simply based on the notion 
that rnhP is plasmid-borne.  It was previously reported that overexpressing the plasmid-
specific sigma factor, SigN (ZpdN), causes pBS32 to hyper-replicate and promote cell 
lysis (39). Plasmid copy number was measured by quantitative PCR during normal 
growth and following hyper-replication by inducing SigN from an IPTG inducible 
promoter. We found that pBS32 was maintained at a low copy number similar to WT in 
ΔrnhC, ΔrnhP, and the double mutant (ΔrnhC, ΔrnhP) when expression of SigN was not 
induced (Fig 4.3A). Induction of SigN caused the plasmid to hyper-replicate in the WT 
and ΔrnhP cells, but not the ΔrnhC cells (Fig 4.3A). Further, cell viability was assessed 
in all strains induced with SigN by measuring optical density and counting CFUs every 
30 minutes up to four hours post-induction.  Induction of SigN in the WT and ΔrnhP 
strains caused a similar loss of cell viability, suggesting that RnhP is not required for the 
pBS32-mediated cell death phenotype. In contrast, the strain with an rnhC deletion 
showed a slight drop and plateau in OD, while CFU counts were reduced less 
drastically than the WT or ΔrnhP mutant but recovered much slower. In the double 
mutant, OD reached a plateau while CFU counts dropped and did not recover over a 
four-hour time course experiment (Fig 4.3BC). Moreover, we found that the double 
mutant cells displayed a severely filamentous phenotype throughout the course of the 
experiment (Fig 4.9). With these data we conclude that chromosomally encoded RNase 
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HIII is important for plasmid hyper-replication and recovery while loss of rnhP alone has 
no effect on pBS32 maintenance or hyper-replication. 
 
Cells lacking both RnhP and RnhC activity have a reduced growth rate. Our results 
thus far demonstrate that RnhP has activity on RNA-DNA hybrids with four or more 
ribonucleotides in vitro and that RnhP does not contribute to pBS32 maintenance or 
hyper-replication. Therefore, we asked if RnhP contributes to chromosome maintenance 
in 3610. If so, it would suggest that 3610 has a fitness advantage when maintaining 
active RNase HI (RnhP), HII, and HIII enzymes for the purpose of resolving the variety 
of RNA-DNA hybrids that form on the chromosome. It has been shown that in the 
absence of RNase HIII, but not RNase HII, there is a decrease in growth rate in B. 
subtilis PY79 (4, 9, 10). To test whether RnhP activity could compensate for the 
decrease in growth observed in the absence of RNase HIII, we performed growth 
curves for 3610 in LB media for the WT, ΔrnhC, ΔrnhP, and ΔrnhP rnhC::erm strains. 
While the doubling times for the ΔrnhC and ΔrnhP single deletion strains (57.8 and 46.8 
min, respectively) appeared to be slower than WT (37.7 min), there was no statistically 
significant difference in growth rate between WT, ΔrnhCI, or ΔrnhP strains based on the 
growth model used here (Fig 4.4A, see Materials and Methods). However, upon loss of 
both rnhP and rnhC the growth rate was significantly slower than WT (37.7 min) or 
either of the single deletion strains, with a doubling time over two times greater than WT 
at 94 minutes (Fig 4.4A). As described in greater detail later in the results, we show that 
ectopic expression of rnhP in a ΔrnhC background of the lab strain PY79 rescues 
ΔrnhC growth defects to WT levels (Fig 4.7B, described below). With these results we 
conclude that RnhP can compensate for RNase HIII (rnhC) and that these enzymes 
have overlapping functions in 3610. 
 
Cells lacking rnhP and rnhC genes filament relative to WT. To test if the differences 
in growth rate were caused by an inhibition of cell division we assayed cell length in 
exponentially growing cultures of WT, ΔrnhC, ΔrnhP, and ΔrnhP rnhC::erm strains. Cell 
membranes were imaged with a lipophilic fluorescent dye and cell length was measured 
as described (Materials and Methods). Consistent with the slight decrease in growth 
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rate observed in both ΔrnhC and ΔrnhP single deletions at 30°C, the average cell 
lengths of ~4.4 μm and ~4.0 μm for each strain respectively was longer than that of the 
WT strain measuring at ~3.7 μm (Fig 4.4C-E). A slight tail on the distribution of cell 
lengths can be observed for each single deletion strain, representing a subpopulation of 
cells that are slow to complete cell division, resulting in a portion of longer cells (Fig 
4.4G). The distribution of cell lengths for the ΔrnhP rnhC::erm double mutant has a 
more pronounced tail and an average cell length greater than WT or the single deletions 
alone at ~5.6 μm (Fig 4.4D, G). These results support the model that single deletions of 
rnhC or rnhP are well tolerated by the cell and we suggest that one gene can 
compensate for loss of the other. However, the double deletion results in a severe 
growth defect that is, at least in part, the product of improper cell division, suggesting 
genome integrity is compromised in the double mutant during normal growth in the 
absence of exogenous stress. 
 
Cells lacking rnhP and rnhC activity are induced for the SOS response. During 
periods of DNA damage cell division is inhibited by the cell division inhibitor, YneA, to 
allow for the chromosome to be properly replicated before cell division resumes (53-55). 
The YneA-enforced DNA damage checkpoint ensures that daughter cells receive a 
complete copy of the chromosome after replication is complete (53-55). Given the 
defects in growth we observe, and the cell filamentation of the double deletion strain, we 
asked if cells lacking rnhP and rnhC are induced for the SOS response. We used the 
SOS reporter construct tagC::tagC-gfp, which like yneA is highly up regulated during the 
SOS response, as a single cell proxy for SOS induction (56). In exponentially growing 
WT cells (OD600 = 0.5-0.7) at 30°C in LB media, we found that ~5.0% of cells expressed 
the SOS reporter while ~88.0% of WT cells expressed the reporter when the DNA 
damage response was induced following addition of mitomycin C (MMC) (Fig 4.5A,C, 
E-F). In contrast to the WT cells, ~71.2% of the double deletion cells expressed the 
SOS reporter under normal growth conditions, which increased to ~91.3% upon 
treatment with MMC (Fig 4.5B,D, E-F). Therefore, we show that cells lacking rnhP and 
rnhC experience a ~14-fold increase in SOS induction during normal growth conditions, 
which explains the slow growth and cell elongation results described above. These 
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results further show that 3610 is able to mitigate the deleterious effects of RNA-DNA 
hybrids when either RnhP or RNase HIII (rnhC) is present. When both genes are 
nonfunctional, the consequences to genome integrity cause most cells to induce the 
SOS response delaying cell division and impairing growth.  
 
Cells lacking rnhP and rnhC exhibit replication stress near the terminus region. 
Having established that loss of rnhP and rnhC results in SOS induction for most cells 
during normal growth, we investigated the genome-wide replication status of the WT 
and double deletion strains in exponential phase cultures. We isolated DNA from each 
strain in triplicate for Illumina DNA-sequencing to determine chromosome and plasmid 
replication status. The resulting reads were aligned to the NCIB 3610 reference 
chromosome and plasmid separately and the average coverage was plotted over the 
length of the reference. There was little to no difference in sequencing coverage 
between the WT and double deletion strain over the length of pBS32 (Fig 4.6A). We 
found a severe drop in sequencing coverage around 60 Kb for pBS32 in the double 
deletion strain, which corresponds to the location of the deleted rnhP gene (62,030 – 
62,497). When visualizing the sequencing coverage map for the chromosome and 
comparing the WT and double deletion strains, we noticed an abrupt drop in sequencing 
reads in the terminus region for the right replicore. This result shows that replication fork 
progression is slowed in this region for the double deletion strain (Fig 4.6B, 4.10).  
Replication interference at the terminus region in the double deletion strain could 
be the result of accumulated R-loops in this region, which cannot be resolved in the 
double deletion due to the lack of RnhC and RnhP. As previously discussed, R-loops 
can impair replication fork progression (19), which could explain the observed drop in 
sequencing coverage. Moreover, the impaired replication forks in the double deletion 
strain also explain the induction of the SOS response that we observe with the tagC-gfp 
reporter. Taken together, we suggest that in the absence of rnhP and rnhC replication 
forks become laggard in the terminus after encountering R-loops that persist in the 
double mutant causing SOS induction, cell elongation, and a decrease in growth rate.      
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Cells lacking both rnhP and rnhC show increased sensitivity to cellular stress. 
Having established that defects in both plasmid-encoded rnhP and chromosomally 
encoded rnhC genes results in a decreased growth rate and inhibition of cell division, 
we asked how cells respond to various stressors in the absence of one or both of these 
RNase H enzymes. In B. subtilis PY79, ΔrnhC cells are sensitive to a myriad of cellular 
stresses, including cold shock, osmotic stress, and treatment with genotoxic agents (9, 
10, 19). To test how the RNase H genes contribute to genotoxic stress responses, we 
tested the susceptibility of the single deletions, ΔrnhB, ΔrnhC, and ΔrnhP, as well as 
pairwise deletion strains, ΔrnhC rnhB::erm, ΔrnhP rnhB::erm, and ΔrnhP rnhC::erm, in 
3610 to various stressors.  We began by testing sensitivity to cold stress (growth at 
25°C), which has been hypothesized to contribute to the stability of Okazaki fragments, 
and growth on sublethal concentrations of hydroxyurea (HU), which has been 
hypothesized to inhibit ribonucleotide reductase in B. subtilis resulting in increased 
rNTP:dNTP pools in the cell (10, 57). We found that in contrast to WT B. subtilis PY79, 
deletion of any of the rnhC gene resulted in a modest (<10 fold) sensitivity relative to 
WT to cold shock or growth in the presence of HU. For cold shock and HU treatment 
conditions, the ΔrnhP rnhC::erm double mutant displayed ~100 and ~1,000 fold 
increases in sensitivity relative to WT cells, respectively (Fig 4.7A).  
Given that RnhP can compensate for loss of RnhC activity in the ancestral strain 
NCIB 3610, we asked if expression of rnhP could rescue the cold and HU sensitivities 
observed in the ΔrnhC strain for B. subtilis PY79, which lacks pBS32 and rnhP. We 
created a strain that expresses rnhP from an IPTG inducible promoter from an ectopic 
chromosomal locus in the ΔrnhC background for PY79 and tested susceptibility to cold 
and HU stress. In support of our results from 3610, we found that ectopic expression of 
rnhP in a ΔrnhC background completely restored cold and HU sensitivities to WT 
survival, with >100- and >1,000-fold growth relative to the ΔrnhC strain for cold stress 
and HU, respectively (Fig 4.7B). With these results we conclude that RnhP activity can 
compensate for loss of RNase HIII when challenged with cold stress or HU challenge 
demonstrating overlapping functions of rnhC and rnhP genes in B. subtilis. 
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Discussion 
RNase H enzymes are biologically universal and required for cleavage of the RNA 
moiety in an RNA-DNA hybrid (21, 22). RNase H genes are present in the genomes of 
bacteria, archaea, eukaryotes, and retroviruses (23-26). Eukaryotes show less diversity 
in the RNase H genes they encode. Almost all eukaryotes contain RNase HI and RNase 
HII (21, 22). Plants, including Arabidopsis, contain multiple RNase HI homologs 
because different RNase HIs are targeted to the nucleus, mitochondria, and chloroplast 
(58).  In the genomes of prokaryotes, RNase H enzymes show striking diversity 
between organisms (21, 22). Phylogenetic studies show that all prokaryotic genomes 
analyzed contain at least one RNase H with most genomes containing two RNase H 
genes (27).  In general, most bacteria contain RNase HI and HII, while a smaller subset 
contains RNase HII and RNase HIII (27).  As RNase HI and HIII are active on the same 
class of substrates and because a prokaryotic genome had not been identified to 
encode functional RNase HI and RNase HIII, it had been proposed that RNase HI and 
HIII are mutually exclusive (27). We show that rnhP (RNase HI) and rnhC (RNase HIII) 
contribute to genome maintenance in 3610 demonstrating that 3610 contains functional 
RNase HI, RNase HII, and RNase HIII enzymes. RNase HIII is chromosomally encoded 
while rnhP is plasmid encoded. We therefore suggest that rnhP was acquired through 
horizontal gene transfer and has resided on the nonessential plasmid pBS32. Our 
experiments in vivo show that 3610 grows well with an ΔrnhC allele, however 3610 
grows poorly and experiences constitutive SOS induction when ΔrnhP and ΔrnhC are 
deficient, indicating that either RNase HI or RNase HIII are important for normal growth 
and resolution of RNA-DNA hybrids that form in vivo. Therefore, although rnhP is 
plasmid-borne, RNase HI activity from this gene product is important for genome 
maintenance in 3610 and, to our knowledge, this is the first organism described where 
functional RNase HI and RNase HIII have been shown to coexist.  
As discussed above, we initially hypothesized that RnhP would be required for 
pBS32 maintenance or hyper-replication. In contrast, we found that RNase HIII (rnhC) 
was required for plasmid hyper-replication while neither rnhP nor rnhC were important 
for normal plasmid maintenance.  We found that while the rnhP deletion alone does not 
confer a phenotype, the ΔrnhC does confer slight growth interference to DNA damage 
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or from cold stress and hydroxyurea (HU), suggesting that RNase HIII is the more 
important enzyme in vivo. The double deletion of ΔrnhP rnhC::erm shows ~100-fold and 
~1,000 fold growth interference from cold stress and HU treatment, respectively. If we 
compare the results of ΔrnhP rnhC::erm on HU for 3610 to the phenotype for ΔrnhC 
from B. subtilis strain PY79 we find the same extent of growth interference. Therefore, 
the comparison of phenotypes between 3610 and PY79 shows that ΔrnhP rnhC::erm in 
3610 largely phenocopies the single ΔrnhC deletion for PY79 on HU and for cold 
sensitivity. Finally, we show that the PY79 ΔrnhC phenotype is rescued with ectopic 
expression of rnhP, further demonstrating functional overlap between RnhP and RNase 
HIII (rnhC) in B. subtilis.  
 
Biochemical characterization shows that RnhP is an RNase H with specificity for 
substrates with four or more embedded ribonucleotides. RnhP is not active on a dsDNA 
or dsRNA substrate. Further, RnhP does not cleave a substrate with a single 
ribonucleotide nested in duplex DNA. Therefore, biochemical characterization of RnhP 
shows that it is a strict RNase H with preference for Mn2+.  Our prior work characterizing 
RNase HIII showed that this enzyme was most active with Mg2+ on the canonical 
substrates for RNase HIII (9, 10). One simple explanation for the coexistence of RNase 
HIII and RnhP is that metals could be scarce for wild Bacillus during growth in the soil. 
One possibility is that RNase HIII is most active when magnesium concentrations are 
sufficient to support activity. During conditions when magnesium concentrations are 
lower and manganese concentrations are sufficient, then RnhP could be more active 
providing RNase H activity and a fitness advantage for B. subtilis cells encoding both 
rnhC and rnhP. Given our studies with the double mutant, all experiments point to a 
model where the growth of 3610 is well supported with either RNase HIII or RnhP. It is 
the double deletion that grows poorly and is constitutively induced for the DNA damage 
response. Therefore, we suggest that RNase HIII activity predominates and RnhP 
activity can be used to supplement RNase HIII during specific growth conditions or 
when the burden of RNA-DNA hybrid resolution overwhelms the capacity of RNase HIII.  
Prior phylogenetic work shows that only a small subset of bacteria in the phylum 
Firmicutes, including B. subtilis and Lactobacillus, contain genes for all three RNase H 
	 170 
proteins (27). Sequence comparisons showed that the predicted RNase HI genes in 
organisms with RNase HIII lack the catalytic residues and the substrate binding a-helix 
3 basic protrusion handle found in active RNase HI enzymes (27). Moreover, prior 
functional studies of the chromosomally encoded and predicted RNase HI genes from 
B. subtilis, including YpdQ and YpeP, were unable to detect RNase H activity, further 
supporting the argument that RNase HI and RNase HIII activities do not coexist (9). 
One possible limitation of prior phylogenetic studies would be if this work only 
interrogated core genomes. Further, our finding that RnhP has a different metal 
preference and cleavage site selection relative to RNase HIII could also provide a 
biochemical difference that allows for these genes to coexist while both contribute to 
genome maintenance. We speculate that functional RNase HI and RNase HIII are 
unlikely to coexist as chromosomally encoded genes. We wish to speculate that other 
bacteria will be identified to have RNase HI and RNase HIII coexist with one gene 
encoded as part of the accessory genome and the other as part of the core genome. 
This would allow for acquisition, transfer, and loss of one RNase H gene and 
maintenance of both when a fitness advantage is conferred.  As more genome 
sequences become available, it will be interesting to learn how many other bacteria 
encode functional RNase HI and RNase HIII and how these genes contribute to growth 
and genome integrity.    
 
Materials and Methods 
General Bacteriology: Unless otherwise specified, the antibiotic concentrations used in  
this study are as follows: 0.5 μg/mL erythromycin, 100 μg/mL spectinomycin, 5 mM 
hydroxyurea, 20 ng/μL mitomycin C, and 100 μg/mL methyl methanesulfonate. Strains 
were grown in Lysogeny Broth (LB) at 30°C. 
 
RNase H alignments: Global alignments were performed on the GenBank protein 
sequences for ZpdC (AGQ21310.1) from Bacillus subtilis NCIB 3610 and RnhA 
(NP_414750) from Escherichia coli MG1655 using the pairwise sequence alignment tool 
from Clustal Omega (https://www.ebi.ac.uk/Tools/psa/). 
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Spot plates: Designated strains were streaked from frozen stocks and grown overnight 
at 30°C on LB agar plates. Plates were washed in LB liquid media and used to inoculate 
2 mL cultures to an OD600 of 0.05. Cultures were grown in a 30°C rolling rack to an 
OD600  0.9-1.5. Cultures were diluted to OD600 of 0.5 in phosphate buffered saline (PBS) 
pH 7.4 followed by 10-fold serial dilutions in 1x PBS. The dilution series was then 
spotted onto LB plates plus the indicated antibiotic or incubated at the indicated 
temperatures. 
 
Growth rate analysis: Designated strains were streaked onto LB agar plates from 
frozen stocks and grown overnight at 30°C. Plates were washed in LB liquid media and 
inoculated at an OD600 of 0.05 into 25 mL of pre-warmed LB liquid media. The cultures 
were grown in a shaking water bath at 200 RPM at 30°C. The OD600 measurement for 
each culture was recorded every 30 minutes.  Biological replicates were performed in 
triplicate on three separate days for each strain and the average growth measurement 
with corresponding standard errors were plotted. A modified Gompertz growth model in 
the form 𝑦 = 𝐴𝑒𝑥𝑝{− 𝑒𝑥𝑝 )!!	×	$" 	(𝜆 − 𝑡) + 11}  was fit to the replicates for each strain to 
obtain estimated growth rates (40). The parameters A, μm, and λ represent the time (t) 
when the growth rate equals zero (asymptote), the maximum growth rate, and the lag 
time, respectively (40). The estimated growth rate (μm) from the Gompertz model was 
then used to calculate doubling time estimates as ln(2)/μm  for each strain (10, 40). 
 
Genomic DNA purifications: Designated strains were streaked from frozen stocks 
onto LB agar plates and grown overnight at 30°C. Plates were washed in LB liquid 
media and used to inoculate 10 mL of LB liquid media at an OD600 of 0.05. The strains 
were grown in triplicate over three separate days prior to harvesting chromosomal DNA. 
At an OD600 of 0.5-0.7, the cells were pelleted via centrifugation, washed in 1 mL of re-
suspension buffer (50 mM Tris-HCl pH 8 with 5% glycerol) and mixed in a final volume 
of 150 µL of re-suspension buffer. For cell lysis, Triton 100 was added to 1% (v/v), 10 
μL of 10 mg/mL RNase A, and lysozyme from the MasterPureTM Gram-positive DNA 
purification kit (Lucigen) were added and used as described. Subsequent lysis and 
purification steps were performed as described in the MasterPureTM Gram-positive DNA 
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purification kit (Lucigen) protocol per the manufacturer’s instructions with the exception 
of the RNase treatment step, which was omitted because RNase treatment was 
performed during cell lysis. 
 
DNA sequencing and chromosome coverage analysis: Library preparation and DNA 
sequencing was performed by the University of Michigan DNA Sequencing Core. 
Sequencing reads were aligned using bwa (v 0.7.8-r455) to the NCIB 3610 
chromosome reference (CP020102.1) and pBS32 (CP020103.1) reference (37, 41). 
The bam files were sorted and filtered using samtools (v 0.1.18) for quality values 
greater than 30 (42) and PCR duplicates were removed using Picard tools 
(https://github.com/broadinstitute/picard). The filtered bam files were used to calculate 
the genome coverage at each base using genomeCoverageBed from bedtools (v 
2.29.1). The coverage at each base was averaged for the three replicates. The average 
coverage over 10kb windows was plotted every 1kb throughout the length of the 
chromosome using the packages ggplot2 and zoo in R (v 3.1.3).  
 
RnhP (D73N). To create a catalytically inactive RnhP variant we mutated the aspartic 
acid residue (GAT) responsible for metal ion coordination at position 73 to asparagine 
(AAT) using overlapping PCR. The 5' blocks were created using B. subtilis NCIB 3610 
genomic DNA as a template with either primer oTN56 or oTN58 and oTN61 for the 
pDR110rnhPD73N and pE-SUMOrnhPD73N vectors, respectively. Similarly, the 3' blocks were 
created using either primer oTN57 or oTN59 with oTN60 for the pDR110rnhPD73N and pE-
SUMOrnhPD73N vectors, respectively. A PCR cleanup was performed and the purified 
products were combined using Gibson assembly (43) to create pDR110rnhPD73N and pE-
SUMOrnhPD73N. pDR110rnhPD73N and pE-SUMOrnhPD73N. Each plasmid generated was 
subsequently used to transform competent MC1061 cells and plated on 100 μg/mL 
spectinomycin or 25 μg/mL kanamycin. Resulting colonies were screened by PCR using 
primers oTN56 and oTN57 for the pDR110rnhPD73N vector and oTN58 and oTN59 for the 
pE-SUMOrnhPD73N vector and the insert sequences were verified as correct using Sanger 
sequencing through the University of Michigan Core sequencing facility.  
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Protein Purification: Recombinant proteins were purified from E. coli BL21DE3 cells 
containing pE-SUMOrnhP and pE-SUMOrnhPD73N as described (4, 10). Briefly, Cultures 
were grown in 2 liters of LB with 25 μg/mL kanamycin at 37ᵒC shaking to an OD of 0.7. 
Overexpression was induced by adding IPTG to 0.5 mM followed by growth for 3 
additional hours. Cells were then pelleted by centrifugation and stored at -80ᵒC. Once 
thawed, the pellet was resuspended in lysis buffer [50 mM Tris-HCl pH 8, 300 mM NaCl, 
10% sucrose, 10 mM imidazole, 1x protease inhibitors (Roche 11873580001)] and cells 
were sonicated at 10 seconds on 20 seconds off cycles for a total of 5 minutes on ice. 
Cell debris was cleared and pelleted by centrifugation. Supernatant was then applied to 
a 4 mL Ni2+-NTA agarose gravity-flow column. The column was washed with wash 
buffer (50 mM Tris-HCl pH 8, 25 mM imidazole, 2 M NaCl, 5% glycerol) and eluted with 
elution buffer (50 mM Tris-HCl pH 8, 400 mM imidazole, 150 mM NaCl, 5% glycerol). 
Following elution, 1 mM DTT and SUMO protease were added to the eluate and 
incubated for 2 hours at room temperature. The SUMO protease treated sample was 
dialyzed into storage buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 5% glycerol) 
overnight at 4°C.  The product was fractionated by application to a 4 mL Ni2+-NTA 
gravity-flow column to separate the recombinant protein from the SUMO tag. SDS-
PAGE was performed to confirm the SUMO tag was removed. The sample was then 
dialyzed into cation exchange start buffer (20 mM Tris-HCl pH 7.5, 5% glycerol, 1 mM 
DTT) overnight at 4°C.  The dialyzed sample was purified using a HiTrap SP HP column 
(GE: 17-1152-01) with an elution gradient of 50-500 mM NaCl at a flow rate of 1 mL/min 
over 90 minutes. SDS-PAGE was performed and fractions containing pure protein were 
pooled. The RnhP (D73N) protein was concentrated, glycerol was added to 25%, 
aliquoted, flash frozen in liquid nitrogen, and stored at -80 ᵒC. The RnhP protein eluted 
slightly earlier from the S-column and required further purification with size exclusion 
chromatography. The concentrated protein was applied to a HiPrep 16/60 Sephacryl 
S200 HR column (GE: 17-1166-01) at a flow rate of 0.6 mL/min with sizing column 
buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 1mM DTT) and eluted in one peak. SDS-
PAGE was again performed and fractions containing only pure protein were pooled, 
concentrated, glycerol was added to 25%, aliquoted, flash frozen, and stored at -80°C. 
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RNase H activity assays: The end infrared (IR) dye-labeled substrates for the 1-rNMP, 
4-rNMP, and all RNA substrates were created by mixing oJR209, oJR210, and oJR227 
respectively, with oJR145 in a 1:2 μM ratio diluted in Buffer A (20 mM Tris-HCl pH8, 50 
nM NaCl, 1 mM DTT) (9, 10).  The Okazaki fragment substrate was assembled by 
mixing oJR339 with oJR340 in a 1:2 μM ratio in Buffer A. The RNA/RNA and DNA/DNA 
hybrids were created by mixing oJR227/oJR166 and oJR348/oJR365, respectively, in 
1:2 μM ratios in Buffer A. The oligos were annealed by heating at 98ᵒC for 1 min 
followed by cooling on the bench top to room temperature. Reactions totaling 10 μL in 
volume included 100 nM substrate and 4 or 50 nM protein as indicated (diluted from 
stock concentrations in Buffer A) in the in vivo metal concentration buffer (20 mM Tris-
HCl pH8, 50 nM NaCl, 1 mM MgCl2, 10 μM MnCl2, and 1 mM DTT) (9, 10). For NaOH 
treated samples, 200 mM of NaOH was added to 500 nM substrate. Reactions were 
allowed to proceed for 10 minutes at 37°C unless otherwise indicated. For all reactions 
except the RNA/RNA hybrid, 10 μL of stop buffer (95% formamide, 20 mM EDTA, 
0.01% bromophenol blue) was added after 10 minutes and reactions were placed at 
98ᵒC for 5 minutes and subsequently snap-cooled on ice. A denaturing 8M urea 20% 
polyacrylamide gel was prepared by pre-electrophoresing the gel at 250V for 30 
minutes in TBE buffer. The gel was subsequently loaded with 4 μL of each reaction and 
electrophoresed at 250V for 1.5 hours. For the RNA/RNA hybrid, 10 μL of RNA hybrid 
stop buffer (66% formamide, 9% formaldehyde, 17.5 mM EDTA, and 0.65x MOPS 
Buffer (10x MOPS buffer: 200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA) was 
added after 10 minutes and the reactions were placed at 55ᵒC for 15 minutes. A 
denaturing 8M urea 20% polyacrylamide gel was prepared by pre-electrophoresing the 
gel at 100V for 30 minutes in 0.5x MOPS buffer. The gel was subsequently loaded with 
4 μL of each reaction and electrophoresed at 150V for 2 hours. For all gels, the 
products were visualized with a LI-COR Odyssey imager. 
 
Plasmid growth analysis following induction: Strains grown overnight in LB at 22°C 
were subcultured into 50 mL fresh LB to an OD600 of 0.1 and cultured at 37°C.  OD was 
measured every 30 minutes until OD reached between 0.07-0.12.  IPTG was added to a 
final concentration of 1 mM, and OD was measured every 30 minutes for a total of 4 
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hours post-induction.  Simultaneously, 100 µL of multiple 10-fold serial dilutions of each 
sample culture was plated on LB plates containing spectinomycin and incubated 
overnight at 37°C.  The following day, plates containing individual colony forming units 
(CFUs) were counted to determine CFU/mL. 
 
Plasmid copy number following induction: Strains grown overnight in LB at 22°C 
were subcultured into 50 mL fresh LB to an OD600 of 0.1 and cultured at 37°C until OD 
reached between 0.07-0.12.   IPTG was added to a final concentration of 1 mM, and 
strains continued to grow for an additional 60 minutes.  Four OD units of each sample 
was pelleted, and genomic and plasmid DNA was isolated from cells by Qiagen DNeasy 
Blood & Tissue Kit (Cat #69504).  The concentration of isolated DNA was quantified by 
Nanodrop, samples were standardized to a DNA concentration of 10 ng/µl, and diluted 
10- and 100-fold to 1 ng/µl and 0.1 ng/µl, respectively.  Quantitative PCR was 
performed with all three dilutions to determine plasmid copy number as previously 
described (44).  Improved determination of plasmid copy number using quantitative real-
time PCR for monitoring fermentation processes).  Primers 3106/3107 (sigA) were used 
to measure chromosomal DNA, and primers 6527/6528 (zpdE) were used to measure 
pBS32 DNA. 
 
Live cell microscopy: Each strain imaged was streaked from frozen stocks onto LB 
agar plates and grown at 30oC for 16 hours. Plates were then washed with LB and 25 
mL cultures were inoculated to an initial OD600 of approximately 0.05. Cultures were 
then placed in a water bath at 30oC with shaking at 212 RPM until reaching an OD600 of 
0.6 – 0.9. Once the desired OD600 was reached, the cultures were filtered to concentrate 
the cells, and subsequently washed three times with 1x PBS. Cells were then pelleted 
via centrifugation and resuspended in 200 µL 1x PBS. The membrane was stained 
using 0.25 ng/µL of FM4-64. 200 µL of cells were then placed onto a microscope slide 
with a 1% agarose pad as described (45). After each slide was prepared, the slides 
were placed under an Olympus BX61microscope equipped with a Hamamatsu camera 
(46). The microscope was focused under an exposure of 20-30 ms. Then the 
microscope was switched from DIC to RFP setting in order to observe the membrane 
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stain of FM4-64 with an exposure of 300 ms. Once the microscope was properly 
focused, an image was recorded. After a combined total of approximately 900 cells 
were imaged for each strain, images were adjusted for brightness, contrast and gamma 
using the CellSense software (Olympus). The length of the cells was measured using 
the polyline tool of CellSense (Olympus). In order for a cell to be considered scorable, 
the cell membrane had to clearly imaged from pole to pole. For cells undergoing division 
incomplete septa were scored as one cell and complete septa were scored as two cells.  
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Figure 4.1. Plasmid encoded ZpdC is an active RNase HI protein. (A) Sequence 
alignment of ZpdC with E. coli RNase HI. Identical and similar residues are indicated in 
black and gray, respectively. Red indicates conserved catalytic residues. (*) denotes 
Eco-HI  MLKQVEIFTDGSCLGN---PGPGGYGAILRYRGREKTFSAGYTRTTNNRM     47
Bs-ZpdC -MKKVVIYCDGAARNNGKDNNVGGFGAVLRYGDHVKTIKAGFRNVTNNMM     49
Eco-HI  ELMAAIVALEALK-EHCEVILSTDSQYVRQGITQ-WIHNWKKRGWKTADK     95
Bs-ZpdC EIRAAIEALKQLKTTNIPVEINTDSAYLCNCMNQGWYKKWMNNGWVTAGK     99
Eco-HI  KPVKNVDLWQRLDAALGQHQ-IKWEWVKGHAGHPE--------NERCDEL    136
Bs-ZpdC KPVENRQLWIELIELVEQFPFITFNKVKGHSGIPDNELADRLANEAMDEL    149
Eco-HI  ARAAAMNPTLEDTGYQVEV    155  
Bs-ZpdC TRGAAV-------------    155
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catalytic residue mutated in catalytically inactive variant (D73N). The a-helix 3 basic 
protrusion handle is boxed. (B) SDS-PAGE stained with Coomassie brilliant Blue of 
purified ZpdC and catalytically inactive variant D73N. (C) ZpdC and D73N were 
incubated with a ribopatch substrate. The 5' end IR-labeled oligo containing four 
embedded rNMPs (squiggly lines) within an otherwise DNA oligo (straight lines) was 
annealed to a complementary DNA oligo (oJR210 and oJR145). A ladder was 
generated via alkaline hydrolysis of the substrate at the embedded rNMPs (lane one). 
(D) Incubation of ZpdC with an RNA-RNA substrate. A 5' end IR-labeled RNA oligo 
(squiggly line) was annealed to a complementary RNA oligo (oJR227 and oJR166). (E) 
Incubation of ZpdC with a DNA-DNA substrate. A 3' end IR-labeled DNA oligo (straight 
line) was annealed to a complementary DNA oligo (oJR348 and oJR365). For C-E, the 
reactions were assembled as described in “Materials and Methods” and products were 
separated on a 20% denaturing urea-PAGE and subsequently visualized with a LI-COR 
Odyssey imager. 
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Figure 4.2. RnhP cleaves several different RNA-DNA hybrid substrates. For each 
reaction, the indicated substrate was incubated separately with RnhP, RnhB, or RnhC in 
reaction buffer for 10 minutes at 37°C (see Materials and Methods). For each substrate, 
a ladder was created via alkaline hydrolysis of the substrate at the rNMPs (lane one). 
The products were separated on a 20% denaturing urea-PAGE and subsequently 
visualized with a LI-COR Odyssey imager. (A) Incubation of RnhP, RnhB, and RnhC 
with a single rNMP substrate. A 5' end IR-labeled oligo containing one embedded rNMP 
(triangle) within an otherwise DNA oligo (straight lines) was annealed to a 
complementary DNA oligo (oJR209 and oJR145). (B) Incubation of RnhP, RnhB, and 
RnhC with a ribopatch substrate. A 5' end IR-labeled oligo containing four embedded 
rNMPs (squiggly lines) within an otherwise DNA oligo (straight lines) was annealed to a 
complementary DNA oligo (oJR210 and oJR145). (C) Incubation of RnhP, RnhB, and 
RnhC with an Okazaki fragment-like substrate. A 3' IR-dye end labeled oligo with 
rNMPs at the 5' end covalently linked to a stretch of DNA was hybridized to an oligo that 
was complementary at the 5' end of the molecule but was significantly longer to 
generate a 3' overhang (oJR339 and oJR340). (D) Incubation of RnhP, RnhB, and 
RnhC with a complementary RNA-DNA hybrid substrate. A 5' end IR-labeled RNA oligo 
(squiggly line) was annealed to a complementary DNA oligo (straight lines) to create an 
RNA-DNA hybrid (oJR227 and oJR145).  
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Figure 4.3. RnhC, not RnhP, is required for plasmid hyper-replication. (A) Plasmid 
copy number for IPTG inducible sigN strains in WT, ΔrnhC, ΔrnhP, and ΔzpdC 
rnhC::erm  backgrounds with (light gray bars) and without (dark gray bars) IPTG. The 
plasmid copy number was assessed via qPCR ratio of the plasmid encoded zpdE gene 
to the chromosomally encoded housekeeping sigma factor sigA. (B) Average OD600 (y-
axis) of sigN inducible strains in WT, ΔrnhC, ΔrnhP, and ΔrnhP rnhC::erm  backgrounds 
over time (x-axis). Representative curves for uninduced strains are indicated. For each 
IPTG induced strain the average and standard error for three independent replicates is 
reported. IPTG was added at time 0. (C) Average colony forming units (y-axis) for three 
replicates of sigN inducible strains in WT, ΔrnhC, ΔrnhP, and ΔrnhP rnhC::erm  
backgrounds over time (x-axis). The standard errors are indicated. 
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Figure 4.4. Loss of RnhP and RnhC results in decreased cell growth and 
increased cell length during exponential growth. (A) Growth curves for WT, ΔrnhC, 
ΔzpdC, and ΔrnhP rnhC::erm in LB media with shaking at 30°C. The growth curves 
were fit to a Gompertz growth model and the estimated growth rates and corresponding 
doubling times are indicated with 95% confidence intervals. (B-E) Representative 
images for scoring cell length for WT, ΔrnhC, ΔrnhP, and ΔrnhP rnhC::erm, 
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respectively. Cells were grown in LB media with shaking at 30°C to mid-exponential 
growth and treated with a membrane strain for subsequent imaging. (F) The 
distributions of cell lengths plotted for each strain. The dashed line for each strain 
indicates the average cell length. The number of scored cells is indicated. 
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Figure 4.5. Loss of RnhP and RnhC results in induction of the SOS response 
under normal growth conditions. (A-B) Representative images for tagC::tagC-gfp 
reporter strains in WT and ΔrnhP rnhC::erm backgrounds. (C-D)  Representative 
images for tagC::tagC-gfp reporter strains in WT and ΔrnhP rnhC::erm backgrounds 
plus treatment with mitomycin C. (E) Quantitation of cells expressing the tagC::tagC-gfp 
reporter in WT and ΔrnhP rnhC::erm with and without mitomycin C treatment. The strain 
backgrounds and treatment status are indicated on the x-axis and the percent of cells 
expressing the reporter is indicated on the y-axis. The percent of fluorescent cells for 
each strain is indicated above the bar. For WT, WT with MMC treatment, ΔrnhP 
rnhC::erm, and ΔrnhP rnhC::erm with MMC treatment reporters 799, 744, 799, and 767 
cells were scored per strain, respectively. (F) Single image GFP intensities for 
tagC::tagC-gfp reporter strains in WT and ΔrnhP rnhC::erm backgrounds plus treatment 
with mitomycin C. The GFP intensity per pixel was quantified for each strain and plotted. 
The white line used to quantify pixels for GFP intensity is indicated in each image. An 
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enhanced image for each strain is also shown. The GFP intensity per pixel was 
quantified for each strain and plotted to demonstrate background fluorescence in (WT) 
relative to the fluorescence intensity observed in cells inducing SOS as measure by 
TagC-GFP fluorescence. 
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Figure 4.6.  Loss of RnhP and RnhC results in replication conflicts around the 
terminus. (A) Average plasmid coverage of exponentially growing WT and ΔrnhP 
rnhC::erm cells. The average sequencing coverage (y-axis) of three independent 
replicates for reads aligned to the pBS32 reference over 1kb regions are plotted in 100 
bp sliding windows over the length of the plasmid on the x-axis. The plots for the WT 
and ΔrnhP rnhC::erm strains are indicated. (B) Average genome coverage of 
exponentially growing WT and ΔrnhP rnhC::erm cells. Average sequencing coverage (y-
axis) of three independent replicates for reads aligned to the NCIB 3610 reference (37) 
chromosome over 10 Kb regions is plotted in 1Kb sliding windows over the length of the 
chromosome (x-axis). The first origin proximal base in the reference genome represents 
position 1. The plots for the WT and ΔrnhP rnhC::erm are indicated. 
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Figure 4.7. RnhP contributes to the mitigation of cell stress caused by DNA 
damage. (A) Single and pairwise deletion strains in NCIB 3610 were serially diluted 10-
fold and spotted onto LB agar media at 30°C, 25°C, and with 5mM hydroxyurea added 
to the plates. Plates were imaged after overnight incubation at indicated temperatures. 
(B) PY79 strains were serially diluted 10-fold and spotted onto LB agar media at 30°C, 
25°C, and with 5 mM hydroxyurea added to the plates. Plates were imaged after 
overnight incubation at indicated temperatures. 
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Figure 4.8. ZpdC is active at various temperatures and prefers Mn2+ as a metal 
cofactor. (A) ZpdC was incubated in reaction buffer (see Materials and Methods) with 
the ribopatch substrate at the indicated temperatures for ten minutes. A 5' end IR-
labeled oligo containing 4 embedded rNMPs (squiggly lines) within an otherwise DNA 
oligo (straight lines) was annealed to a complementary DNA oligo (oJR210 and 
oJR145) and treated with 4 nM ZpdC at the indicated temperatures. (B) ZpdC was 
incubated with the ribopatch substrate described in (A) in a reaction buffer (20 mM Tris-
HCl pH8, 50 nM NaCl, and 1 mM DTT) containing the indicated concentrations of metal 
ions. For both experiments, a ladder was created via alkaline hydrolysis of the substrate 
at the embedded rNMPs (lane one). The products were separated on a 20% denaturing 
urea-PAGE gel and subsequently visualized with a LI-COR Odyssey imager. 
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Figure 4.9. Double deletion cells are elongated during induction of plasmid hyper-
replication. (A-B) Representative images for IPTG inducible sigN strains in WT and 
ΔrnhP rnhC::erm backgrounds pre-induction with IPTG, respectively. (C-D) 
Representative images for IPTG inducible sigN strains in WT and ΔrnhP rnhC::erm 
backgrounds 4 hours post induction with IPTG, respectively. 
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Fig 
4.10. 
Sequencing coverage of replicates for WT and double deletion strains. Genome 
coverage for three independent replicates of exponentially growing WT and ΔrnhP 
rnhC::erm cells. Sequencing coverage (y-axis) of reads aligned to the NCIB 3610 
reference chromosome over 10 Kb regions is plotted in 1Kb sliding windows over the 
length of the chromosome (x-axis). The first origin proximal base in the reference 
genome represents position 1. The independent replicates for each strain are plotted 
separately. 
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Table 4.1. Strains used in this study 
Strains Genotype Source 
TMN73 
DK1042 
JWS207 
BKE28620 
BKE16060 
TMN107 
DK7047 
TMN110 
TMN103 
TMN104 
TMN112 
KJW7 
TMN115 
TMN128 
DK1634 
DK7765 
DK7814 
DK7868 
PY79 
NCIB 3610 comIQ12I 
PY79 ΔrnhC 
rnhC::lox-erm-lox 
rnhB::lox-erm-lox 
DK1042 ΔrnhC 
DK1042 ΔzpdC 
DK1042 ΔzpdC, rnhC::erm 
PY79 ΔrnhC, amyE::Pspac-zpdC 
BL21 x pE-SUMOzpdC 
BL21 x pE-SUMOzpdCD73N 
PY79 tagC::tagC-gfp 
DK1042 tagC::tagC-gfp 
DK1042 ΔzpdC,rnhC::erm, tagC::tagC-gfp 
ΔPBSX ΔSPβ ΔcomI amyE::hyspank-zpdN 
 
ΔPBSX ΔSPβ ΔcomI ΔzpdC amyE::hyspank-sigN 
 
ΔPBSX ΔSPβ ΔcomI ΔzpdC rnhC::erm amyE::hyspank-
sigN 
comIQ12L rnhC::erm amyE::hyspank-sigN 
(59) 
(38) 
(14) 
BGSC 
BGSC 
 
 
 
 
 
 
 
 
 
 
 
(60) 
 
 
 
 
 
(61) 
Unless otherwise indicated, the ‘Source’ is this study. 
Table 4.2. Plasmids used in this study 
Plasmid Vector Insert Source 
pTNzpdC1 pDR110 rnhP This study 
pTNzpdC2 pE-SUMO rnhP This study 
pTNzpdC2 pE-SUMO rnhP D73N This study 
pAMB32 pMiniMAD2   (62) 
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Table 4.3. Oligos used in this study 
Primer name  Primer sequence 
oTN56 
oTN57 
oTN58 
TTAGTCGACTAAGGAGGTATACATATGAAAAAGGTTGTAATTTAC 
TTGCATGCGGCTAGCttaTCATACGGCAG 
CGCGAACAGATTGGAGGTATGAAAAAGGTTGTAATT 
oTN59 GTGGTGGTGCTCGATCATACGGCAGC 
oTN60 CCCTGTAGAAATCAATACTAATTCTGCATATCTGTGCAAC 
oTN61 GTTGCACAGATATGCAGAATTAGTATTGATTTCTACAGGG 
oJR209 
oJR210 
oJR227 
oJR145 
oJR339 
oJR340 
oJR166 
oJR348 
oJR365 
oAB6715 
oAB6716 
oAB6717 
oAB6718 
/5IRD800CWN/CGATCGTAArGCTAGCTCTGC 
/5IRD800CWN/CGATCGTArArGrCrUAGCTCTGC 
/5IRD800CWN/rCrGrArUrCrGrUrArArGrCrUrArGrCrUrCrUrGrC 
GCAGAGCTAGCTTACGATCG 
rArGrUrArGrUrGrArArCrCrATGCTTACG/3IR800CWN/ 
CGTAAGCATGGTTCACTACTCGCGCTTGATGC 
rGrCrArGrArGrArCrUrArGrCrUrUrArCrGrArUrCrG 
AGTAGTGAACCATGCTTACG/3IRD800CWN/ 
CGTAAGCATGGTTCACTACT 
AGGAGGAAGCTTGCCCGAAAATGATGATTATGG 
 
CCTCCTGTCGACGTAAATTACAACCTTTTTCATTAAAG 
 
AGGAGGGTCGACGCCGTATGAATGAATCAGTCTTC 
 
CCTCCTGGTACCGAGCAATAGGATATGCCCGAC 
 
Black and red text represents DNA and RNA sequences, respectively. IRDXXX represents infrared dye 
with excitation at 700 or 800 nM either at the 5’ (5) or 3’ (3) end of the oligo. CWN is NHS ester 
conjugation. 
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Supplemental text 
Supplemental materials and methods 
Strain construction: Chromosome deletion strains were created by transforming 
competent DK1042 cells (38) with genomic DNA purified from Bacillus subtilis 168 
strains with the gene of interest replaced by an erythromycin resistance cassette 
flanked by loxP sites obtained from the Bacillus Genetic Stock Center 
(http://www.bgsc.org/). The erythromycin resistance cassette was subsequently 
removed with Cre recombinase (63).  
 
To generate the ΔrnhP in-frame markerless deletion plasmid pAMB32 was constructed. 
The region 5' to rnhP was amplified using the primer pair 6715/6716 and subsequently 
digested with HindIII and SalI, and the region 3' of rnhP was amplified with primer pair 
6717/6718 and digested with SalI and KpnI.  The two fragments were simultaneously 
ligated into HindIII/KpnI-digested pMiniMAD2, which contains a temperature-sensitive 
origin of replication and an erythromycin resistance cassette (62).  Escherichia coli TG1 
was transformed with the resulting product to generate pAMB32.  The pAMB32 plasmid 
was introduced into DK1042 by transformation at the permissive temperature for 
plasmid replication (22°C) using mls resistance as a selection.  The resulting strain 
(DK7021) was grown on plates containing mls at the restrictive temperature for plasmid 
replication (37°C) to force integration of the extra-chromosomal plasmid into pBS32.  To 
evict the plasmid, the strain was incubated in 3 mL LB at the permissive temperature for 
14h, diluted 30-fold in fresh LB, and incubation continued at the permissive temperature 
for another 24h.  Cells were serially diluted and plated on LB agar at 37°C.  Individual 
colonies were replica patched onto LB plates ad LB plates containing mls to identify 
mls-sensitive colonies that evicted the plasmid.  Colonies that had evicted the plasmid 
were screened by PCR using primers 6715/6718 to assess which isolates retained the 
ΔrnhP allele. 
 
The tagC::tagC-gfp reporter strains were created by transforming genomic DNA purified 
from tagC::tagC-gfp  in B. subtilis PY79 (KJW7) into the appropriate background and 
verified via resistance to the selectable marker spectinomycin and microscopy (60). The 
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inducible sigN strains were created by transduction with lysate from DK1634 and 
subsequently verified 
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CHAPTER V 
 
Concluding Remarks and Future Research 
 
 
 
Introduction 
There has been a growing recognition that post-replicative DNA methylation regulates 
critical cellular functions across all three domains of life. In bacteria, the study of the 
regulatory functions of DNA methylation has largely been confined to orphan MTases 
from Gram-negative E. coli, C. crescentus, and related Proteobacteria (for review (15; 
20). Studies investigating the regulatory effects of Type III RM system MTases have 
primarily focused on Gram-negative species as well (for review (32-35)). In this 
dissertation I describe the important contribution of DNA methylation to gene regulation 
in Gram-positive bacteria. In Chapter II, I describe how DNA methylation from a Type I 
RM system promotes the expression of a subset of genes in the Gram-positive 
pathogen Streptococcus pyogenes (Chapter II (22)). I show that among the differentially 
expressed genes is the Mga core regulon, which includes genes involved in adhesion, 
internalization, and immune evasion phenotypes (12; 16), and that all of these genes 
are substantially down regulated in the absence of the RM system MTase. Further, I 
demonstrate that the m6A-dependent decrease in gene expression results in attenuated 
adherence and virulence of the RM system mutant relative to the wild type strain 
(Chapter II (22)). In Chapter III I describe how genomic m6A modifications from the 
previously uncharacterized MTase, DnmA, functions to promote expression of a small 
subset of genes involved in chromosome maintenance in the Gram-positive Firmicute 
Bacillus subtilis (Chapter III (23)). I also identify an m6A-sensitive transcription factor, 
providing some of the first mechanistic insight into m6A-dependent regulation in Gram-
positive bacteria (23). Finally, in Chapter IV I describe how RNA incorporated into DNA, 
representing the most frequent type of noncanonical nucleotide found in DNA (29; 38) 
can be resolved by a plasmid encoded RNase H protein providing the first example of a 
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bacterial organism encoding functional RNase HI, HII, and HIII enzymes. My work 
establishes the importance of DNA modifications to regulation of cell physiology in 
Firmicutes and opens many new paths of study for future research.  
 
Elucidating direct and indirect mechanisms of m6A-dependent changes in gene 
expression. The gene expression changes described in Chapters II and III can be the 
result of both direct and indirect regulation by m6A (Fig 1.6). A direct regulatory 
mechanism would consist of m6A influencing transcription factor binding directly within 
the promoter region of a differentially expressed gene, such as the m6A-sensitive ScoC 
binding described in Chapter III. Indirect mechanisms of regulation can occur 
downstream of direct regulation, such as differential expression of a transcription factor 
or DNA binding protein that subsequently results in many genes being differentially 
expressed, or may be independent of a direct change in gene expression. Here I 
describe how this thesis directly contributes to future studies of both direct and indirect 
mechanisms of m6A-dependent changes in gene expression. 
 
Direct mechanisms for m6A-dependent regulation of gene expression in 
Firmicutes. In Chapter III I described a subset of genes that were down regulated in the 
absence of m6A in B. subtilis (23). The differentially expressed genes contained a 
DnmA recognition site proximal to the -35 binding box of SigA. To elucidate the 
mechanism of m6A-dependent gene expression changes, I performed a pull down of B. 
subtilis whole cell lysates using biotinylated oligos for the promoter region of scpA, one 
of the differentially expressed genes upon loss of m6A. I found that ScoC, a 
transcriptional repressor of genes expressed in the transition state, preferentially bound 
to an umethylated promoter sequence. I further confirmed the differential binding of 
ScoC to the scpA promoter region using gel shift assays with purified ScoC and labeled 
promoter probes (23).  Previous studies in Gram-negative E. coli and C. crescentus 
have identified transcriptional regulators whose binding is dependent on m6A from 
orphan MTases Dam and CcrM methylation, respectively (2; 10; 11; 18; 28). To my 
knowledge, ScoC is the first example of m6A-sensitive transcription factor binding in 
Gram-positive bacteria.  Moreover, ScoC provides a rare example of methylation 
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sensitive transcription factor binding that is not dependent on methylation from an 
orphan MTase. 
 
ScoC mediated transcriptional repression is complex. ScoC acts to repress many genes 
that are expressed in the transition from exponential to stationary growth and is 
regulated by the transcriptional repressor, CodY (1; 4). CodY influences the expression 
of over 200 genes, most of which are involved in nutrient acquisition, and binds DNA in 
nutrient rich conditions when amino acids are plentiful (3; 19), and for review (31)). As 
amino acids become unavailable, CodY-mediated repression is lifted and a subset of 
genes within the CodY regulon is up regulated, including ScoC (1; 30). Intriguingly, the 
increased expression of ScoC results in further repression of genes within the CodY 
regulon that share both ScoC and CodY binding sites, resulting in a redundancy in the 
repression of these genes (1). Thus, in order to better understand the downstream 
regulatory affects of m6A-mediated ScoC binding, future studies will have to investigate 
gene expression effects in amino acid limited media to understand ScoC mediated 
repression without the inhibitory effects of CodY expression. It is also worth noting that 
ScoC has not previously been shown to be a regulator of the scpA promoter region as 
demonstrated in Chapter III of this work. A Chromosome Immunoprecipitation followed 
by deep sequencing (ChIP-seq) experiment of ScoC binding throughout the B. subtilis 
genome in amino acid limited media as well as PacBio sequencing of genomic DNA 
under the same amino acid limiting conditions is necessary to better understand how 
ScoC binding is affected by the presence of DNA methylation in B. subtilis.  
 
The initial pull down experiment of B. subtilis lysates with the scpA promoter region 
revealed the potential for several differentially bound proteins between the two promoter 
sequences. Due to technical limitations at the time of the experiment, I used a promoter 
region containing a thymine at the m6A position for the methylated promoter, as this 
mutation showed wild type expression levels in the gene expression experiments. Also, 
I was only able to identify the differentially bound proteins between 20-40 kDa in size. 
With the necessary conditions for the pull-down established, this experiment could 
easily be repeated with an IDT-synthesized methylated promoter region. Additionally, 
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protein identification via mass spectrometry can be performed directly from the beads 
used in the pull-down, allowing for differentially bound proteins of all sizes to be 
identified in subsequent experiments. This protocol could also be adapted for the other 
differentially expressed promoter regions identified in Chapter III, allowing for further 
identification of the m6A-senstive transcriptional regulators in B. subtilis. These 
experiments would provide the most comprehensive and mechanistic understanding of 
m6A-dependent gene regulation in Gram-positive bacteria to date. 
 
Indirect mechanisms of m6A-dependent regulation resulting from direct 
regulation of gene expression. In addition to the m6A-dependent decrease in gene 
expression of scpA discussed in the previous section, in Chapter III I also identified a 
subset of genes that were down regulated in the absence of m6A (23). Among the 
differentially expressed genes was hbs, encoding the highly abundant and essential 
histone-like protein HBsu (17). Although the m6A-dependent decrease of hbs 
expression was small, given the high expression of the hbs gene, which is expected to 
result in 50,000 HBsu monomers per cell (27), a slight decrease in gene expression 
could have important consequences for protein levels. Altered HBsu binding patterns 
throughout the B. subtilis genome due to decreased protein expression could result in 
altered chromosome structure (14), which could in turn have downstream effects on 
gene expression (7). Thus, the direct m6A-dependent decrease in hbs levels could 
result in indirect differential gene expression throughout the B. subtilis chromosome.  
 
In order to assess HBsu protein levels and occupancy throughout the B. subtilis 
chromosome, I purified HBsu for antiserum production. Preliminary Western Blots with 
the HBsu antiserum against whole cell protein lysates and purified HBsu suggest that 
the antiserum recognizes and is specific for HBsu. However, further validation 
experiments need to be completed because hbs is essential, preventing use of a 
deletion control for the pull-down experiments. Once these experiments are complete, 
the antiserum can be used in quantitative Western Blots to determine if the m6A-
dependent decrease in hbs gene expression also results in decreased levels of HBsu. 
Furthermore, as a part of ongoing experiments in collaboration with Dr. Peter 
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Freddolino’s Lab, genome-wide protein occupancy can be assessed in the wild type and 
m6A deficient cells using the In vivo Protein Occupancy Display in High Resolution  
(IPOD-HR) technique (7). Briefly, the technique involves crosslinking proteins to DNA, 
degrading all DNA not occupied by protein, reversing the crosslinks, and sequencing 
the remaining DNA to map all genomic loci bound by protein (8; 37). Moreover, the 
HBsu antiserum will allow for ChIP-seq to be performed with the IPOD experiments to 
determine which loci HBsu specifically occupies in the wild type and m6A deficient 
strains. Subsequent RNA-seq experiments can be performed to determine if differences 
in protein occupancy between the strains result in differences in gene expression. This 
work will help to elucidate indirect mechanisms of m6A regulation of gene expression 
that arise from the direct m6A-dependent promoter regulation described above. 
 
Indirect mechanisms of m6A-dependent regulation of gene expression 
independent of direct regulatory mechanisms. While my study of m6A-dependent 
regulation of gene expression in B. subtilis revealed possibilities for both direct and 
indirect mechanisms of regulation, my study of the regulatory functions of m6A in S. 
pyogenes strongly suggest an indirect role for DNA methylation in tuning gene 
expression (22). In Chapter II I established that loss of m6A from an active Type I RM 
system resulted in significant down regulation of 20 genes, a subset of which comprised 
genes in the core Mga regulon. Mga is a stand-alone transcriptional regulator that 
regulates ~10% of the S. pyogenes genome during exponential phase growth, including 
genes involved in host cell adhesion, internalization, and immune evasion phenotypes 
(12; 16). The mga gene encoding the Mga transcriptional regulator showed a log2 fold-
change of -1.24 in the absence of m6A (22). While the decrease in expression of the 
transcriptional activator explains the reduced expression of genes within the regulon, 
the nearest Type I RM system recognition site occurs 800 base pairs upstream of mga 
within the coding region of another gene, making it an unlikely candidate for direct 
regulation of mga expression.  
 
Indirect regulation of gene expression by a Type I RM system would not be unique to S. 
pyogenes. As discussed in the Chapter I, m6A from a Type I RM system in M. 
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tuberculosis also appears to indirectly affect gene expression, with no recognition sites 
proximal to differentially expressed genes (6). To date, no known mechanism for m6A-
dependent indirect regulation of gene expression has been described. In order to better 
understand how indirect regulation occurs, IPOD-HR could provide genome-wide 
protein occupancy information in S. pyogenes (8). Differences in protein occupancy 
could result in gene expression changes through differential binding of proteins in 
promoter or gene body regions that affect transcription initiation and elongation, 
respectively. Alternatively, more global changes in occupancy could result in varied 
chromosome conformation, resulting in changes in RNA-polymerase occupancy and 
gene expression. The relatively small number of differentially expressed genes in S. 
pyogenes suggests that the changes are less likely to be the result of global changes in 
chromosome conformation. To further elucidate the indirect mechanism of regulation, 
subsequent to IPOD-HR, locus specific pull-down experiments can be performed to 
identify differentially bound proteins at specific loci and gross chromosome structure 
changes can be determined by Chromosome Conformation Capture followed by deep 
sequencing (Hi-C). Determining the indirect mechanisms of m6A-dependent gene 
expression changes remains an open and largely unexplored area of research across 
all bacteria. 
 
RNA modifications within genomic DNA. In Chapter IV I describe a plasmid-borne 
RNase HI protein that contributes to genome maintenance in the ancestral strain of B. 
subtilis NCIB 3610. RNase H proteins are ubiquitous throughout all three domains of life 
and function to remove the RNA component of RNA-DNA hybrids within genomic DNA 
(5; 24). Prior to research presented in Chapter IV, no bacterial species had been 
identified to carry active RNase HI, HII, and HIII proteins. Most bacteria encode active 
RNase HI and HII or RNase HII and HIII proteins (13). While genes encoding all three 
putative RNase H proteins were found in the chromosomes of some species, one of the 
three types of RNase H proteins was found to be inactive (25). The observation that 
organisms lack of all three active RNase H proteins has previously been explained by 
the redundant activity of RNase HI and RNase HIII enzymes, which recognize and 
cleave the same substrates (13; 21; 25; 26). However, in Chapter IV I showed that, 
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despite having activity on the same substrates, the RNase HI and HIII proteins in B. 
subtilis cleave the substrates at different locations within the hybrids, which could affect 
the accessibility and efficiency of downstream repair proteins (26). Thus, RNase HI and 
HIII enzymes could have varying efficiencies for resolving the overlapping substrates 
that occur during varied cellular processes.  In the next section I describe open areas of 
research to further investigate if RNase HI and HIII are redundant in function and how 
these enzymes contribute to genome maintenance in B. subtilis.  
 
Contribution of plasmid-borne RNase HI to genome maintenance. The different 
incision preferences of RNase HI and HIII from B. subtilis NCIB 3610 on ribopatch, 
Okazaki fragment, and hybridized RNA-DNA substrates could affect the accessibility 
and efficiency of downstream repair proteins that remove the remaining RNA, fill the 
gaps with DNA, and ligate the break in the DNA backbone (26). Variation of efficiencies 
in RNase HI and HIII-based repair pathways could in turn explain how both enzymes 
co-exist in the same genome. To test the efficiency of hybrid resolution, DNA 
polymerase I (Pol I) extension assays can be completed, as done previously in the 
Simmons lab, wherein various hybrid substrates are incubated with DNA polymerase I 
subsequent to incubation with RNase HI or RNase HIII to assay for the efficiency of 
extension from the RNase H treated hybrid substrates (26). In previous experiments it 
was found that treatment with RNase HIII stimulated Pol I activity on an Okazaki 
fragment substrate to a greater extent than treatment with RNase HII, suggesting that 
differences in incision pattern on various substrates might also affect the efficiency of 
repair between RNase HI and HIII (26).  
 
In addition to challenging the model that RNase HI and HIII are truly functionally 
redundant, the work presented in Chapter IV provides important mechanistic insight into 
the phenotypic effects observed upon loss of RNase HI and HIII activity in B. subtilis. 
Similar to previous reports, I have shown that loss of RNase HI and HIII activities results 
in a cell elongation phenotype and constitutive expression of the DNA damage 
response in normally growing cells (9). Furthermore, using whole genome re-
sequencing I identify the pps operon, encoding genes for production of the antibiotic 
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plipastatin (36), as a locus with decreased sequencing coverage in the strain lacking 
both RNase HI and HIII proteins, suggesting DNA replication and transcription conflicts 
at this region. The pps operon consists of five very long genes totaling ~38 kb in length 
that are all oriented in the head-on direction relative to DNA replication. In unpublished 
work from the Simmons and Freddolino labs, this region has also been shown to 
accumulate RNA-DNA hybrids in the lab strain B. subtilis PY79. In a separate set of 
unpublished experiments, we show that deletion of the entire pps operon results in loss 
of the constitutive SOS induction phenotype observed in cells lacking RNase HI and 
HIII, suggesting that replication conflicts at the pps operon are responsible for the 
replication conflicts that induce the SOS response. Intriguingly, despite the loss of SOS 
response induction, cells lacking both RNase HI and HIII activity are still elongated in 
the absence of the pps operon, suggesting that the cell elongation phenotype is either 
independent of the SOS response or that the microscopy-based reporter assay used to 
determine the status of the SOS response is not sensitive enough to account for the 
expression changes that result in cell elongation. While much of the work in Chapter IV 
establishes a foundation for future studies, further work will need to be done to 
understand the mechanism(s) of cell elongation and SOS induction upon loss of RNase 
HI and RNase HIII activity in B. subtilis NCIB 3610. 
 
To my knowledge, all previous studies have limited the search of functional RNase H 
proteins to the chromosome (13). As shown in Chapter IV, while the ancestral strain B. 
subtilis NCIB 3160 does not encode a functional RNase HI protein on the chromosome, 
the plasmid encoded RNase HI is functional. Moreover, while the chromosomally 
encoded RNase HIII protein appears to be necessary for plasmid hyper-replication, the 
plasmid encoded RNase HI is not, and appears instead to contribute to genome 
maintenance and survival of cellular stress. The research presented in Chapter IV 
challenges the current opinion in the field that RNase HI and HIII are mutually exclusive 
and encourages researchers to investigate the contributions of plasmid-encoded RNase 
H proteins to genome maintenance in bacteria. 
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Conclusion 
In this thesis I have investigated the physiological consequences of modifications to 
genomic DNA in the form of both DNA methylation and RNA misincorporation events. In 
Chapters II and III I describe how DNA methylation in Gram-positive S. pyogenes and 
B. subtilis regulates gene expression in both bacteria (Chapters II and III (22; 23)). This 
work provided some of the first investigation into the regulatory effects of DNA 
methylation outside of phase variation in Firmicutes, and demonstrated that DNA 
methylation could be an important contributor to virulence in other Gram-positive 
pathogens as well. In Chapter IV I show that the ancestral strain of B. subtilis encodes 
functional RNase HI, HII, and HIII enzymes for the removal of RNA incorporated into 
DNA, providing the first example of an organism that encodes all three active RNase H 
enzymes.  
 
As described throughout this thesis, despite the importance and prevalence of DNA 
methylation across bacteria, few studies have investigated the regulatory effects of DNA 
methylation in Gram-positive bacteria outside of phase variable MTases in 
Streptococcus species. The Firmicutes phylum includes many important Gram-positive 
pathogens that represent significant public health burdens. My work strongly suggests 
that interference of DNA MTase activity would not only make pathogens such as S. 
pyogenes more susceptible to phage predation but can also severely attenuate the 
virulence potential of these pathogens. I predict that further study of DNA MTases 
across Firmicutes will reveal important regulatory roles in pathogenicity and 
development, providing strong candidates for vaccine development and therapeutic 
interventions in Gram-positive bacteria during a period of emerging antibiotic resistance.  
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